{"title": "Henry Seth Friedman", "author": null, "url": null, "hostname": null, "description": "Henry Seth Friedman | Scholars@Duke profile: Publications", "sitename": null, "date": "1995-01-19", "cleaned_text": "Selected Publications Journal Article Lancet Child Adolesc Health \u00b7 July 2023 BACKGROUND: Outcomes of recurrent paediatric high-grade glioma are poor, with a median overall survival of less than 6 months. Viral immunotherapy, such as the polio-rhinovirus chimera lerapolturev, is a novel for treatment [Recombinant 2022 [CTIM-15. OF A PHASE IB TRIAL OF RECOMBINANT POLIO:RHINOVIRUS IMMUNOTHERAPY FOR RECURRENT 2022 [QOL-08. PHASE II RANDOMIZED STUDY TO EVALUATE EFFICACY AND SATISFACTION OF ROLAPITANT PLUS ONDANSETRON VS. ONDANSETRON Care Cancer \u00b7 April 2022 PURPOSE: At diagnosis and throughout the disease course, patients with high-grade glioma (HGG) experience a diminished quality of life (QOL) and increased fatigue. Naltrexone, an orally semisynthetic opiate antagonist, of ... naltrexone (World Health Organization [WHO] grade 2) and malignant (WHO grade 3) meningiomas have high rates of local recurrence, and questions remain about the role of adjuvant radiation therapy (RT) for patients with WHO grade 2 disease. These pat ... [Long-Term Outcomes for Patients With Atypical or Malignant Meningiomas Treated With or Without Radiation Therapy: A 25-Year Retrospective Analysis of and mutant-specific (EGFRvIII) monoclonal antibody (Ab) fragment and a genetically engineered form of the Pseudomonas exotoxin. When injected dir ... [A phase 1 in Fc-engineered anti-CD40 monoclonal antibody (2141-V11) administered intratumorally via convectionenhanced delivery with (MG). ](/publication/1555277) [Full text](https://dx.doi.org/10.1200/JCO.2022.40.16_suppl.e14015) [Link (HGGs) are immunologically 'cold' tumors. This phenomenon is partly due to reduced expression of major histocompatibility class (MHC) I on the surface of tumor cells, which prevents CD8+ cytotoxic T lymphocyte activity (CTLs) [Reproducibility of outcomes in sequential ADMINISTERED INTRATUMORALLY WITH 2021 AbstractINTRODUCTIONThere is increasing recognition that palliative care (PC) can benefit patients with advanced cancers. However, ear ... [QOLP-28. COMPARING KNOWLEDGE OF AND BELIEFS ABOUT PALLIATIVE CARE AMONG NEURO-ONCOLOGY PATIENTS, CAREGIVERS, PROVIDERS AND (IDH1) is commonly mutated in grade II-III gliomas, and the mutant enzyme leads to the production of the oncometabolite 2-hydroxyglutarate (2-HG). 2-HG is responsible for t ... RESPONSE AND SEIZURE CONTROL AbstractINTRODUCTIONVaccination with dendritic cells (DCs) fares poorly Moreover, September 1, 2021 Purpose: To describe our population of primary brain tumor (PBT) patients, a subgroup of cancer patients whose intensive care unit (ICU) outcomes are understudied. Methods: Retrospective analysis of PBT patients admitted to an ICU between 2013 to 2018 for ... [Primary brain tumor patients admitted to a US intensive care unit: a descriptive 2021 BACKGROUND: Spirituality can impact patients' attitudes and decisions about treatment and end-of-life care when coping with cancer. Previous studies documented health-related quality of life (HRQoL) and spiritual well-being (SWB) as positively correlated w ... [Spiritual well-being and its association with health-related quality of life in primary brain tumor patients. ](/publication/1484423) [Full text](https://dx.doi.org/10.1093/nop/npaa084) [Link to item](https://www.ncbi.nlm.nih.gov/pubmed/34055377) [Cite](/publication/1484423#cite) \u00b7 May 20, 2021 TPS2065 Background: The prognosis for patients (pts) with recurrent (r) glioblastoma (GBM) is poor, with no highly effective approved therapies. Treatment failure may result from poor penetration of drugs through the blood-brain ... [LUMINOS-101: Phase 2 study ](/publication/1502701) [Full Commun \u00b7 13, 2021 Several immunotherapy clinical trials in recurrent glioblastoma have reported long-term survival benefits in 10-20% of patients. Here we perform genomic analysis of tumor tissue from recurrent WHO grade IV glioblastoma patients acquired prior to immunother ... [Very low mutation burden is a feature of Standard 6-week and hypofractionated 3-week courses of adjuvant radiation therapy (RT) are both options for older patients with glioblastoma (GBM), but deciding the optimal regimen can be challenging. This analysis explores clinical factors ass ... [Adjuvant Radiation in Older Patients With Glioblastoma: A Oncology*Biology*Physics \u00b7 September 1, 2020 2230 ... [Outcomes Following Adjuvant Radiation Therapy in Elderly Patients with Glioblastoma: A Retrospective Single Institution Analysis ](/publication/1414293) [Full text](https://dx.doi.org/10.1016/j.ijrobp.2019.06.2296) [Link to item](https://www.sciencedirect.com/science/article/pii/S0360301619331311?via%3Dihub) [Cite](/publication/1414293#cite) Journal Article Ca Cancer J Clin \u00b7 July 2020 Glioblastoma is the most common malignant primary brain tumor. Overall, the prognosis for patients with this disease is poor, with a median survival of <2 years. There is a slight predominance in males, and incidence increases with age. The standard approa ... [Management of glioblastoma: State of the ](/publication/1446606) [Full text](https://dx.doi.org/10.3322/caac.21613) [Link to item](https://www.ncbi.nlm.nih.gov/pubmed/32478924) [Cite](/publication/1446606#cite) Conference \u00b7 May 20, 2566 ... [Phase D2C7 immunotoxin (D2C7-IT) [Full [Link to item](https://ascopubs.org/doi/10.1200/JCO.2020.38.15_suppl.2566) [Cite](/publication/1458260#cite) Lancet Child Adolesc Health \u00b7 July 2023 BACKGROUND: Outcomes of recurrent paediatric high-grade glioma are poor, with a median overall survival of less than 6 months. Viral immunotherapy, such as the polio-rhinovirus chimera lerapolturev, is a novel for treatment [Recombinant 2022 [CTIM-15. OF A PHASE IB TRIAL OF RECOMBINANT POLIO:RHINOVIRUS IMMUNOTHERAPY FOR RECURRENT 2022 [QOL-08. PHASE II RANDOMIZED STUDY TO EVALUATE EFFICACY AND SATISFACTION OF ROLAPITANT PLUS ONDANSETRON VS. ONDANSETRON Care Cancer \u00b7 April 2022 PURPOSE: At diagnosis and throughout the disease course, patients with high-grade glioma (HGG) experience a diminished quality of life (QOL) and increased fatigue. Naltrexone, an orally semisynthetic opiate antagonist, of ... naltrexone (World Health Organization [WHO] grade 2) and malignant (WHO grade 3) meningiomas have high rates of local recurrence, and questions remain about the role of adjuvant radiation therapy (RT) for patients with WHO grade 2 disease. These pat ... [Long-Term Outcomes for Patients With Atypical or Malignant Meningiomas Treated With or Without Radiation Therapy: A 25-Year Retrospective Analysis of and mutant-specific (EGFRvIII) monoclonal antibody (Ab) fragment and a genetically engineered form of the Pseudomonas exotoxin. When injected dir ... [A phase 1 in Fc-engineered anti-CD40 monoclonal antibody (2141-V11) administered intratumorally via convectionenhanced delivery with (MG). ](/publication/1555277) [Full text](https://dx.doi.org/10.1200/JCO.2022.40.16_suppl.e14015) [Link (HGGs) are immunologically 'cold' tumors. This phenomenon is partly due to reduced expression of major histocompatibility class (MHC) I on the surface of tumor cells, which prevents CD8+ cytotoxic T lymphocyte activity (CTLs) [Reproducibility of outcomes in sequential ADMINISTERED INTRATUMORALLY WITH 2021 AbstractINTRODUCTIONThere is increasing recognition that palliative care (PC) can benefit patients with advanced cancers. However, ear ... [QOLP-28. COMPARING KNOWLEDGE OF AND BELIEFS ABOUT PALLIATIVE CARE AMONG NEURO-ONCOLOGY PATIENTS, CAREGIVERS, PROVIDERS AND (IDH1) is commonly mutated in grade II-III gliomas, and the mutant enzyme leads to the production of the oncometabolite 2-hydroxyglutarate (2-HG). 2-HG is responsible for t ... RESPONSE AND SEIZURE CONTROL AbstractINTRODUCTIONVaccination with dendritic cells (DCs) fares poorly Moreover, September 1, 2021 Purpose: To describe our population of primary brain tumor (PBT) patients, a subgroup of cancer patients whose intensive care unit (ICU) outcomes are understudied. Methods: Retrospective analysis of PBT patients admitted to an ICU between 2013 to 2018 for ... [Primary brain tumor patients admitted to a US intensive care unit: a descriptive 2021 BACKGROUND: Spirituality can impact patients' attitudes and decisions about treatment and end-of-life care when coping with cancer. Previous studies documented health-related quality of life (HRQoL) and spiritual well-being (SWB) as positively correlated w ... [Spiritual well-being and its association with health-related quality of life in primary brain tumor patients. ](/publication/1484423) [Full text](https://dx.doi.org/10.1093/nop/npaa084) [Link to item](https://www.ncbi.nlm.nih.gov/pubmed/34055377) [Cite](/publication/1484423#cite) \u00b7 May 20, 2021 TPS2065 Background: The prognosis for patients (pts) with recurrent (r) glioblastoma (GBM) is poor, with no highly effective approved therapies. Treatment failure may result from poor penetration of drugs through the blood-brain ... [LUMINOS-101: Phase 2 study ](/publication/1502701) [Full Commun \u00b7 13, 2021 Several immunotherapy clinical trials in recurrent glioblastoma have reported long-term survival benefits in 10-20% of patients. Here we perform genomic analysis of tumor tissue from recurrent WHO grade IV glioblastoma patients acquired prior to immunother ... [Very low mutation burden is a feature of Standard 6-week and hypofractionated 3-week courses of adjuvant radiation therapy (RT) are both options for older patients with glioblastoma (GBM), but deciding the optimal regimen can be challenging. This analysis explores clinical factors ass ... [Adjuvant Radiation in Older Patients With Glioblastoma: A Oncology*Biology*Physics \u00b7 September 1, 2020 2230 ... [Outcomes Following Adjuvant Radiation Therapy in Elderly Patients with Glioblastoma: A Retrospective Single Institution Analysis ](/publication/1414293) [Full text](https://dx.doi.org/10.1016/j.ijrobp.2019.06.2296) [Link to item](https://www.sciencedirect.com/science/article/pii/S0360301619331311?via%3Dihub) [Cite](/publication/1414293#cite) Journal Article Ca Cancer J Clin \u00b7 July 2020 Glioblastoma is the most common malignant primary brain tumor. Overall, the prognosis for patients with this disease is poor, with a median survival of <2 years. There is a slight predominance in males, and incidence increases with age. The standard approa ... [Management of glioblastoma: State of the ](/publication/1446606) [Full text](https://dx.doi.org/10.3322/caac.21613) [Link to item](https://www.ncbi.nlm.nih.gov/pubmed/32478924) [Cite](/publication/1446606#cite) Conference \u00b7 May 20, 2566 ... [Phase D2C7 immunotoxin (D2C7-IT) [Full text](https://dx.doi.org/10.1200/JCO.2020.38.15_suppl.2566) [Link to item](https://ascopubs.org/doi/10.1200/JCO.2020.38.15_suppl.2566) [Cite](/publication/1458260#cite) Support Care Cancer \u00b7 May 2020 PURPOSE: CINV remains a distressing side effect experienced by glioma patients receiving multi-day temozolomide therapy, in spite of guideline-based antiemetic therapy with Antiemetic research with aprepitant ... trial of 5-day aprepitant plus ondansetron compared to ondansetron alone in the prevention of chemotherapy-induced April 2020 PURPOSE: Primary central nervous system lymphoma (PCNSL) is a subtype of non-Hodgkin's lymphoma that involves the brain, spinal cord, or leptomeninges, without evidence of systemic disease. This rare disease accounts for ~ 3% of all primary central nervous ... [Patterns of relapse after successful completion of initial therapy in primary central nervous system lymphoma: a case series. ](/publication/1288553) [Full text](https://dx.doi.org/10.1007/s11060-020-03446-3) [Link to item](https://www.ncbi.nlm.nih.gov/pubmed/32140975) Cancer \u00b7 2020 MASCC20-ABS-1534 ... [Cognitive Outcomes of Phase I Trial of Novel Metalloporphyrin Radioprotectant and Radiosensitizer in Newly Diagnosed High Grade Glioma Patients. ](/publication/1458678) [Cite](/publication/1458678#cite) Conference Journal of Clinical Oncology \u00b7 [Phase trial of D2C7 immunotoxin (D2C7-IT) administered intratumorally via delivery [Link to item](https://www.webofscience.com/api/gateway?GWVersion=2&SrcApp=PARTNER_APP&SrcAuth=LinksAMR&KeyUT=WOS:000560368301261&DestLinkType=FullRecord&DestApp=ALL_WOS&UsrCustomerID=47d3190e77e5a3a53558812f597b0b92) [Cite](/publication/1467315#cite) Journal 1, 2019 Aim: Central neurocytoma (CN) is a rare WHO grade II central nervous system (CNS) tumor. This is an update on chemotherapeutic agents used in its treatment. Patients & methods: An institutional review board-approved, chart review of patients seen at our in ... [The role of chemotherapy in the 2019 BACKGROUND: Overall survival (OS) in glioblastoma (GBM) is poor at an average of 14 to 18 months, and long-term survivors (LTS) of GBM are rare. LTS of GBM, defined as surviving >5 years postdiagnosis, represent only 2% to 10% of all GBM patients. LTS of c ... [Second primary cancers in text](https://dx.doi.org/10.1093/nop/npz001) [Link to item](https://www.ncbi.nlm.nih.gov/pubmed/31555453) [Cite](/publication/1411790#cite) Oncology*Biology*Physics \u00b7 September 2019 2239 ... [First in Human Clinical Trial of a Metalloporphyrin Radioprotectant and Radiosensitizer, BMX-001, Pract \u00b7 August 2019 BACKGROUND AND PURPOSE: Little is known about complementary and integrative health intervention usage in the primary brain tumor population. We aimed to identify the percentage of patients using these practices and explore the impact on quality of life. MA ... [Complementary and integrative health interventions and their association with health-related quality of life in the primary brain tumor population. ](/publication/1387989) [Full text](https://dx.doi.org/10.1016/j.ctcp.2019.05.002) [Link to item](https://www.ncbi.nlm.nih.gov/pubmed/31383442) [Cite](/publication/1387989#cite) Journal Article Cancer July 1, 2019 Homozygous deletion of methylthioadenosine phosphorylase (MTAP) is one of the most frequent genetic alterations in glioblastoma (GBM), but its pathologic consequences remain unclear. In this study, we report that loss of MTAP results in profound epigenetic ... [MTAP Loss Promotes Stemness in Glioblastoma [Full [Link to item](https://www.ncbi.nlm.nih.gov/pubmed/31040154) [Cite](/publication/1382631#cite) 20, 2019 e13526 Background: Recurrence of high-grade glioma (HGG) (WHO grade III-IV) is a nearly universal phenomenon and necessitates the development of new therapeutic modalities. Two possible immunotherapeutic modalities are checkpoint ... [Safety of nivolumab in high-grade ](/publication/1415015) [Full text](https://dx.doi.org/10.1200/jco.2019.37.15_suppl.e13526) [Cite](/publication/1415015#cite) Conference \u00b7 May 20, 2019 2060 Background: We completed a study evaluating a single intratumoral delivery of PVSRIPO in recurrent WHO grade IV MG patients (N Engl J Med. 2018 Jul 12;379(2):150-161). Some patients who originally benefitted from the infusion of PVSRIPO demonstrated ... [Oncolytic polio/rhinovirus recombinant (PVSRIPO) against WHO grade IV malignant glioma (MG): Experience with retreatment of survivors from the ](/publication/1415615) [Full text](https://dx.doi.org/10.1200/JCO.2019.37.15_suppl.2060) [Link to item](https://ascopubs.org/doi/10.1200/JCO.2019.37.15_suppl.2060) [Cite](/publication/1415615#cite) Conference Neurology \u00b7 April 16, 2019 [Primary brain tumors admitted to the neurological intensive care unit: a single institution observational study. ](/publication/1459067) [Link to item](https://n.neurology.org/content/92/15_Supplement/P1.6-009) [Cite](/publication/1459067#cite) Journal Article Health Sci Rep \u00b7 April 2019 BACKGROUND AND AIMS: This retrospective review of patients with recurrent glioblastoma treated at the Preston Robert Tisch Brain Tumor Center investigated treatment patterns, survival, and safety with bevacizumab in a real-world setting. METHODS: Adult pat ... [Single-institution retrospective review of patients with recurrent glioblastoma treated with bevacizumab in clinical practice. ](/publication/1383103) \u00b7 January 1, 2019 Glioma therapeutic resistance to alkylating chemotherapy is mediated via O6-methylguanine-DNA methyltransferase (MGMT). We hypothesized that a CD45/HAM56/MGMT double-stained cocktail would improve MGMT discrimination in tumor cells versus inflammatory and of a nomogram for IDH-wild-type survival December 2018 OBJECTIVES: To describe the adaptability to the patterns in symptoms and quality of life (QoL) during 6 months post low-grade glioma diagnosis by valid and reliable tools; to identify through qualitative interviews patient/provider adaptive techniques and ... [Pilot Study to Describe the Trajectory of Symptoms and Adaptive Strategies of Adults Living Glioma. \u00b7 August 2018 LESSONS LEARNED: Due to evolving imaging criteria in brain tumors and variation in magnetic resonance imaging evaluation, it is not ideal to use response rate as a primary objective. Future studies involving antiangiogenic agents should use overall surviva ... [Phase II Study to Evaluate the Efficacy and Safety of Rilotumumab and Bevacizumab in Subjects with to item](https://www.ncbi.nlm.nih.gov/pubmed/29666296) [Cite](/publication/1313731#cite) Journal Engl J Med \u00b7 July 12, 2018 BACKGROUND: The prognosis of patients with recurrent World Health Organization (WHO) grade IV malignant glioma is dismal, and there is currently no effective therapy. We conducted a dose-finding and toxicity study in this population of patients, evaluating ... [Recurrent Glioblastoma \u00b7 July 2018 BACKGROUND: Sym004 is a mixture of monoclonal antibodies and modotuximab, targeting non-overlapping epitopes on the epidermal growth factor receptor (EGFR). Previous studies have shown that Sym004 is more efficient at inducing interna ... [Sym004-induced EGFR elimination is associated POLIO VACCINE SABIN-RHINOVIRUS POLIOVIRUS (PVSRIPO) IN to item](http://gateway.webofknowledge.com/gateway/Gateway.cgi?GWVersion=2&SrcApp=PARTNER_APP&SrcAuth=LinksAMR&KeyUT=WOS:000438339000296&DestLinkType=FullRecord&DestApp=ALL_WOS&UsrCustomerID=47d3190e77e5a3a53558812f597b0b92) [Cite](/publication/1335932#cite) Journal Article Nat Commun \u00b7 May 25, 2018 The majority of glioblastomas can be classified into molecular subgroups based on mutations in the TERT promoter (TERTp) and isocitrate dehydrogenase 1 or 2 (IDH). These molecular subgroups utilize distinct genetic mechanisms of telomere maintenance, eithe 27, 2018 150 ... [Long-term outcomes of adult patients with ependymoma. ](/publication/1458264) [Link to item](https://n.neurology.org/content/90/15_Supplement/P6.150.abstract) [Cite](/publication/1458264#cite) Journal Article Neurology \u00b7 April 10, 2018 150 ... [Long-term outcomes of adult patients with ependymoma. ](/publication/1459076) [Link to item](https://n.neurology.org/content/90/15_Supplement/P6.150.abstract) [Cite](/publication/1459076#cite) Conference Neurology \u00b7 April 9, 2018 158 Objective: The purpose of this study is to analyze adult patients with pilocytic astrocytomas and to identify factors associated with recurrence and survival. Background: Pilocytic astrocytomas (WHO grade I) represent the most common central nervous s ... [Adult pilocytic astrocytoma: item](https://n.neurology.org/content/90/15_Supplement/P6.158.abstract) [Cite](/publication/1460332#cite) Journal Article J Neurooncol \u00b7 April 2018 Prognosis of recurrent glioblastoma (GBM) is poor with 6-month progression-free survival (PFS6) ranging from 9 to 48% depending on the treatment regimen and use of anti-angiogenic therapies. We sought to study vorinostat (VOR), [Link to item](https://www.ncbi.nlm.nih.gov/pubmed/29264836) [Cite](/publication/1292729#cite) Journal Article Cancer Causes Control \u00b7 March 2018 PURPOSE: The Caribbean population faces a growing burden of multiple non-communicable chronic diseases (NCDs). Breast cancer is the leading cause of cancer death for women in the Caribbean. Given the substantial burden of NCDs across the region, cancer pre ... [Non-communicable chronic diseases and timely breast cancer screening among women of the Eastern Caribbean Health Outcomes Research Network (ECHORN) Cohort Study. ](/publication/1504645) [Full text](https://dx.doi.org/10.1007/s10552-018-1005-4) [Link to Article LESSONS LEARNED: Combination regimen with bevacizumab (BEV) and vorinostat is well tolerated in patients with recurrent glioblastoma.Treatment of recurrent glioblastoma remains challenging as this study and others attempt to improve progression-free surviv ... [Phase II Study of Bevacizumab and Vorinostat for Patients with Recurrent World Health Organization Grade 4 Malignant Glioma. ](/publication/1286027) [Full text](https://dx.doi.org/10.1634/theoncologist.2017-0501) [Link to item](https://www.ncbi.nlm.nih.gov/pubmed/29133513) [Cite](/publication/1286027#cite) Journal Article Cancer Res \u00b7 January 1, 2018 Median survival for glioblastoma (GBM) remains <15 months. Human cytomegalovirus (CMV) antigens have been identified in GBM but not normal brain, providing an unparalleled opportunity to subvert CMV antigens as tumor-specific immunotherapy Polyfunctionality text](https://dx.doi.org/10.1158/0008-5472.CAN-17-0469) [Link to item](https://www.ncbi.nlm.nih.gov/pubmed/29093005) [Cite](/publication/1284281#cite) Journal Article Cancer Res \u00b7 January 1, 2018 Hotspot mutations in the isocitrate dehydrogenase 1 (IDH1) gene occur in a number of human cancers and confer a neomorphic enzyme activity that catalyzes the conversion of oncometabolite Epilepsy Behav Case Rep \u00b7 2018 Glioma-associated epilepsy is associated with excessive glutamate signaling. We hypothesized that perampanel, an amino-3-hydroxy-5-methyl-4-isoxazolepropionic acid (AMPA)-type glutamate receptor [A SINGLE INSTITUTION'S EXPERIENCE EXPLORING THE ASSOCIATION OF 1, 2017 [INCREASED FATIGUE ASSOCIATED WITH TUMOR PROGRESSION IN NEWLY DIAGNOSED PATIENTS ](/publication/1288523) [Link November 2017 [MAINTENANCE OF HEALTH RELATED QUALITY OF LIFE (QOL) BEYOND PROGRESSION IN NEWLY DIAGNOSED GLIOBLASTOMA PATIENTS TREATED ](/publication/1288525) [Link [PHASE 2 2017 [PERAMPANEL OF IN [Link RATE-36 Primary central system lymphoma (PCNSL) is a subtype of non-Hodgkin's lymphoma that involves the brain, spinal cord or leptomeninges, without evidence of systemic disease. This rare disease accounts for ~3% of all primary centr ... [PATTERNS OF RELAPSE AFTER SUCCESSFUL COMPLETION OF INITIAL THERAPY IN PRIMARY CENTRAL NERVOUS SYSTEM LYMPHOMA ](/publication/1458265) [Full text](https://dx.doi.org/10.1093/neuonc/nox168.878) [Link Neurooncol \u00b7 September 2017 Primary brain tumor patients experience high levels of distress. The purpose of this cross-sectional, retrospective study is to evaluate the level and different sources of psychosocial distress and how these pertain to health-related quality of life (HRQoL ... [A cross sectional analysis from a single institution's experience of psychosocial distress and health-related quality of life in the primary brain tumor population. ](/publication/1264108) [Full text](https://dx.doi.org/10.1007/s11060-017-2535-4) [Link to item](https://www.ncbi.nlm.nih.gov/pubmed/28669010) \u00b7 June 2017 BACKGROUND: Children with high-risk medulloblastoma historically have had a poor prognosis. The Children's Oncology Group completed a Phase II study using oral etoposide given with radiotherapy followed by intensive chemotherapy. PROCEDURE: Patients enroll ... [A Phase II feasibility study of oral etoposide given concurrently with radiotherapy followed by dose intensive adjuvant chemotherapy for children with newly diagnosed high-risk medulloblastoma (protocol POG 9631): A 20, 2017 e13533 Background: The live attenuated oral poliovirus vaccine was modified to contain a heterologous internal ribosomal entry site stemming from human rhinovirus type 2, creating PVSRIPO. PVSRIPO recognizes CD155, an oncofetal c ... [Dose the intratumoral administration of the oncolytic polio/rhinovirus recombinant (PVSRIPO) against [Full [Link to item](https://ascopubs.org/doi/10.1200/JCO.2017.35.15_suppl.e13533) May 20, 2017 e21636 Background: At diagnosis, GBM patients face the immediate challenge of significant morbidity and mortality. In this population, we have shown that better exercise behavior is an independent prognostic factor for improved s ... [Reductions in exercise behavior and tumor progression in newly (GBM) 27, 2017 Objective: To evaluate the feasibility and safety of administering brain tumor stem cell (BTSC) mRNA-loaded dendritic cells (DC) to patients with recurrent GBM. Background: BTSC CD133+ contribute to GBM propagation chemo-radiation ... [Tumor stem cell RNA-leaded dedritic cell vaccine for a phase 1 trail. ](/publication/1459087) [Link to item](https://n.neurology.org/content/88/16_Supplement/S41.004) [Cite](/publication/1459087#cite) Journal Article Clin Cancer Res \u00b7 April 15, 2017 Purpose: Patients with glioblastoma have less than 15-month median survival despite surgical resection, high-dose radiation, and chemotherapy with temozolomide. We previously demonstrated that targeting cytomegalovirus pp65 using dendritic cells (DC) can e \u00b7 2017 PURPOSE: Given that the prognosis of recurrent malignant glioma (MG) remains poor, improving quality of life (QoL) through symptom management is important. Meta-analyses establishing antiemetic guidelines have demonstrated the superiority of palonosetron ( ... [A Phase II single-arm trial of palonosetron for the prevention of acute and delayed chemotherapy-induced nausea and vomiting in malignant glioma patients receiving \u00b7 January 1, 2017 [The critical role of nonhuman primates in [Full text](https://dx.doi.org/10.20411/pai.v2i3.186) [Cite](/publication/1504644#cite) Journal Article Cns Oncol \u00b7 October 2016 All cancer patients experience distress from the diagnosis, the effects of the disease or the treatment. Clinically significant distress decreases overall quality of life and the recognition of distress with prompt intervention is essential. The National C ... [Psychosocial distress and its effects on the health-related quality of life of primary brain tumor patients. ](/publication/1084023) [Full text](https://dx.doi.org/10.2217/cns-2016-0010) [Link Biol Phys \u00b7 October 1, 2016 [Long-Term Outcomes for Patients With Atypical or Malignant Meningiomas Treated With Radiation Therapy: text](https://dx.doi.org/10.1016/j.ijrobp.2016.06.802) [Link to [Cite](/publication/1146592#cite) Conference Support Care Cancer \u00b7 October 2016 BACKGROUND: In malignant glioma (MG) patients undergoing radiation therapy (RT) with concomitant temozolomide, chemoradiation-induced nausea and vomiting (cRINV) degrades quality of life (QoL) and reduces treatment adherence, which thereby potentially comp ... [Phase II study to evaluate the safety and efficacy of intravenous palonosetron (PAL) in primary malignant glioma (MG) patients receiving (RT) Oncology \u00b7 May 20, 2016 Background: The live attenuated oral (SABIN) serotype 1 poliovirus vaccine was modified to contain a heterologous internal ribosomal entry site stemming from human rhinovirus type 2, creating PVSRIPO. PVSRIPO recognizes CD155, an oncofetal cell adhesion mo ... [Patient survival on the dose escalation phase of the Oncolytic Polio/Rhinovirus Recombinant (PVSRIPO) against WHO grade IV malignant glioma (MG) clinical trial compared to historical controls. ](/publication/1266745) [Full text](https://dx.doi.org/10.1200/jco.2016.34.15_suppl.2061) [Link to item](https://ascopubs.org/doi/10.1200/JCO.2016.34.15_suppl.2061) [Cite](/publication/1266745#cite) Conference Journal of Oncology \u00b7 May 20, 2016 ackground: The inherent biologic specificity of immunotherapy offers the prospect of targeting neoplastic cells more precisely. Dendritic cells (DCs) are endowed with an extraordinary ability to activate CD4+ and CD8+ T-cells, and DCs loaded with combination against cytomegalovirus (CMV) Clinical Oncology \u00b7 May 20, 2016 Background: Overall survival of patients with glioblastoma (GBM) remains dismal with range from 12-14 months. In addition to the oncologic burden that these patients face during the disease trajectory, there are demonstrable neurologic and cognitive challe ... [Baseline cognitive function ](/publication/1402771) [Full text](https://dx.doi.org/10.1200/jco.2016.34.15_suppl.10125) [Link to item](https://ascopubs.org/doi/10.1200/JCO.2016.34.15_suppl.10125) [Cite](/publication/1402771#cite) Book \u00b7 March 31, 2016 The management of patients with a glioma is challenging and best achieved by a team approach encompassing a combination of chemotherapy, radiotherapy, immunotherapy, and surgical excision in a specialist Cancer Center - the balance of treatment depending o ... [The Duke glioma handbook: Pathology, diagnosis, and management text](https://dx.doi.org/10.1017/CBO9781107588721.005) [Cite](/publication/1319080#cite) Journal Article Oncology (Williston Park) \u00b7 March 2016 After years of active research and refinement, vaccine therapy and oncolytic viruses are becoming part of the arsenal in the treatment of gliomas. In contrast to standard treatment with radiation therapy and chemotherapy, vaccines are more specific to the ... [Vaccine Therapy, Oncolytic Viruses, and [Cite](/publication/1129415#cite) Journal Article J Biol Chem \u00b7 December 25, 2015 Under normal physiologic conditions, the glutathione S-transferase P1 (GSTP1) protein exists intracellularly as a dimer in reversible equilibrium with its monomeric subunits. In the latter form, GSTP1 binds to GSTP1-c-Jun N-terminal kinase (JNK) Complex and Suppresses JNK [Full text](https://dx.doi.org/10.1074/jbc.M115.656140) [Link to item](https://www.ncbi.nlm.nih.gov/pubmed/26429914) [Cite](/publication/1091555#cite) Conference International Journal of Radiation Oncology*Biology*Physics \u00b7 November 2015 [Outcomes for Patients With Intracranial Meningiomas Treated With Radiation therapy Bevacizumab: A Analysis ](/publication/1130879) [Full text](https://dx.doi.org/10.1016/j.ijrobp.2015.07.813) [Cite](/publication/1130879#cite) Journal Article Oncologist LEARNED: Trials focusing on unresectable multifocal glioblastoma are needed because of the extremely poor prognosis and challenges in receiving standard therapy, such as concurrent radiation and chemotherapy.Developing a strategy to chemically debu ... [Phase II Clinical Oncology \u00b7 May 20, 2015 [Secondary cancers in long-term survivors of primary glioblastoma. ](/publication/1084021) [Link to item](http://gateway.webofknowledge.com/gateway/Gateway.cgi?GWVersion=2&SrcApp=PARTNER_APP&SrcAuth=LinksAMR&KeyUT=WOS:000358036904232&DestLinkType=FullRecord&DestApp=ALL_WOS&UsrCustomerID=47d3190e77e5a3a53558812f597b0b92) [Cite](/publication/1084021#cite) Conference Journal of Clinical Oncology \u00b7 May 20, 2015 [Phase II study of vorinostat for recurrent [Full text](https://dx.doi.org/10.1200/jco.2015.33.15_suppl.2034) [Cite](/publication/1084022#cite) Journal of Clinical Oncology \u00b7 May 20, 2015 [Phase I study of combination of antitumor immunotherapy targeted against cytomegalovirus (CMV) plus regulatory text](https://dx.doi.org/10.1200/jco.2015.33.15_suppl.e13030) [Cite](/publication/1084025#cite) [Oncolytic polio/rhinovirus recombinant [Cite](/publication/1084027#cite) Clinical Oncology \u00b7 May 20, 2015 [Carboxyamidotriazole orotate (CTO) in combination with bevacizumab (BEV) for adult patients with recurrent Phase 1. ](/publication/1084028) [Full text](https://dx.doi.org/10.1200/jco.2015.33.15_suppl.2067) [Cite](/publication/1084028#cite) of Clinical Oncology \u00b7 May 20, 2015 [Phase 1 clinical trial of carboxyamidotriazole orotate (CTO) in combination with lomustine (CCNU) for adult with recurrent malignant glioma (MG). ](/publication/1084029) [Full text](https://dx.doi.org/10.1200/jco.2015.33.15_suppl.e13004) [Cite](/publication/1084029#cite) Conference Journal \u00b7 20, 2015 2034 ... [Phase II [Link to 210 ... [Placebo-controlled, double-blind, randomized pilot study to evaluate the effects of low-dose naltrexone on quality of life and fatigue in newly diagnosed high-grade glioma. ](/publication/1460565) [Link to item](https://n.neurology.org/content/84/14_Supplement/P4.210) [Cite](/publication/1460565#cite) Journal Article Cancer Immunol Res \u00b7 April 2015 Therapeutic vaccination of patients with cancer-targeting tumor-associated antigens is a promising strategy for the specific eradication of invasive malignancies with minimal toxicity to normal tissues. However, as increasingly potent modalities for stimul ... [Severe adverse immunologic reaction in a patient with glioblastoma receiving autologous dendritic 2015 Histologic grading methods dependent upon H&E staining review have not been shown to reliably predict survival in children with intracranial ependymomas due to the subjectivity of the analytical methods. We hypothesized that the immunohistochemical detecti ... to item](https://www.ncbi.nlm.nih.gov/pubmed/25563815) [Cite](/publication/1055360#cite) \u00b7 March 19, 2015 After stimulation, dendritic cells (DCs) mature and migrate to draining lymph nodes to induce immune responses. As such, autologous DCs generated ex vivo have been pulsed with tumour antigens and injected back patients vacci ... [Tetanus toxoid and CCL3 \u00b7 March 2015 Adoptive cellular therapy (ACT) after lymphodepletive conditioning can induce dramatic clinical responses, but this approach has been largely limited to melanoma due to a lack of reliable methods for expanding tumor-specific lymphocytes from the majority o ... [Novel role of hematopoietic stem cells text](https://dx.doi.org/10.4161/2162402X.2014.994374) [Cite](/publication/1072464#cite) Conference Neurooncol \u00b7 December 2014 Quality of life (QoL) impairment and fatigue are frequently experienced during treatment for recurrent high-grade glioma (HGG). Fatigue and QoL impairments can be due to primary neurological dysfunction, cytotoxic treatments, mood disturbances, and support ... [Impact of health-related quality of life and fatigue on of recurrent glioma patients. ](/publication/1041239) December 2014 Retaspimycin hydrochloride (IPI-504), an Hsp90 (heat shock protein 90) inhibitor, has shown activity in multiple preclinical cancer models, such as lung, breast and ovarian cancers. However, its biological effects in gliomas and normal brain derived cellul ... [Profiling Hsp90 differential expression and the [Cite](/publication/1041402#cite) Article Cancer \u00b7 November 1, 2014 Recently, the century-old idea of targeting cancer with viruses (oncolytic viruses) has come of age, and promise has been documented in early stage and several late-stage clinical trials in a variety of cancers. Although originally prized for their direct ... [Oncolytic polio item](https://www.ncbi.nlm.nih.gov/pubmed/24939611) [Cite](/publication/1033314#cite) Journal Article Support Care Cancer \u00b7 July 2014 PURPOSE: A quality improvement project was implemented to improve adherence to evidence-based antiemetic guidelines for malignant glioma patients treated with moderately emetic chemotherapy (MEC). Poorly controlled chemotherapy-induced nausea and vomiting ... [Adherence to antiemetic guidelines in patients with malignant glioma: a quality improvement project to translate evidence into practice. ](/publication/1023600) [Full text](https://dx.doi.org/10.1007/s00520-014-2136-0) [Link to item](https://www.ncbi.nlm.nih.gov/pubmed/24570103) [Cite](/publication/1023600#cite) Journal Article July 2014 Gliomas arising in the brainstem and thalamus are devastating tumors that are difficult to surgically resect. To determine the genetic and epigenetic landscape of these tumors, we performed exomic sequencing of the live attenuated, oral (SABIN) serotype 1 poliovirus vaccine containing a heterologous internal ribosomal entry site stemming from human rhinovirus type 2. PVSRIPO recognizes nectin-like molecule-5, recombinant (pvsripo) in recurrent glioblastoma (gbm): first trial 2014 The Cancer Genome Atlas (TCGA) Network recently catalogued recurrent genomic abnormalities in glioblastoma (GBM). This genomic profiling lead to the molecular classification of GBMs into four subtypes: Proneural, Neural, Classical and Mesenchymal. Cancer \u00b7 May 28, 2014 MASCC-0215 ... [Complementary and alternative medicine in the primary brain tumor population and its association with health-related quality of life. ](/publication/1460567) [Link to item](https://doi.org/10.1007/s00520-014-2222-3) [Cite](/publication/1460567#cite) Conference Journal of Clinical Oncology \u00b7 May 20, 2014 [Phase I study of the intratumoral administration of an May 20, 2014 [Long-term survivorship in adult primary glioblastoma: Clinical and neurological outcomes of a large, single-center study. ](/publication/1084026) [Full text](https://dx.doi.org/10.1200/jco.2014.32.15_suppl.9519) [Cite](/publication/1084026#cite) Conference Journal T-cell inhibition plus antitumor immunotherapy targeted text](https://dx.doi.org/10.1200/jco.2014.32.15_suppl.3069) [Cite](/publication/1084030#cite) Oncology \u00b7 May 20, 2014 [Single-institution retrospective review of newly diagnosed glioblastoma (GBM) patients (pts) treated on bevacizumab (BEV) in clinical ](/publication/1085395) [Full text](https://dx.doi.org/10.1200/jco.2014.32.15_suppl.2082) [Cite](/publication/1085395#cite) Conference Journal of Clinical Oncology \u00b7 [Randomized phase IIb study of nivolumab (anti-PD-1; BMS-936558, ONO-4538) alone or in combination with ipilimumab (pts) with [Full text](https://dx.doi.org/10.1200/jco.2014.32.15_suppl.tps2101) [Cite](/publication/1085397#cite) Journal Article 30, 2014 Frequent mutations in isocitrate dehydrogenase 1 and 2 (IDH1 and IDH2) and the promoter of telomerase reverse transcriptase (TERT) represent two significant discoveries in glioma genomics. Understanding the degree to which these two mutations co-occur or o ... [Mutations in IDH1, IDH2, and in the TERT promoter define clinically distinct adult 30, 2014 Anaplastic astrocytoma WHO grade III (A3) is a lethal brain tumor that often occurs in middle aged patients. Clinically, it is challenging to distinguish A3 from glioblastoma multiforme (GBM) WHO grade IV. To reveal the genetic landscape of this tumor type ... [The genetic item](https://www.ncbi.nlm.nih.gov/pubmed/24140581) Nature Genetics \u00b7 January 1, 2014 Gliomas arising in the brainstem and thalamus are devastating tumors that are difficult to surgically resect. To determine the genetic and epigenetic landscape of these tumors, we performed exomic sequencing of ](/publication/1039923) [Full text](https://dx.doi.org/10.2217/cns.13.53) to item](https://www.ncbi.nlm.nih.gov/pubmed/25054891) [Cite](/publication/1039923#cite) Conference [Intratumoral administration of an Oncolytic Polio/Rhinovirus Recombinant (PVSRIPO) in recurrent glioblastoma(GBM): Preliminary results of the Phase I clinical trial ](/publication/1073265) [Full text](https://dx.doi.org/10.1158/1538-7445.AM2014-CT416) [Link to item](https://www.webofscience.com/api/gateway?GWVersion=2&SrcApp=PARTNER_APP&SrcAuth=LinksAMR&KeyUT=WOS:000349910205123&DestLinkType=FullRecord&DestApp=ALL_WOS&UsrCustomerID=47d3190e77e5a3a53558812f597b0b92) [Cite](/publication/1073265#cite) Conference Cancer Research 2014 BACKGROUND: phase II study of bevacizumab (BVZ) plus irinotecan (CPT-11) was conducted in children with recurrent low-grade glioma to measure sustained response and/or stable disease lasting 6 months and progression-free survival. METHODS: Thirty-five e ... [Efficacy in children with recurrent Pediatric study. ](/publication/878356) [Full text](https://dx.doi.org/10.1093/neuonc/not154) [Link to item](https://www.ncbi.nlm.nih.gov/pubmed/24311632) [Cite](/publication/878356#cite) Conference Cancer \u00b7 December 1, 2013 BACKGROUND: The incidence and spectrum of acute toxicities related to the use of bevacizumab (BVZ)-containing regimens in children are largely unknown. This report describes the adverse events in a recently completed large phase 2 trial of BVZ plus irinote ... [Bevacizumab (BVZ)-associated toxicities in children with recurrent central nervous system tumors treated with BVZ and irinotecan (CPT-11): a Pediatric Brain [Link to \u00b7 December 2013 OBJECT: Recurrent malignant gliomas have inherent resistance to traditional chemotherapy. Novel therapies target specific molecular mechanisms involved in abnormal signaling and resistance to apoptosis. The proteasome is a key regulator of multiple cellula ... [Proteasome inhibition with bortezomib [Cite](/publication/966173#cite) Journal Article Blood & Cancer \u00b7 September 1, 2013 [ADOPTIVE LYMPHOCYTE THERAPY (ALT) PLUS DENDRITIC CELL VACCINATION (DCV) AFTER MYELOABLATIVE (MA) OR NON-MYELOABLATIVE (NMA) CONDITIONING IN PATIENTS RECURRENT CENTRAL PNET (C-PNET) [Link to item](http://gateway.webofknowledge.com/gateway/Gateway.cgi?GWVersion=2&SrcApp=PARTNER_APP&SrcAuth=LinksAMR&KeyUT=WOS:000324735500046&DestLinkType=FullRecord&DestApp=ALL_WOS&UsrCustomerID=47d3190e77e5a3a53558812f597b0b92) [Cite](/publication/1000245#cite) \u00b7 August 10, 2013 PURPOSE: To compare event-free survival (EFS) in children with high-risk medulloblastoma randomly assigned to receive either chemotherapy before radiation or chemotherapy after radiation. PATIENTS AND METHODS: One hundred twelve patients were randomly assi ... [High-risk medulloblastoma: a pediatric oncology group randomized trial after ](/publication/1025329) [Full Biol Phys \u00b7 August 1, 2013 PURPOSE: Virtually all patients with malignant glioma (MG) eventually recur. This study evaluates the safety of concurrent stereotactic radiosurgery (SRS) and bevacizumab (BVZ), an antiangiogenic agent, MATERIALS: [Concurrent stereotactic radiosurgery and [Link to August 2013 Temozolomide, an alkylating agent, has shown promise in treating primary nervous lymphoma (PCNSL). The enzyme O(6)-methylguanine-DNA methyltransferase (MGMT) repairs alkylating damage, We hypothesized th ... [O6-methylguanine-DNA methyltransferase (MGMT) immunohistochemistry as Clinical Oncology \u00b7 May 20, 2013 [Dose-finding and safety study of an oncolytic polio/rhinovirus recombinant against recurrent glioblastoma. ](/publication/1023954) [Link to item](http://gateway.webofknowledge.com/gateway/Gateway.cgi?GWVersion=2&SrcApp=PARTNER_APP&SrcAuth=LinksAMR&KeyUT=WOS:000335419601010&DestLinkType=FullRecord&DestApp=ALL_WOS&UsrCustomerID=47d3190e77e5a3a53558812f597b0b92) [Cite](/publication/1023954#cite) Conference Journal of Clinical Oncology \u00b7 May 20, 2013 [Phase II trial for patients with newly diagnosed glioblastoma (GBM) treated with carmustine wafers followed by concurrent radiation therapy (RT), temozolomide (TMZ), and bevacizumab item](http://gateway.webofknowledge.com/gateway/Gateway.cgi?GWVersion=2&SrcApp=PARTNER_APP&SrcAuth=LinksAMR&KeyUT=WOS:000335419603365&DestLinkType=FullRecord&DestApp=ALL_WOS&UsrCustomerID=47d3190e77e5a3a53558812f597b0b92) [Cite](/publication/1033315#cite) May 20, 2013 [Analysis of high-dose methotrexate with rituximab versus other treatment system (CNS) lymphoma. ](/publication/1033428) [Link to item](http://gateway.webofknowledge.com/gateway/Gateway.cgi?GWVersion=2&SrcApp=PARTNER_APP&SrcAuth=LinksAMR&KeyUT=WOS:000335419601006&DestLinkType=FullRecord&DestApp=ALL_WOS&UsrCustomerID=47d3190e77e5a3a53558812f597b0b92) [Cite](/publication/1033428#cite) Conference Cancer Research \u00b7 April 15, 2013 AbstractINTRODUCTION: INC280 is an oral, highly selective c-Met receptor tyrosine kinase inhibitor. The hepatocyte growth factor (HGF)-c-Met pathway is one of the most frequently dysregulated pathways in hum ... [Abstract 2079: Natl Acad Sci U S A \u00b7 April 9, 2013 Malignant cells, like all actively growing cells, must maintain their telomeres, but genetic mechanisms responsible for telomere maintenance in tumors have only recently been discovered. In particular, mutations of the telomere binding proteins alpha thala ... [TERT promoter mutations occur frequently in gliomas and a subset of tumors derived from cells with low rates of self-renewal. ](/publication/932635) [Full text](https://dx.doi.org/10.1073/pnas.1303607110) [Link to item](https://www.ncbi.nlm.nih.gov/pubmed/23530248) [Cite](/publication/932635#cite) Journal Med \u00b7 April 2013 Patients with unresectable glioblastomas have a poor prognosis, with median survival of 6-10 months. We conducted a phase II trial of upfront 5-day temozolomide (TMZ) and bevacizumab (BV) multifocal ... [Phase II TUMORS ](/publication/952429) Conference Cancer Research \u00b7 2013 [Efficacy of Sym004, a novel anti-EGFR Clinical Oncology \u00b7 2013 [Dose-finding and safety study of an oncolytic recombinant against recurrent glioblastoma. ](/publication/1033316) [Link to January 2013 Glioblastoma multiforme (GBM) is a devastating disease with a dismal prognosis and a very limited response to treatment. The current standard of care for GBM usually consists of surgery, radiation and chemotherapy with the alkylating agent temozolomide, al ... [Mibefradil, a novel therapy for glioblastoma multiforme: cell cycle synchronization and interlaced therapy in model. ](/publication/760899) [Full text](https://dx.doi.org/10.1007/s11060-012-0995-0) [Link to item](https://www.ncbi.nlm.nih.gov/pubmed/23086436) [Cite](/publication/760899#cite) Journal Article Pediatric Blood & Cancer \u00b7 December 1, 2012 [MISMATCH REPAIR DEFICIENCY: A TEMOZOLOMIDE RESISTANCE FACTOR IN MEDULLOBLASTOMA CELL LINES WHICH IS UNCOMMON IN PRIMARY MEDULLOBLASTOMA TUMORS ](/publication/1106234) [Link to item](http://gateway.webofknowledge.com/gateway/Gateway.cgi?GWVersion=2&SrcApp=PARTNER_APP&SrcAuth=LinksAMR&KeyUT=WOS:000309754300477&DestLinkType=FullRecord&DestApp=ALL_WOS&UsrCustomerID=47d3190e77e5a3a53558812f597b0b92) [Cite](/publication/1106234#cite) Journal Article Neuro Oncol \u00b7 November 2012 A phase II study of bevacizumab (BVZ) plus irinotecan (CPT-11) was conducted in cases of pediatric recurrent ependymoma (EPN) to estimate sustained objective response rate and progression-free survival (PFS). Eligible patients received 2 doses of single-ag ... [Lack of efficacy of bevacizumab + irinotecan in cases of pediatric recurrent ependymoma--a Pediatric Brain Tumor Consortium study. ](/publication/772054) [Full text](https://dx.doi.org/10.1093/neuonc/nos213) [Link to item](https://www.ncbi.nlm.nih.gov/pubmed/23019233) [Cite](/publication/772054#cite) Journal Article Br J Cancer \u00b7 October 23, 2012 BACKGROUND: Bevacizumab improves outcome for most recurrent glioblastoma patients, but the duration of benefit is limited and survival after initial bevacizumab progression is poor. We evaluated bevacizumab continuation beyond initial progression among rec ... [Bevacizumab continuation beyond initial bevacizumab J Cancer \u00b7 October 9, 2012 BACKGROUND: Tumours are responsive to temozolomide (TMZ) if they are deficient in O(6)-methylguanine-DNA methyltransferase (MGMT), and mismatch repair (MMR) proficient. METHODS: The effect of TMZ on medulloblastoma (MB) killing analysed with clono [Mismatch repair deficiency: a temozolomide resistance factor in medulloblastoma cell lines that uncommon [Full text](https://dx.doi.org/10.1038/bjc.2012.403) [Link to Cancer \u00b7 October 1, 2012 BACKGROUND: We evaluated the efficacy of imatinib plus hydroxyurea in patients with progressive/recurrent low-grade glioma. total of 64 patients with recurrent/progressive low-grade glioma were enrolled in this single-center study ... [Phase II study of Gleevec plus hydroxyurea 2012 [A PHASE II SINGLE-ARM TRIAL OF PALONOSETRON FOR THE PREVENTION OF ACUTE AND DELAYED CHEMOTHERAPY-INDUCED NAUSEA AND VOMITING IN MALIGNANT GLIOMA PATIENTS RECEIVING IRINOTECAN 2012 [NEWLY DIAGNOSED GLIOBLASTOMA TREATED WITH GLIADEL (R) FOLLOWED BY RADIATION THERAPY (RT), TEMOZOLOMIDE AND BEVACIZUMAB, AND POST-RT BEVACIZUMAB AND [Cite](/publication/928900#cite) Conference Neuro [EZN-2208, A NOVEL PEGYLATED SN38 DRUG CONJUGATE, MARKEDLY INHIBITS TUMOR IN ](/publication/928924) [Link to item](http://gateway.webofknowledge.com/gateway/Gateway.cgi?GWVersion=2&SrcApp=PARTNER_APP&SrcAuth=LinksAMR&KeyUT=WOS:000310971300122&DestLinkType=FullRecord&DestApp=ALL_WOS&UsrCustomerID=47d3190e77e5a3a53558812f597b0b92) [Cite](/publication/928924#cite) Conference 1, 2012 [BEVACIZUMAB GIVEN WITH TEMOZOLOMIDE AND RADIATION THERAPY (RT) IN NEWLY DIAGNOSED PATIENTS WITH GLIOBLASTOMA MULTIFORME (GBM) REDUCES THE CHANCE OF to item](http://gateway.webofknowledge.com/gateway/Gateway.cgi?GWVersion=2&SrcApp=PARTNER_APP&SrcAuth=LinksAMR&KeyUT=WOS:000310971300327&DestLinkType=FullRecord&DestApp=ALL_WOS&UsrCustomerID=47d3190e77e5a3a53558812f597b0b92) 2012 [LONG-TERM SURVIVORSHIP IN PRIMARY GLIOBLASTOMA: A FOCUS ON QUALITY OF LIFE ](/publication/929130) [Link to item](http://gateway.webofknowledge.com/gateway/Gateway.cgi?GWVersion=2&SrcApp=PARTNER_APP&SrcAuth=LinksAMR&KeyUT=WOS:000310971300625&DestLinkType=FullRecord&DestApp=ALL_WOS&UsrCustomerID=47d3190e77e5a3a53558812f597b0b92) [Cite](/publication/929130#cite) Journal Article J Neurooncol \u00b7 August 2012 Intracranial meningiomas are often indolent tumors which typically grow over years to decades. Nonetheless, meningiomas that progress after maximum safe resection and radiation therapy pose a significant therapeutic challenge and effective therapies have y ... [Bevacizumab therapy for adults with recurrent/progressive [Cite](/publication/747983#cite) Journal Article J Neurooncol \u00b7 July 2012 To determine the maximum tolerated dose (MTD) and dose-limiting toxicity (DLT) of dasatinib, an inhibitor Src family kinase an epidermal growth factor inhibitor, among malignant pat ... [Phase 1 trial of dasatinib plus to item](https://www.ncbi.nlm.nih.gov/pubmed/22407177) [Cite](/publication/747981#cite) Journal 2012 Mutations in the critical chromatin modifier ATRX and mutations in CIC and FUBP1, which are potent regulators of cell growth, have been discovered in specific subtypes of gliomas, the most common type of primary malignant brain tumors. However, the frequen ... [Frequent ATRX, CIC, FUBP1 and PCV chemo hikes survival: Commentary ](/publication/768327) Vascular endothelial growth factor receptor (VEGFR) and epidermal growth factor receptor (EGFR) play a significant role in glioblastoma angiogenesis and proliferation, making tyrosine kinase (TK) receptors logical targets for treatment. We evaluat [Phase I study of [Cite](/publication/772055#cite) of Clinical Oncology \u00b7 May 20, 2012 [Phase II study of bevacizumab plus irinotecan and carboplatin for recurrent WHO grade 3 malignant gliomas with no prior bevacizumab failure. ](/publication/951250) [Link to item](http://gateway.webofknowledge.com/gateway/Gateway.cgi?GWVersion=2&SrcApp=PARTNER_APP&SrcAuth=LinksAMR&KeyUT=WOS:000318009801396&DestLinkType=FullRecord&DestApp=ALL_WOS&UsrCustomerID=47d3190e77e5a3a53558812f597b0b92) [Cite](/publication/951250#cite) Conference Journal of Clinical Oncology \u00b7 May 20, 2012 [The addition of bevacizumab to temozolomide and radiation therapy followed by bevacizumab, temozolomide, [Cite](/publication/951251#cite) \u00b7 May 20, 2012 [Vorinostat, temozolomide, and bevacizumab for patients with recurrent I/II trial ](/publication/951253) [Link to item](http://gateway.webofknowledge.com/gateway/Gateway.cgi?GWVersion=2&SrcApp=PARTNER_APP&SrcAuth=LinksAMR&KeyUT=WOS:000318009801584&DestLinkType=FullRecord&DestApp=ALL_WOS&UsrCustomerID=47d3190e77e5a3a53558812f597b0b92) [Cite](/publication/951253#cite) Conference Journal of Clinical Oncology \u00b7 May 20, 2012 [Safety and efficacy of the addition of bevacizumab to temozolomide and radiation therapy followed by bevacizumab, to item](http://gateway.webofknowledge.com/gateway/Gateway.cgi?GWVersion=2&SrcApp=PARTNER_APP&SrcAuth=LinksAMR&KeyUT=WOS:000318009801593&DestLinkType=FullRecord&DestApp=ALL_WOS&UsrCustomerID=47d3190e77e5a3a53558812f597b0b92) [Cite](/publication/951254#cite) Journal Article Cancer Research \u00b7 April 15, 2012 AbstractINTRODUCTION: Finding new ways to improve the efficacy and/or overcome resistance to conventional chemotherapy for brain tumor patients is an ongoing research paradigm. Interlaced TherapyTM is a syne ... [Abstract LB-76: Mibefradil, a therapy approach ](/publication/1132027) [Full text](https://dx.doi.org/10.1158/1538-7445.am2012-lb-76) [Cite](/publication/1132027#cite) Journal Article Br J Radiol \u00b7 April 2012 OBJECTIVES: The aim of this study was to determine the prognostic significance of changes in parameters derived from diffusion tensor imaging (DTI) that occur in response to treatment with bevacizumab and irinotecan in patients with recurrent glioblastoma ... [A change in the apparent diffusion coefficient after treatment with bevacizumab is associated with decreased survival in patients with multiforme. ](/publication/758989) [Full Biol Phys \u00b7 April 1, 2012 PURPOSE: Patients with recurrent malignant gliomas treated with stereotactic radiosurgery (SRS) and multiagent systemic therapies were reviewed to determine the effects of patient- and treatment-related factors on survival and toxicity. METHODS AND MATERIA ... [Safety and efficacy of stereotactic radiosurgery and [Full to item](https://www.ncbi.nlm.nih.gov/pubmed/21489708) [Cite](/publication/768330#cite) Neurol \u00b7 March 20, 2012 [Neuro-oncology: Glioblastoma--community adjusts to new of care. ](/publication/768328) [Link to item](https://www.ncbi.nlm.nih.gov/pubmed/22430106) [Cite](/publication/768328#cite) Journal Article J Neurooncol \u00b7 March 2012 We evaluated the efficacy of carboplatin, irinotecan, and bevacizumab among bevacizumab-na\u00efve, recurrent glioblastoma (GBM) patients in a phase 2, open-label, single arm trial. Forty eligible patients received carboplatin (area under the plasma curve [AUC] ... [Phase Neurooncol \u00b7 March 2012 Although outcome following bevacizumab among recurrent grade IV malignant glioma patients is documented as poor by several analyses, outcome for recurrent grade III patients following bevacizumab therapy has not been specifically evaluated. We performed a ... [Outcome after bevacizumab clinical trial therapy among recurrent grade glioma patients. ](/publication/768331) [Full text](https://dx.doi.org/10.1007/s11060-011-0740-0) [Link to item](https://www.ncbi.nlm.nih.gov/pubmed/21997879) [Cite](/publication/768331#cite) Journal Article Cancer \u00b7 March 1, 2012 BACKGROUND: The authors performed a phase 2 trial of combined protracted daily temozolomide and biweekly bevacizumab for patients with recurrent glioblastoma who had previously received radiation therapy and temozolomide. METHODS: There was no limit on the ... Biol Phys \u00b7 January 1, 2012 PURPOSE: To determine the safety of the addition of bevacizumab to standard radiation therapy and daily temozolomide for newly diagnosed glioblastoma multiforme (GBM). METHODS AND MATERIALS: A total of 125 patients with newly diagnosed GBM were enrolled in ... [Addition of bevacizumab to standard radiation therapy and daily temozolomide is associated with minimal toxicity in newly One \u00b7 2012 BACKGROUND: Preclinical studies in mice have demonstrated that the prophylactic depletion of immunosuppressive regulatory T-cells (T(Regs)) through targeting the high affinity receptor (IL-2R/CD25) can enhance anti-tumor immunotherapy ... [A of IL-2R blockade during lymphopenia depletes regulatory T-cells and correlates with enhanced immunity J Neurooncol \u00b7 January 2012 We prospectively evaluated the efficacy and safety of imatinib plus hydroxyurea in patients with progressive/recurrent meningioma. A total of 21 patients with progressive/recurrent meningioma were enrolled in this dual center, single-arm, phase II trial. A ... [Phase II study of Gleevec\u00ae plus hydroxyurea (HU) in with progressive ](/publication/747975) [Full text](https://dx.doi.org/10.1007/s11060-011-0687-1) [Link agents: Part B. methylating agents ](/publication/1350980) [Cite](/publication/1350980#cite) Journal Article J Neurooncol \u00b7 December 2011 We determined the maximum tolerated dose (MTD) and dose-limiting toxicities (DLT) of (VEGFR) inhibitor, sunitinib, when administered with irinotecan among recurrent malignant glioma (MG) patients. For ea ... [Phase I study of sunitinib and text](https://dx.doi.org/10.1007/s11060-011-0631-4) [Link to item](https://www.ncbi.nlm.nih.gov/pubmed/21744079) [Cite](/publication/732147#cite) Journal Article December 1, 2011 BACKGROUND: The efficacy of carboplatin, irinotecan, and bevacizumab among recurrent glioblastoma (GBM) patients after prior progression on bevacizumab therapy in a phase 2, open-label, single-arm trial was evaluated. METHODS: Eligible patients received ca ... [Phase 2 study of carboplatin, irinotecan, and bevacizumab item](https://www.ncbi.nlm.nih.gov/pubmed/21590689) [Cite](/publication/740081#cite) Journal Article J Neurooncol \u00b7 December 2011 We conducted a phase I clinical trial of the combination of SCH 66336 with temozolomide administered on the standard 5-day dosing schedule. The primary objective was to determine the maximum tolerated dose and dose limiting toxicity (DLT) of twice daily SC ... [A phase I the farnesyl transferase Oncology 1, 2011 [MIBEFRADIL, A NOVEL THERAPY FOR GLIOBLATOMA MULTIFORME: INTERLACED THERAPY IN A MURINE item](http://gateway.webofknowledge.com/gateway/Gateway.cgi?GWVersion=2&SrcApp=PARTNER_APP&SrcAuth=LinksAMR&KeyUT=WOS:000297026600429&DestLinkType=FullRecord&DestApp=ALL_WOS&UsrCustomerID=47d3190e77e5a3a53558812f597b0b92) [Cite](/publication/865357#cite) Journal Article 2011 [ACTIVITY OF THE PAN-HER INHIBITOR PF-00299804 AGAINST A to item](http://gateway.webofknowledge.com/gateway/Gateway.cgi?GWVersion=2&SrcApp=PARTNER_APP&SrcAuth=LinksAMR&KeyUT=WOS:000297026600643&DestLinkType=FullRecord&DestApp=ALL_WOS&UsrCustomerID=47d3190e77e5a3a53558812f597b0b92) [Cite](/publication/865391#cite) Journal Article Neuro November 1, 2011 [PHASE II STUDY OF PANITUMUMAB IN COMBINATION WITH IRINOTECAN FOR MALIGNANT GLIOMA to item](http://gateway.webofknowledge.com/gateway/Gateway.cgi?GWVersion=2&SrcApp=PARTNER_APP&SrcAuth=LinksAMR&KeyUT=WOS:000297026600363&DestLinkType=FullRecord&DestApp=ALL_WOS&UsrCustomerID=47d3190e77e5a3a53558812f597b0b92) Article Neuro Oncology \u00b7 November 1, 2011 [PROGNOSTIC IMPORTANCE OF QUALITY OF LIFE AND FATIGUE IN PATIENTS WITH RECURRENT HIGH-GRADE GLIOMA ](/publication/874918) [Link to item](http://gateway.webofknowledge.com/gateway/Gateway.cgi?GWVersion=2&SrcApp=PARTNER_APP&SrcAuth=LinksAMR&KeyUT=WOS:000297026600485&DestLinkType=FullRecord&DestApp=ALL_WOS&UsrCustomerID=47d3190e77e5a3a53558812f597b0b92) 1, 2011 [THE ADDITION OF BEVACIZUMAB TO TEMOZOLOMIDE AND RADIATION THERAPY FOLLOWED BY BEVACIZUMAB, TEMOZOLOMIDE, ORAL October 1, 2011 [Bevacizumab-induced reversible posterior leukoencephalopathy syndrome and successful \u00b7 October 2011 INTRODUCTION: Better understanding of aberrantly active molecular pathways in tumors offers potential to develop more specific and less toxic therapies. Abnormal mammalian target of rapamycin (mTOR) complex signaling and defects in TSC1 and TSC2 have been ... [Everolimus tablets text](https://dx.doi.org/10.1517/14656566.2011.601742) [Link to \u00b7 September 15, 2011 Lymphodepletion augments adoptive cell transfer during antitumor immunotherapy, producing dramatic clinical responses in patients with malignant melanoma. We report that the lymphopenia induced IL-2 receptor during lymphopenia selectively depletes regulatory T cells in mice and humans. ](/publication/741865) [Full text](https://dx.doi.org/10.1182/blood-2011-02-334565) [Link to item](https://www.ncbi.nlm.nih.gov/pubmed/21768296) [Cite](/publication/741865#cite) Oncol \u00b7 July 20, 2011 PURPOSE: Identifying strong markers of prognosis are critical to optimize treatment and survival outcomes in patients with malignant recurrent glioma. We investigated the prognostic significance of exercise behavior and functional capacity in this populati ... [Exercise behavior, functional capacity, and survival in adults recurrent glioma. ](/publication/744065) [Full text](https://dx.doi.org/10.1200/JCO.2011.34.9852) [Link to item](https://www.ncbi.nlm.nih.gov/pubmed/21690470) 1, 2011 temozolomide fails to hike glioblastoma survival: Commentary ](/publication/772056) [Cite](/publication/772056#cite) Journal Article Clin Cancer Res \u00b7 June 15, 2011 PURPOSE: To determine if the addition of bevacizumab to radiation therapy and temozolomide, followed by bevacizumab, temozolomide, and irinotecan, for newly diagnosed glioblastoma patients is safe and effective. EXPERIMENTAL DESIGN: A total of 75 patients ... [The addition of bevacizumab to standard radiation therapy and temozolomide followed by bevacizumab, [Cite](/publication/740088#cite) Journal Article J Neurooncol \u00b7 June 2011 We evaluated the efficacy of metronomic etoposide or temozolomide administered with bevacizumab among recurrent glioblastoma (GBM) patients who progressed on prior bevacizumab therapy in a phase 2, open-label, two-arm trial. Twenty-three patients received ... [Phase II study of metronomic chemotherapy with bevacizumab for after \u00b7 June 2011 Neurocognitive decline is a frequent adverse effect of glioblastoma. Antitumor therapies that are efficacious, as measured by traditional endpoints such as objective response (OR) and progression-free survival (PFS), and have beneficial effects on neurocog ... [Neurocognitive function in patients [Full text](https://dx.doi.org/10.1093/neuonc/nor024) Journal Clinical Oncology \u00b7 May 20, 2011 [Bevacizumab, temozolomide, and radiation therapy followed by Oncology \u00b7 May 20, 2011 [Upfront bevacizumab with temozolomide of Clinical Oncology \u00b7 May 20, 2011 [Phase II clinical trial of bortezomib and bevacizumab combination in recurrent glioblastoma. ](/publication/1030962) [Link to item](http://gateway.webofknowledge.com/gateway/Gateway.cgi?GWVersion=2&SrcApp=PARTNER_APP&SrcAuth=LinksAMR&KeyUT=WOS:000208880301272&DestLinkType=FullRecord&DestApp=ALL_WOS&UsrCustomerID=47d3190e77e5a3a53558812f597b0b92) [Cite](/publication/1030962#cite) Journal Article Journal Oncology \u00b7 May 20, 2011 [A pharmacokinetic (PK) study of AC480 administered twice daily in patients with surgically resectable, recurrent malignant glioma (MG) [Cite](/publication/1030963#cite) Journal Clinical 20, 2011 [Bevacizumab (BV) continuation following BV item](http://gateway.webofknowledge.com/gateway/Gateway.cgi?GWVersion=2&SrcApp=PARTNER_APP&SrcAuth=LinksAMR&KeyUT=WOS:000208880301246&DestLinkType=FullRecord&DestApp=ALL_WOS&UsrCustomerID=47d3190e77e5a3a53558812f597b0b92) [Cite](/publication/1030964#cite) May 20, 2011 2030 Background: Although BV benefits most recurrent GBM patients, the duration of benefit is limited and subsequent survival after BV progression is poor due to lack of effective therapeutic options. METHODS: We performed a meta-analysis of item](http://www.ncbi.nlm.nih.gov/pubmed/28023816) [Cite](/publication/1163234#cite) Oncol \u00b7 May 20, 2011 9090 Background: Although the prognosis for malignant glioma remains poor, the introduction of bevacizumab has improved survival for patients with this devastating illness. Bevacizumab is a humanized monoclonal antibody to vascular endothelial growth ... [Venous thromboembolic complications in patients with malignant glioma treated a bevacizumab clinical trial. ](/publication/1163235) [Link to item](http://www.ncbi.nlm.nih.gov/pubmed/28021530) [Cite](/publication/1163235#cite) Journal Clin 2055 Background: Patients with unresectable or multifocal glioblastomas (GBs) have a poor prognosis with median survival of 6-10 months. Given the angiogenic phenotype of GB, we conducted two phase II trials upfront 5-day temozolomide (TMZ) May 20, 2011 2056 Background: The only approved 2nd-line treatment for with estimated 6-month progression-free survival (PFS) rate of 42.6% and overall survival (OS) of 9.2 months. Laboratory data show Bortezomib (Velcade) is an e ... [Phase II clinical trial bortezomib and recurrent glioblastoma. [Cite](/publication/1163237#cite) May 20, Background: AC480 is novel oral tyrosine kinase inhibitor of the human epidermal growth factor receptor family, especially EGFR and HER2. EGFR is an important therapeutic target in MG. We performed a pilot study to evaluate the tumor and plasma PK o ... [A pharmacokinetic (PK) study of AC480 administered twice daily in patients with surgically resectable, recurrent malignant glioma (MG) not 20, 2011 2098 Background: The prognosis for newly-diagnosed GBM remains poor. Adding temozolomide to radiation therapy improved the median event-free survival (EFS) to 6.9 months and median overall survival to 14.6 months. The five year survival remains < 10%. GBM' ... [Bevacizumab, temozolomide, and radiation Netw \u00b7 April 2011 Glioblastoma, the most common primary malignant brain tumor among adults, is a highly angiogenic and deadly tumor. Angiogenesis in glioblastoma, driven by hypoxia-dependent and independent mechanisms, is primarily mediated by vascular endothelial growth fa ... J Radiol \u00b7 April 2011 OBJECTIVE: The aim of this study was to determine the prognostic significance of the volume and intensity of abnormal (18)F-fluorodeoxyglucose positron emission tomography (FDG-PET) accumulation within areas of contrast enhancement on post-therapeutic volu ... [Prognostic significance of parameters derived from co-registered March 2011 Epidermal growth factor receptor variant III (EGFRvIII) is a tumor-specific mutation widely expressed in glioblastoma multiforme (GBM) and other neoplasms, but absent from normal tissues. Immunotherapeutic targeting of EGFRvIII eliminate neoplastic c ... lymphopenia enhances tumor-specific immune responses glioblastoma. ](/publication/741860) [Full text](https://dx.doi.org/10.1093/neuonc/noq157) [Link to item](https://www.ncbi.nlm.nih.gov/pubmed/21149254) 1, 2011 [O6-Methylguanine-DNA Methytransferase (MGMT) Immunohistochemistry as a Predictor CNS Lymphoma ](/publication/874932) [Link to item](http://gateway.webofknowledge.com/gateway/Gateway.cgi?GWVersion=2&SrcApp=PARTNER_APP&SrcAuth=LinksAMR&KeyUT=WOS:000291285001276&DestLinkType=FullRecord&DestApp=ALL_WOS&UsrCustomerID=47d3190e77e5a3a53558812f597b0b92) [Cite](/publication/874932#cite) Journal Article Science \u00b7 January 28, 2011 Medulloblastoma (MB) is the most common malignant brain tumor of children. To identify the genetic alterations in this tumor type, we searched for copy number alterations using high-density microarrays and sequenced all known protein-coding genes and micro ... [The genetic of [Link to oral VEGFR-2, Raf, PDGFR, c-KIT and Flt-3 inhibitor, is active against renal cell and hepatocellular carcinomas, and has recently demonstrated promising activity for lung and breast cancers. In addition, various protracted temozolomide dosing ... [Effect of CYP3A-inducing anti-epileptics on a phase II study of sorafenib plus daily temozolomide in adults \u00b7 January 2011 Striae distensae (stretch marks) are a common complication seen in patients on chronic corticosteroid therapy. Under certain circumstances, primary brain tumor patients require chronic corticosteroid therapy and can suffer from Oncology Report \u00b7 January 1, 2011 [Cediranib falls short in phase III recurrent glioblastoma study: Commentary ](/publication/772058) [Cite](/publication/772058#cite) Journal Article Neuro Oncol \u00b7 January 2011 Development of effective therapies for recurrent glioblastoma multiforme (GBM) and reliable, timely evaluation of their benefit are needed. Understanding the relationship between objective response (OR) and survival is important for determining whether OR ... [Response as a predictor of survival in patients with recurrent glioblastoma treated with bevacizumab. January 1, 2011 [Frail elderly benefit from post-op temozolomide for glioblastoma: Commentary Vascular growth factor (VEGF) and epidermal growth factor receptor (EGFR) signaling are established contributors to malignant glioma (MG) biology. We, therefore, evaluated bevacizumab, a humanized anti-VEGF monoclonal antibody, in combination w ... [Phase II trial of bevacizumab and erlotinib text](https://dx.doi.org/10.1093/neuonc/noq099) [Link to item](https://www.ncbi.nlm.nih.gov/pubmed/20716591) [Cite](/publication/732135#cite) Journal Article Cellular Therapy and Transplantation \u00b7 December 1, 2010 The clinical manifestations of Fanconi's anemia, an autosomal recessive disorder, include progressive pancyto-penia, to nonhematopoietic developmental ... [Hematopoietic reconstitution in a patient with Fanconi's anemia 1, 2010 PURPOSE: Immunologic targeting of tumor-specific gene mutations may allow precise eradication of neoplastic cells without toxicity. Epidermal growth factor receptor variant III (EGFRvIII) is a constitutively activated and immunogenic mutation not expressed ... [Immunologic escape after prolonged progression-free survival with epidermal growth factor receptor variant III peptide vaccination in patients with newly diagnosed glioblastoma. ](/publication/741857) [Link to item](https://www.ncbi.nlm.nih.gov/pubmed/20921459) \u00b7 November 2010 Glioblastoma multiforme (GBM) is the most aggressive primary brain tumor in adults. Current therapy includes surgery, radiation and chemotherapy with temozolomide (TMZ). Major determinants of clinical response to TMZ include methylation status of the O6-me ... [Decoupling of DNA damage response signaling from DNA temozolomide resistance 1, 2010 [ACTIVITY OF GMX1777 AGAINST A PANEL OF BRAIN [Link to item](http://gateway.webofknowledge.com/gateway/Gateway.cgi?GWVersion=2&SrcApp=PARTNER_APP&SrcAuth=LinksAMR&KeyUT=WOS:000285082400420&DestLinkType=FullRecord&DestApp=ALL_WOS&UsrCustomerID=47d3190e77e5a3a53558812f597b0b92) [Cite](/publication/865504#cite) 2010 [EFFICACY OF LBH589 (PANOBINOSTAT) AGAINST A PANEL OF PEDIATRIC [Link to item](http://gateway.webofknowledge.com/gateway/Gateway.cgi?GWVersion=2&SrcApp=PARTNER_APP&SrcAuth=LinksAMR&KeyUT=WOS:000285082400421&DestLinkType=FullRecord&DestApp=ALL_WOS&UsrCustomerID=47d3190e77e5a3a53558812f597b0b92) [Cite](/publication/865508#cite) Conference Neuro Oncology \u00b7 2010 [CHARACTERIZATION OF LONG-TERM SURVIVORS OF PRIMARY GLIOBLASTOMA MULTIFORME AND THEIR USE OF [DASATINIB AND ERLOTINIB (TARCEVA) FOR PATIENTS WITH RECURRENT MALIGNANT A PHASE TRIAL ](/publication/874876) [Link to item](http://gateway.webofknowledge.com/gateway/Gateway.cgi?GWVersion=2&SrcApp=PARTNER_APP&SrcAuth=LinksAMR&KeyUT=WOS:000285082400224&DestLinkType=FullRecord&DestApp=ALL_WOS&UsrCustomerID=47d3190e77e5a3a53558812f597b0b92) [Cite](/publication/874876#cite) Neuro Oncology [A I/II STUDY OF VORINOSTAT PLUS DAILY TEMOZOLOMIDE AND BEVACIZUMAB IN THE TREATMENT OF PATIENTS WITH RECURRENT GLIOMA ](/publication/874913) [Link to item](http://gateway.webofknowledge.com/gateway/Gateway.cgi?GWVersion=2&SrcApp=PARTNER_APP&SrcAuth=LinksAMR&KeyUT=WOS:000285082400314&DestLinkType=FullRecord&DestApp=ALL_WOS&UsrCustomerID=47d3190e77e5a3a53558812f597b0b92) [Cite](/publication/874913#cite) Conference Neuro Oncology \u00b7 November 1, 2010 [FINAL RESULTS OF A PHASE II STUDY OF IMATINIB MESYLATE 1, 2010 [RETROSPECTIVE ANALYSIS OF INSOMNIA IN RECURRENT GLIOMA PATIENTS AND ITS ASSOCIATION WITH DEXAMETHASONE to \u00b7 November 1, 2010 [SURVIVAL AND TOXICITY UPDATE OF THE PHASE 2 TRIAL OF BEVACIZUMAB (BV) IN COMBINATION WITH TEMOZOLOMIDE (TMZ) AND RADIATION THERAPY (RT) FOLLOWED BY BV, Neurosurg \u00b7 August 2010 OBJECT: Convection-enhanced delivery (CED) is a novel intracerebral drug delivery technique with considerable promise for delivering therapeutic agents throughout the CNS. Despite this promise, Phase III clinical trials employing CED have failed to meet cl ... [Poor drug distribution as a possible explanation for the results of the PRECISE trial. ](/publication/741859) [Full text](https://dx.doi.org/10.3171/2009.11.JNS091052) [Link to item](https://www.ncbi.nlm.nih.gov/pubmed/20020841) August 2010 BACKGROUND: Poly(ADP-ribose) polymerase (PARP) is an important regulator of programmed cell death in response to alkylating agents such as temozolomide (TMZ). The goal of this study was to determine if a systemically administered PARP-inhibitor (INO-1001) ... [Inhibition of poly(ADP-ribose) polymerase enhances the effect of chemotherapy in an animal model of regional therapy for the treatment of advanced extremity malignant melanoma. ](/publication/757355) \u00b7 July 2010 Temporal paragangliomas are highly vascular tumors treated primarily by surgical resection. However, surgery to remove these tumors is associated with significant morbidity, including cranial nerve dysfunction. Interestingly, these tumors have been shown t ... [Bevacizumab fails to treat temporal paraganglioma: discussion [Full text](https://dx.doi.org/10.1007/s11060-009-0091-2) [Link to item](https://www.ncbi.nlm.nih.gov/pubmed/20020179) [Cite](/publication/724126#cite) Journal Article Oncology Report \u00b7 July 1, 2010 [Bevacizumab-irinotecan data hold up in recurrent GBM: Comment ](/publication/772062) [Cite](/publication/772062#cite) Journal Article Oncology Report \u00b7 July 1, 2010 [Novel electric fields device may offer alternative to chemotherapy: Comment ](/publication/772063) [Cite](/publication/772063#cite) Journal Article J Clin Oncol \u00b7 June 20, 2010 PURPOSE: A phase II study of bevacizumab (BVZ) plus irinotecan (CPT-11) was conducted in children with recurrent malignant glioma (MG) and intrinsic brainstem glioma (BSG). PATIENTS AND METHODS: Eligible patients received two doses of BVZ intravenously (10 ... [Lack of efficacy of bevacizumab plus irinotecan in children with recurrent malignant glioma and diffuse brainstem glioma: a Pediatric Brain ](/publication/732137) [Full text](https://dx.doi.org/10.1200/JCO.2009.26.8789) [Link to item](https://www.ncbi.nlm.nih.gov/pubmed/20479404) [Cite](/publication/732137#cite) Journal Article Journal of Clinical Oncology \u00b7 May 20, 2010 [Phase I trial of the addition of oral topotecan to 5-day temozolomide for malignant gliomas. [Cite](/publication/1024932#cite) Journal of May 20, 2010 [CYP3A-inducing antiepileptics decrease sorafenib exposures: Results of a phase II in adults with recurrent glioblastoma. ](/publication/1024933) [Full text](https://dx.doi.org/10.1200/jco.2010.28.15_suppl.2089) [Cite](/publication/1024933#cite) Journal Article Journal of Clinical Oncology \u00b7 May 20, 2010 [Phase II trial of bevacizumab plus erlotinib for patients with recurrent malignant gliomas: Final results. ](/publication/1024935) [Full text](https://dx.doi.org/10.1200/jco.2010.28.15_suppl.2055) [Cite](/publication/1024935#cite) Journal Article Journal of Clinical Oncology \u00b7 May 20, 2010 [Imatinib mesylate plus hydroxyurea for adults with recurrent/progressive II study results. ](/publication/1024936) [Full text](https://dx.doi.org/10.1200/jco.2010.28.15_suppl.2060) [Cite](/publication/1024936#cite) Journal Article Journal of Clinical Oncology \u00b7 May 20, 2010 [Bevacizumab (BEV) in combination with temozolomide (TMZ) and radiation therapy (XRT) followed by Journal Clinical Oncology \u00b7 May 20, 2010 [Phase I trial of vandetanib and oral etoposide malignant gliomas (MG). [Full text](https://dx.doi.org/10.1200/jco.2010.28.15_suppl.2038) [Cite](/publication/1024938#cite) Journal Article Journal of Clinical Oncology \u00b7 May 20, 2010 [Long-term survival from the initial trial of bevacizumab and irinotecan. ](/publication/1024939) [Link to item](http://gateway.webofknowledge.com/gateway/Gateway.cgi?GWVersion=2&SrcApp=PARTNER_APP&SrcAuth=LinksAMR&KeyUT=WOS:000208852003040&DestLinkType=FullRecord&DestApp=ALL_WOS&UsrCustomerID=47d3190e77e5a3a53558812f597b0b92) [Cite](/publication/1024939#cite) Journal Article Journal of Clinical Oncology \u00b7 May 20, 2010 [Updated safety and survival of patients with relapsed glioblastoma treated with bevacizumab in the BRAIN study ](/publication/1106240) [Link to item](http://gateway.webofknowledge.com/gateway/Gateway.cgi?GWVersion=2&SrcApp=PARTNER_APP&SrcAuth=LinksAMR&KeyUT=WOS:000208852003003&DestLinkType=FullRecord&DestApp=ALL_WOS&UsrCustomerID=47d3190e77e5a3a53558812f597b0b92) [Cite](/publication/1106240#cite) Journal Article Journal of Clinical Oncology \u00b7 April 20, 2010 [Reply to W. Wick et al ](/publication/772064) [Full text](https://dx.doi.org/10.1200/JCO.2009.26.9472) [Cite](/publication/772064#cite) In-transit metastatic melanoma, which typically presents as multifocal lesions, provides a unique setting to evaluate the utility of gene signatures for defining optimal regional therapeutic strategies and assessing the efficacy of treatment. The goal of t ... [Gene expression signatures as a guide to Cancer \u00b7 February 1, 2010 BACKGROUND: The study was undertaken to evaluate cardiorespiratory fitness, skeletal muscle function, and body composition of patients with newly diagnosed and untreated, postsurgical primary malignant glioma. METHODS: By using a cross-sectional design, pa ... [Quantitative assessment of cardiorespiratory fitness, skeletal muscle function, and body composition in adults with primary malignant glioma. ](/publication/744047) [Full text](https://dx.doi.org/10.1002/cncr.24808) [Link to item](https://www.ncbi.nlm.nih.gov/pubmed/20029975) [Cite](/publication/744047#cite) Journal Neurooncol \u00b7 January 2010 We evaluated the anti-tumor activity and safety of erlotinib, a receptor tyrosine kinase inhibitor of the epidermal growth factor receptor, plus sirolimus, an inhibitor of the mammalian target of rapamycin, among patients with recurrent glioblastoma (GBM) ... [Phase 2 trial of \u00b7 2010 PURPOSE: To investigate the feasibility of longitudinal assessment of functional performance measures in newly diagnosed postsurgical malignant glioma patients. METHODS: Patients with histologically confirmed, clinically stable, postsurgical, and previousl ... [Changes in functional performance measures in adults undergoing chemoradiation for primary malignant glioma: a feasibility study. Vascular endothelial growth factor inhibitors have corticosteroid-sparing effects in patients with high-grade gliomas. We assessed corticosteroid use in patients with recurrent glioblastoma treated with bevacizumab (BEV) in the BRAIN study (J C ... [Corticosteroid use in patients with glioblastoma at first or second relapse treated with bevacizumab in BRAIN study. ](/publication/772061) [Full text](https://dx.doi.org/10.1634/theoncologist.2010-0105) [Link to item](https://www.ncbi.nlm.nih.gov/pubmed/21147867) [Cite](/publication/772061#cite) Journal Article Br J Cancer \u00b7 December 15, 2009 BACKGROUND: We evaluated bevacizumab with metronomic etoposide among recurrent malignant glioma patients in a phase 2, open-label trial. METHODS: A total of 59 patients, including 27 with glioblastoma (GBM) and 32 with grade 3 malignant glioma, received 10 ... [Metronomic chemotherapy with daily, oral etoposide plus bevacizumab for recurrent malignant glioma: J Neurooncol \u00b7 December 2009 This phase II trial evaluated efficacy and safety of temozolomide (TMZ) in combination with irinotecan (CPT-11) before radiotherapy in with newly diagnosed glioblastoma multiforme (GBM). Prior to radiotherapy, patients were treated with a maximum ... [Phase II trial of temozolomide (TMZ) plus irinotecan 2009 [PHASE II STUDY OF BEVACIZUMAB PLUS ETOPOSIDE AMONG RECURRENT MALIGNANT PATIENTS: to Oncology [BEVACIZUMAB PLUS ERLOTINIB IN RECURRENT HIGH-GRADE GLIOMA: A to Conference Neuro Oncology \u00b7 December 2009 [A PHASE I STUDY OF SUNITINIB PLUS IRINOTECAN IN THE TREATMENT OF PATIENTS WITH RECURRENT GLIOMA ](/publication/874951) [Link to item](http://gateway.webofknowledge.com/gateway/Gateway.cgi?GWVersion=2&SrcApp=PARTNER_APP&SrcAuth=LinksAMR&KeyUT=WOS:000272974100332&DestLinkType=FullRecord&DestApp=ALL_WOS&UsrCustomerID=47d3190e77e5a3a53558812f597b0b92) [Cite](/publication/874951#cite) [BEVACIZUMAB PLUS ERLOTINIB IN RECURRENT HIGH-GRADE GLIOMA: A PHASE II TRIAL ](/publication/874956) [Link to item](http://gateway.webofknowledge.com/gateway/Gateway.cgi?GWVersion=2&SrcApp=PARTNER_APP&SrcAuth=LinksAMR&KeyUT=WOS:000272974100149&DestLinkType=FullRecord&DestApp=ALL_WOS&UsrCustomerID=47d3190e77e5a3a53558812f597b0b92) [Cite](/publication/874956#cite) Conference International Journal of Radiation Oncology*Biology*Physics \u00b7 November 2009 [Radiotherapy, Temozolomide and Bevacizumab followed by Irinotecan, Temozolomide and Well-tolerated and Efficacious in Newly Diagnosed Glioblastoma Multiforme: Results from a Phase II Trial ](/publication/874935) [Full text](https://dx.doi.org/10.1016/j.ijrobp.2009.07.250) [Cite](/publication/874935#cite) Journal Article J Neurooncol \u00b7 October 2009 The purpose of this study was to determine the safety of tinzaparin for deep vein thrombosis prophylaxis in newly diagnosed grade III-IV malignant glioma patients. Patients were initiated on daily tinzaparin at a fixed dose of [Tinzaparin item](https://www.ncbi.nlm.nih.gov/pubmed/19415455) October 2009 PURPOSE: Sphingosine kinase is an oncogene that is up-regulated in several solid tumors. The product of the sphingosine kinase activity, sphingosine-1-phosphate is a potent mitogen involved in diverse cell processes such as cell survival and migration. Cur ... [A sphingosine kinase inhibitor October 2009 Conventional therapies for glioblastoma multiforme (GBM) fail to target tumor cells exclusively, such that their efficacy is ultimately limited by nonspecific toxicity. Immunologic targeting of tumor-specific gene mutations, however, may allow more precise ... [An epidermal growth factor receptor variant III-targeted vaccine is in Oncol \u00b7 October 2009 This phase I clinical trial conducted with patients who had recurrent or progressive malignant glioma (MG) was designed to determine the maximum tolerated dose (MTD) and toxicity of three different 5-day dosing regimens of (TMZ) Oncol \u00b7 October 1, 2009 PURPOSE: We evaluated the efficacy of bevacizumab, alone and in combination with irinotecan, in patients with recurrent glioblastoma in a phase II, multicenter, open-label, noncomparative trial. PATIENTS AND METHODS: One hundred sixty-seven patients were r ... [Bevacizumab alone and in [Full text](https://dx.doi.org/10.1200/JCO.2008.19.8721) [Link to item](https://www.ncbi.nlm.nih.gov/pubmed/19720927) [Cite](/publication/772066#cite) Conference European Journal of Cancer Supplements \u00b7 September 2009 [8721 Evaluation of objective response as a predictor of survival in bevacizumab-treated patients with glioblastoma at first or second relapse in the BRAIN Study ](/publication/1106242) [Full text](https://dx.doi.org/10.1016/s1359-6349(09)71695-7) [Cite](/publication/1106242#cite) Journal Article Oncology Report \u00b7 September 1, 2009 [Bevacizumab, chemotherapy, and RT delay progression: Commentary ](/publication/772067) [Cite](/publication/772067#cite) Conference European Journal of Cancer Supplements \u00b7 September 2009 [8707 Clinical assessment of corticosteroid use and neurocognitive function in patients with glioblastoma at first or second relapse treated with bevacizumab in the BRAIN study ](/publication/878342) [Full text](https://dx.doi.org/10.1016/s1359-6349(09)71681-7) [Cite](/publication/878342#cite) Journal Cancer \u00b7 August 1, 2009 BACKGROUND: Glioblastoma multiforme (GBM), the most lethal type of brain tumor, has a 1-year median survival. The effect of carmustine wafers on the survival of newly diagnosed GBM patients treated with radiotherapy (RT) and concurrent temozolomide (TMZ) p ... [Overall survival of newly diagnosed glioblastoma patients receiving carmustine wafers followed by radiation and J Neurooncol \u00b7 August 2009 BACKGROUND: Performance status (PS) scoring systems are tools of immense clinical importance in the management of patients with malignant disease but these tools are subjective and do not provide an objective evaluation of physical functioning. We conducte ... [Assessment of physical functioning in recurrent glioma: preliminary comparison of performance status to functional capacity testing. ](/publication/743995) [Full text](https://dx.doi.org/10.1007/s11060-009-9803-x) [Link to item](https://www.ncbi.nlm.nih.gov/pubmed/19212703) [Cite](/publication/743995#cite) Journal Article Cancer \u00b7 July 1, 2009 BACKGROUND: The current study was a phase 1 clinical trial conducted with patients who had recurrent or progressive malignant glioma (MG). The trial was designed to determine the maximum tolerated dose (MTD) and toxicity of irinotecan (CPT-11) when adminis trial of temozolomide to item](https://www.ncbi.nlm.nih.gov/pubmed/19402172) [Cite](/publication/732190#cite) Biol Chem \u00b7 June 19, 2009 Epidermal growth factor receptor (EGFR) gene amplification, mutations, and/or aberrant activation are frequent abnormalities in malignant gliomas and other human cancers and have been associated with an aggressive clinical course and a poor therapeutic out ... [Tyrosine phosphorylation of the human glutathione Journal Article Mol \u00b7 June 2009 The presence of DNA damage initiates signaling through the ataxia-telangiectasia mutated kinase (ATM) and the ATM- and the Rad3-related (ATR), which phosphorylate, thus activating, the checkpoint kinases (Chk) 1 and 2, which leads to cell ... [Bifunctional DNA alkylator 1,3-bis(2-chloroethyl)-1-nitrosourea activates the ](/publication/722135) [Full text](https://dx.doi.org/10.1124/mol.108.053124) [Link to item](https://www.ncbi.nlm.nih.gov/pubmed/19261750) [Cite](/publication/722135#cite) Conference Journal of Clinical Oncology \u00b7 May 20, 2009 [Neurocognitive function in patients with glioblastoma multiforme in first or second relapse treated with bevacizumab in the BRAIN study ](/publication/1106238) [Link to item](http://gateway.webofknowledge.com/gateway/Gateway.cgi?GWVersion=2&SrcApp=PARTNER_APP&SrcAuth=LinksAMR&KeyUT=WOS:000276606602204&DestLinkType=FullRecord&DestApp=ALL_WOS&UsrCustomerID=47d3190e77e5a3a53558812f597b0b92) [Cite](/publication/1106238#cite) Journal Article J May 20, 2009 e13007 Background: Malignant glioma (MG), an incurable primary CNS tumor, is characterized by frequent aberrant activation of EGFR, VEGFR, and PDGFR. This study will determine the MTD and DLT of vandetanib (V), a once-daily, oral [Cite](/publication/1162798#cite) May 20, 2009 e13024 Background: Malignant glioma (MG), an incurable primary CNS tumor, are highly angiogenic due to overexpression of VEGF/VEGFR. The current study was designed to determine the MTD and DLT of sunitinib (S), a once-daily, oral selective of ... [A phase I study of sunitinib plus irinotecan in the treatment of patients with recurrent malignant glioma. ](/publication/1162965) [Link to item](http://www.ncbi.nlm.nih.gov/pubmed/27962793) [Cite](/publication/1162965#cite) Journal May 20, 2009 2034 Background: TRegs are increased in patients with GBM and constitutively express the high affinity interleukin-2 receptor (IL-2R). Treatment with an antibody that blocks IL-2R signaling functionally inactivates and eliminates TRegs without inducing a ... [Effect of daclizumab on item](http://www.ncbi.nlm.nih.gov/pubmed/27964629) [Cite](/publication/1163133#cite) \u00b7 May 20, 2009 2021 Background: Unlike conventional therapies for GBM, immunologic targeting of tumor-specific gene mutations allows precise eradication of neoplastic cells with reduced toxicity. EGFRvIII is a constitutively activated and immunogenic mutation not express ... [Epidermal growth factor receptor variant May 20, 2009 2058 Background: To determine the prognostic significance of changes in parameters derived from diffusion tensor imaging (DTI) that occur in response to combination chemotherapy with the antiangiogenesis agent bevacizumab (BEV) in patients with recurrent g ... [Prognostic significance of early changes in the apparent diffusion coefficient that occurs after treatment of patients with glioblastoma multiforme with bevacizumab. May 20, 2009 e13016 Background: Recurrent malignant gliomas have a poor prognosis, with a median survival of 6-15 months, with grade 4 glioblastomas more aggressive than grade 3 anaplastic astrocytomas endothelial I and malignant gliomas. item](http://www.ncbi.nlm.nih.gov/pubmed/27962830) [Cite](/publication/1163160#cite) 20, 2009 e13025 Background: GBMs are vascular tumors and inherently resistant to therapy. The prognosis for patients is poor with a median survival of 9-15 months. Patients with unresectable or multifocal GBMs have an even poorer prognosis, with a median survival o ... [Temozolomide (TMZ) and bevacizumab Background: Patients with glioblastoma multiforme (GBM) suffer from neurocognitive decline due to both the disease and its treatment. We analyzed neurocognitive function of patients with recurrent GBM who participated in the BRAIN study, a phase II, m ... [Neurocognitive function in patients with glioblastoma multiforme in first or second relapse treated with bevacizumab in the BRAIN study. ](/publication/1163242) [Link to item](http://www.ncbi.nlm.nih.gov/pubmed/27964669) [Cite](/publication/1163242#cite) Journal Article VEGF monoclonal antibody, has activity as single agent and in combination with cytotoxic therapy. Erlotinib (E), an EGFR tyrosine [Phase II study [Cite](/publication/1163243#cite) Journal Article J \u00b7 May 20, 2009 2015 Background: Standard GBM treatment includes TMZ and RT, and results in a median progression-free survival and median survival of 6.9 and 15.8 months, respectively. GBM have high concentrations of vascular endothelial growth factor (VEGF), higher level ... [Safety and of the addition of bevacizumab (BV) to temozolomide (TMZ) and radiation therapy (RT) followed [Cite](/publication/1163244#cite) \u00b7 May 20, 2009 [Effect of daclizumab on T-Reg counts and GBM [Link to item](http://gateway.webofknowledge.com/gateway/Gateway.cgi?GWVersion=2&SrcApp=PARTNER_APP&SrcAuth=LinksAMR&KeyUT=WOS:000276606602182&DestLinkType=FullRecord&DestApp=ALL_WOS&UsrCustomerID=47d3190e77e5a3a53558812f597b0b92) [Cite](/publication/861270#cite) Conference Journal of Clinical Oncology \u00b7 May 20, 2009 [Epidermal growth factor receptor variant III (EGFRvIII) GBM of Clinical Oncology \u00b7 May 20, 2009 [Prognostic significance of early changes in the apparent diffusion coefficient that occurs after treatment of patients with glioblastoma multiforme with bevacizumab ](/publication/863648) [Link to item](http://gateway.webofknowledge.com/gateway/Gateway.cgi?GWVersion=2&SrcApp=PARTNER_APP&SrcAuth=LinksAMR&KeyUT=WOS:000276606602206&DestLinkType=FullRecord&DestApp=ALL_WOS&UsrCustomerID=47d3190e77e5a3a53558812f597b0b92) [Cite](/publication/863648#cite) May 20, 2009 [Temozolomide (TMZ) and bevacizumab Clinical Oncology \u00b7 May 20, 2009 [Safety and efficacy of the addition of bevacizumab (BV) to temozolomide (TMZ) and radiation therapy (RT) followed [Cite](/publication/874871#cite) Clinical Oncology \u00b7 May 20, 2009 [Phase I study of vandetanib, mesylate, item](http://gateway.webofknowledge.com/gateway/Gateway.cgi?GWVersion=2&SrcApp=PARTNER_APP&SrcAuth=LinksAMR&KeyUT=WOS:000276606602236&DestLinkType=FullRecord&DestApp=ALL_WOS&UsrCustomerID=47d3190e77e5a3a53558812f597b0b92) [Cite](/publication/874883#cite) Conference Journal of Clinical Oncology \u00b7 May 20, 2009 [Phase II study of bevacizumab plus erlotinib for recurrent malignant gliomas ](/publication/874914) [Link to item](http://gateway.webofknowledge.com/gateway/Gateway.cgi?GWVersion=2&SrcApp=PARTNER_APP&SrcAuth=LinksAMR&KeyUT=WOS:000276606602193&DestLinkType=FullRecord&DestApp=ALL_WOS&UsrCustomerID=47d3190e77e5a3a53558812f597b0b92) [Cite](/publication/874914#cite) Conference Journal of Clinical Oncology \u00b7 May 20, 2009 [Phase I trial of vendetanib and oral etoposide for recurrent malignant gliomas ](/publication/874944) [Link to item](http://gateway.webofknowledge.com/gateway/Gateway.cgi?GWVersion=2&SrcApp=PARTNER_APP&SrcAuth=LinksAMR&KeyUT=WOS:000276606602243&DestLinkType=FullRecord&DestApp=ALL_WOS&UsrCustomerID=47d3190e77e5a3a53558812f597b0b92) [Cite](/publication/874944#cite) Journal Article Cancer \u00b7 May 15, 2009 BACKGROUND: This study determined the maximum tolerated dose (MTD) and dose-limiting toxicities (DLT) of inhibitor, vatalanib, when ... [Phase I Imaging \u00b7 May 2009 PURPOSE: To quantify the repeatability of apparent diffusion coefficient (ADC) and fractional anisotropy (FA) in patients with glioblastoma multiforme. MATERIALS AND METHODS: IRB approval and informed consent were obtained for this Health Insurance Portabi ... [Repeatability of quantitative parameters derived from diffusion to item](https://www.ncbi.nlm.nih.gov/pubmed/19388113) Research \u00b7 May 1, 2009 [Correction: Article on genomic and molecular profiling to predict response to temozolomide (Clinical Cancer Research (2009) 15, (502-510)) ](/publication/757360) [Full text](https://dx.doi.org/10.1158/1078-0432.CCR-15-9-COR) [Cite](/publication/757360#cite) Conference Molecular Therapy \u00b7 May [RNA Transfected Dendritic Cell Vaccines Targeting Human April 1, 2009 [INDUCTION OF IMMUNOLOGIC AND CLINICAL RESPONSES WITH EGFRVIII-TARGETED VACCINE (CDX-110) WITH CYCLES OF TEMOZOLOMIDE IN PATIENTS DIAGNOSED item](http://gateway.webofknowledge.com/gateway/Gateway.cgi?GWVersion=2&SrcApp=PARTNER_APP&SrcAuth=LinksAMR&KeyUT=WOS:000264993800042&DestLinkType=FullRecord&DestApp=ALL_WOS&UsrCustomerID=47d3190e77e5a3a53558812f597b0b92) 1, 2009 [PHASE II STUDY OF BEVACIZUMAB AND ERLOTINIB IN 2009 [EGF RECEPTOR TYROSINE KINASE MEDIATES A NOVEL PATHWAY OF DRUG RESISTANCE IN MALIGNANT GLIOMAS VIA TYROSINE PHOSPHORYLATION AND FUNCTIONAL ](/publication/928423) [Link to item](http://gateway.webofknowledge.com/gateway/Gateway.cgi?GWVersion=2&SrcApp=PARTNER_APP&SrcAuth=LinksAMR&KeyUT=WOS:000264993800018&DestLinkType=FullRecord&DestApp=ALL_WOS&UsrCustomerID=47d3190e77e5a3a53558812f597b0b92) [Cite](/publication/928423#cite) Journal Article British Journal of Cancer \u00b7 March 24, 2009 [In vitro sensitivity testing of minimally passaged and uncultured gliomas with TRAIL and/or chemotherapy drugs (British Journal of Cancer (2008) 99, (294-304) DOI: \u00b7 March 10, 2009 PURPOSE: This phase II trial was designed to define the role of O(6)-benzylguanine (O(6)-BG) in restoring temozolomide sensitivity in patients with recurrent or progressive, temozolomide-resistant malignant glioma and to evaluate the safety of administerin ... [Phase II trial of temozolomide plus \u00b7 March 2009 PURPOSE: Resistance of neoplastic cells to the alkylating drug BCNU [1,3-bis(2-chloroethyl)-1-nitrosourea] has been correlated with expression of O (6)-methylguanine-DNA methyltransferase, which repairs the O (6)-chloroethylguanine produced by the drug. Ot ... [BCNU-sequestration by metallothioneins may contribute to resistance in line. ](/publication/722161) [Full text](https://dx.doi.org/10.1007/s00280-008-0792-9) [Link to item](https://www.ncbi.nlm.nih.gov/pubmed/18633619) [Cite](/publication/722161#cite) Journal Article N Engl J Med \u00b7 February 19, 2009 BACKGROUND: A recent genomewide mutational analysis of glioblastomas (World Health Organization [WHO] grade IV glioma) revealed somatic mutations of the isocitrate dehydrogenase 1 gene (IDH1) in a fraction of such tumors, most frequently in tumors that wer ... [IDH1 and Cancer Res \u00b7 February 1, 2009 PURPOSE: This phase II trial was designed to define the efficacy of Gliadel wafers in combination with an infusion of O6-benzylguanine (O6-BG) that suppresses tumor O6-alkylguanine-DNA alkyltransferase recurrent m ... [Phase II trial of Gliadel \u00b7 February 2009 Malignant glioma is the most commonly occurring primary malignant brain tumor. It is difficult to treat and is usually associated with an inexorable, rapidly fatal clinical course. Chemotherapy, radiotherapy, and surgical excision are core components in th ... [Experience with irinotecan for the 2009 recirculation of irinotecan and one of its metabolites, SN-38, has been observed in pharmacokinetic data sets from previous studies. A mathematical model that can incorporate this phenomenon was developed to describe the pharmacok ... [Enterohepatic recirculation model Blood Cancer \u00b7 February 2009 SU5416 is a novel small molecule tyrosine kinase inhibitor of the VEGF receptors 1 and 2. A phase I dose escalation study stratified by concurrent use (stratum II) or absence (stratum I) of enzyme-inducing anticonvulsant drugs was undertaken to estimate th ... [Phase I study of SU5416, a small molecule inhibitor of the vascular endothelial growth factor receptor (VEGFR) in pediatric tumors. [Link to item](https://www.ncbi.nlm.nih.gov/pubmed/19065567) [Cite](/publication/772070#cite) Journal Article Clin Cancer Res \u00b7 January 15, 2009 PURPOSE: Despite objective response rates of only approximately 13%, temozolomide remains one of the most effective single chemotherapy agents against metastatic melanoma, second only to dacarbazine, the current standard of care for systemic treatment of m ... [Genomic and molecular profiling predicts response [Full of Hospice and Palliative Nursing \u00b7 January 1, 2009 Caregivers of patients with brain tumors frequently provide care to a patient with a potentially short terminal disease trajectory. Understanding the impact of caregiving is important because caregivers are often called upon to make difficult decisions reg ... [Family appraisal of caregiving in a brain cancer model ](/publication/772071) [Full text](https://dx.doi.org/10.1097/NJH.0b013e3181917e35) [Cite](/publication/772071#cite) Journal Article 2008 INTRODUCTION: Glioblastoma multiforme (GBM) is the most common and aggressive type of primary brain tumor. The prognosis for GBM patients is extremely poor with an estimated median survival of 12 months. Despite this statistic, a number of GBM patients are ... [Distress persists in Immunol Methods \u00b7 November 30, 2008 The epidermal growth factor receptor variant III (EGFRvIII) is a consistent tumor-specific mutation that is widely expressed in glioblastoma multiforme (GBM) and other neoplasms. As such it tumor-specific target for antitumor immunothera ... [Detection of Clin Cancer Res \u00b7 November 1, 2008 PURPOSE: Although patients with newly diagnosed WHO grade 3 malignant glioma have a more favorable prognosis than those with WHO grade 4 malignant glioma, salvage therapies following recurrence offer essentially palliative benefit. We did a phase II trial ... [Bevacizumab plus irinotecan in recurrent WHO [Link to item](https://www.ncbi.nlm.nih.gov/pubmed/18981004) Blood Cancer \u00b7 November 2008 PURPOSE: To determine the response, toxicity, and survival for children with progressive or recurrent medulloblastoma and germinoma using a single myeloablative course of chemotherapy supported by autologous hematopoietic stem cells. PATIENTS AND cyclophosphamide October 2008 The efficacy of high-dose chemotherapy (HDC) or standard salvage therapy was evaluated in patients with recurrent medulloblastoma (MBL) using retrospective chart review of all patients with recurrent MBL treated at Duke University Medical Center between 19 ... [Efficacy of high-dose chemotherapy or standard salvage therapy in recurrent medulloblastoma. ](/publication/732141) [Full text](https://dx.doi.org/10.1215/15228517-2008-044) [Link to item](https://www.ncbi.nlm.nih.gov/pubmed/18755919) [Cite](/publication/732141#cite) Conference European Journal of Cancer Supplements \u00b7 October 2008 [558 POSTER Pediatric Preclinical Testing Program (PPTP) evaluation of the fully human anti-IGF-1R antibody IMC-A12 ](/publication/878371) [Full text](https://dx.doi.org/10.1016/s1359-6349(08)72492-3) [Cite](/publication/878371#cite) Journal [Bevacizumab drove 6-month survival in glioblastoma: Commentary ](/publication/772073) [Cite](/publication/772073#cite) Journal Article Oncology Report \u00b7 September 1, 2008 [Blocking p-STAT-3 restored in vitro T-cell function in glioblastoma: Commentary ](/publication/772074) [Cite](/publication/772074#cite) Journal Article Clin Cancer Res \u00b7 August 1, 2008 PURPOSE: A major mechanism of resistance to methylating agents, including temozolomide, is the DNA repair protein O(6)-alkylguanine-DNA alkyltransferase (AGT). Preclinical data indicates that defective DNA mismatch repair (MMR) results in tolerance to temo ... [Mismatch repair deficiency does not mediate clinical malignant glioma. ](/publication/724130) [Full text](https://dx.doi.org/10.1158/1078-0432.CCR-07-4807) [Link to item](https://www.ncbi.nlm.nih.gov/pubmed/18676759) [Cite](/publication/724130#cite) Journal Article Br J Cancer \u00b7 July 22, 2008 TRAIL/Apo-2L has shown promise as an anti-glioma drug, based on investigations of TRAIL sensitivity in established glioma cell lines, but it is not known how accurately TRAIL signalling pathways of glioma cells in vivo are reproduced in these cell lines in ... [In vitro sensitivity testing of minimally passaged and uncultured with TRAIL text](https://dx.doi.org/10.1038/sj.bjc.6604459) [Link to item](https://www.ncbi.nlm.nih.gov/pubmed/18594532) [Cite](/publication/772075#cite) Journal Article Clin Cancer Res \u00b7 July 15, 2008 PURPOSE: Identifying novel therapeutic agents for the treatment of childhood cancers requires preclinical models that recapitulate the molecular characteristics of their respective clinical histotypes. EXPERIMENTAL DESIGN AND RESULTS: Here, we have applied ... [Molecular characterization of the pediatric preclinical testing panel. [Link to item](https://www.ncbi.nlm.nih.gov/pubmed/18628472) [Cite](/publication/772076#cite) Journal Article Neuro Oncol \u00b7 June 2008 The purpose of this study is to determine the maximum tolerated dose (MTD), dose-limiting toxicity (DLT), and intracerebral distribution of a recombinant toxin (TP-38) targeting the epidermal growth factor receptor in patients with recurrent malignant brai ... [Intracerebral infusion of an EGFR-targeted toxin in tumors. ](/publication/724105) to item](https://www.ncbi.nlm.nih.gov/pubmed/18403491) [Cite](/publication/724105#cite) Journal Article Neuro Oncol \u00b7 June 2008 We determined the maximum tolerated dose (MTD) and dose-limiting toxicity (DLT) of factor receptor (PDGFR), the proto-oncogene product and the fusion pharmacokinetics of dose-intensive imatinib mesylate plus text](https://dx.doi.org/10.1215/15228517-2008-003) [Link to item](https://www.ncbi.nlm.nih.gov/pubmed/18359865) \u00b7 June 2008 GOALS OF WORK: Patients with brain cancer are at a risk of experiencing elevated levels of distress due to the severe functional, neurocognitive, and neuropsychological sequelae of the disease. Using the National Comprehensive Cancer Network's Distress The ... [Screening for distress in patients with brain cancer using the NCCN's rapid screening measure. ](/publication/772077) [Full text](https://dx.doi.org/10.1002/pon.1271) [Link to item](https://www.ncbi.nlm.nih.gov/pubmed/17973236) [Cite](/publication/772077#cite) Journal Article Journal of Clinical Oncology \u00b7 May 20, 2008 [A phase II, randomized, non-comparative clinical trial of the effect of bevacizumab (BV) alone or in combination with irinotecan (CPT) on 20, 2008 2057 Background: Angiogenesis is a hallmark of MG with VEGF as a key regulator. Imatinib mesylate (IM) and hydroxyurea (H) have recently demonstrated promising anti-glioma activity. We attempt to extend the efficacy of IM and H by adding a VEGF receptor in ... [Final report: Phase I trial of imatinib mesylate, hydroxyurea, for patients (MG). ](/publication/1161903) [Link to item](http://www.ncbi.nlm.nih.gov/pubmed/27948101) [Cite](/publication/1161903#cite) Journal Article Journal of Clinical Oncology \u00b7 May 20, 2008 [Effect of EGFRvIII-targeted vaccine (CDX-110) on immune response and TTP when given with simultaneous standard and continuous temozolomide in patients with GBM ](/publication/861322) [Full text](https://dx.doi.org/10.1200/jco.2008.26.15_suppl.2011) [Cite](/publication/861322#cite) Journal Article Journal of Clinical Oncology \u00b7 May 20, 2008 [Efficacy of a phase II vaccine targeting Cytomegalovirus antigens in newly diagnosed GBM ](/publication/861323) [Link to item](http://gateway.webofknowledge.com/gateway/Gateway.cgi?GWVersion=2&SrcApp=PARTNER_APP&SrcAuth=LinksAMR&KeyUT=WOS:000208457400494&DestLinkType=FullRecord&DestApp=ALL_WOS&UsrCustomerID=47d3190e77e5a3a53558812f597b0b92) [Cite](/publication/861323#cite) Journal Article Journal of Oncology \u00b7 May 20, 2008 [Effect of bevacizumab (BEV) and irinotecan (CPT-11) patients text](https://dx.doi.org/10.1200/jco.2008.26.15_suppl.2026) [Cite](/publication/863609#cite) Journal Journal of Clinical Oncology \u00b7 May 20, 2008 [Update on survival from the original phase II trial of bevacizumab and irinotecan in recurrent malignant gliomas ](/publication/874862) [Full text](https://dx.doi.org/10.1200/jco.2008.26.15_suppl.2021) [Cite](/publication/874862#cite) Journal Article Journal of Clinical Oncology \u00b7 May 20, 2008 [Phase II study of bevacizumab and erlotinib in glioblastoma multiforme ](/publication/874872) to item](http://gateway.webofknowledge.com/gateway/Gateway.cgi?GWVersion=2&SrcApp=PARTNER_APP&SrcAuth=LinksAMR&KeyUT=WOS:000208457400521&DestLinkType=FullRecord&DestApp=ALL_WOS&UsrCustomerID=47d3190e77e5a3a53558812f597b0b92) [Cite](/publication/874872#cite) Journal Article Clinical Oncology \u00b7 May 20, 2008 [Final report: Phase I trial of imatinib mesylate, hydroxyurea, and for patients (MG) ](/publication/874882) [Link to item](http://gateway.webofknowledge.com/gateway/Gateway.cgi?GWVersion=2&SrcApp=PARTNER_APP&SrcAuth=LinksAMR&KeyUT=WOS:000208457400501&DestLinkType=FullRecord&DestApp=ALL_WOS&UsrCustomerID=47d3190e77e5a3a53558812f597b0b92) [Cite](/publication/874882#cite) Journal Article Journal of Clinical Oncology \u00b7 May 20, 2008 [Treatment of adults with recurrent of Clinical Oncology \u00b7 May 20, 2008 [Phase I trial of temozolomide plus O6-benzylguanine on three different [Cite](/publication/874910#cite) Journal Article Journal of Oncology \u00b7 May 20, 2008 [Bevacizumab and Clinical Oncology \u00b7 May 20, 2008 [Phase II study of bevacizumab and etoposide in patients with recurrent malignant glioma ](/publication/874941) [Link to item](http://gateway.webofknowledge.com/gateway/Gateway.cgi?GWVersion=2&SrcApp=PARTNER_APP&SrcAuth=LinksAMR&KeyUT=WOS:000208457400520&DestLinkType=FullRecord&DestApp=ALL_WOS&UsrCustomerID=47d3190e77e5a3a53558812f597b0b92) [Cite](/publication/874941#cite) Journal Article Journal of Clinical Oncology \u00b7 May 20, 2008 [Phase II trial of Article Curr Cancer Drug Targets \u00b7 May 2008 The total expression profiles of two medulloblastoma cell lines resistant to the preactivated form of cyclophosphamide (4-hydroperoxycyclophosphamide, 4-HC) were examined using the Affymetrix GeneChip U133A array. Our primary objective was to look for poss ... [The gene expression profiles of Anticancer Ther \u00b7 May 2008 Angiogenesis, the growth of new blood vessels from previously existing vasculature, is a requirement for tumor growth and metastasis. The first US FDA-approved drugs targeting angiogenesis have shown potential in the treatment of malignant gliomas. Immunot ... [Immunotherapy against angiogenesis-associated targets: evidence Oncol \u00b7 April 2008 The purpose of this study was to determine the feasibility and assess the efficacy and toxicity, among newly diagnosed malignant glioma patients, of administering (131)I-labeled murine antitenascin \u00b7 February 15, 2008 PURPOSE: VNP40101M (Cloretazine), a novel DNA alkylating agent, was evaluated in a phase I study in children with recurrent brain tumors. EXPERIMENTAL DESIGN: VNP40101M was given i.v. daily for 5 consecutive days every 6 weeks for up to eight cycles. Dose ... [Phase I trial of VNP40101M (Cloretazine) in children with recurrent brain tumors: a pediatric brain tumor consortium study. ](/publication/732159) to item](https://www.ncbi.nlm.nih.gov/pubmed/18281546) [Cite](/publication/732159#cite) Journal Article Neuro Oncol \u00b7 February 2008 We describe the case of a patient with transcobalamin II deficiency, hypogammaglobulinemia, absent corpus callosum, and mental retardation who presented at an early age with colorectal cancer and multifocal anaplastic astrocytoma. He was found to have a po ... [Multifocal anaplastic astrocytoma in a patient with hereditary colorectal cancer, transcobalamin II deficiency, agenesis of the corpus callosum, retardation, ](/publication/732174) Oncol \u00b7 January 10, 2008 PURPOSE: The combination of a vascular endothelial growth factor (VEGF) -neutralizing antibody, bevacizumab, and irinotecan is associated with high radiographic response rates and improved survival outcomes in patients with recurrent malignant gliomas. The ... [Tumor angiogenic and hypoxic profiles predict radiographic response and survival in malignant astrocytoma treated January 2008 alpha-Particle-emitting radionuclides, such as (211)At, with a 7.2-h half-life, may be optimally suited for the molecularly targeted radiotherapy of strategically sensitive tumor sites, such as those in the central nervous system. Because of th ... [Clinical experience with alpha-particle emitting 211At: treatment of recurrent Article Support Care Cancer \u00b7 December 2007 INTRODUCTION: Adult brain tumor patients are joining the ranks of cancer survivors in increasing numbers in the United States. As a result, health care providers are faced with new challenges to address the need for psychosocial support in this population. ... [Stress and long-term survivors brain cancer. [Link to item](https://www.ncbi.nlm.nih.gov/pubmed/17609991) [Cite](/publication/772078#cite) Journal Article Pediatr Blood Cancer \u00b7 December 2007 BACKGROUND: The Pediatric Preclinical Testing Program (PPTP) is an initiative supported by the National Cancer Institute (NCI) to identify novel therapeutic agents that may have significant activity against childhood cancers. The PPTP has established panel ... [The pediatric preclinical testing program: description of models and testing results. ](/publication/772079) [Full text](https://dx.doi.org/10.1002/pbc.21078) [Link to item](https://www.ncbi.nlm.nih.gov/pubmed/17066459) [Cite](/publication/772079#cite) Journal Article Molecular Cancer Therapeutics \u00b7 December 1, 2007 [Pediatric preclinical testing program (PPTP) of Cancer Therapeutics \u00b7 December 1, 2007 [Pediatric preclinical testing program (PPTP) evaluation of the fully human anti-IGF-1R antibody SCH 717454 ](/publication/878375) [Link to item](http://gateway.webofknowledge.com/gateway/Gateway.cgi?GWVersion=2&SrcApp=PARTNER_APP&SrcAuth=LinksAMR&KeyUT=WOS:000251969000221&DestLinkType=FullRecord&DestApp=ALL_WOS&UsrCustomerID=47d3190e77e5a3a53558812f597b0b92) [Cite](/publication/878375#cite) Journal Article Clin Cancer Res \u00b7 November 15, 2007 PURPOSE: To estimate the maximum tolerated dose (MTD) and dose-limiting toxicity (DLT) of escalating doses of temozolomide combined with O(6)-benzylguanine in patients < or =21 years with recurrent brain tumors. EXPERIMENTAL DESIGN: Treatment strata consis ... [Phase I trial of single-dose temozolomide and continuous administration of o6-benzylguanine in children with brain tumors: a pediatric brain tumor consortium report. ](/publication/732144) [Full to item](https://www.ncbi.nlm.nih.gov/pubmed/18006772) Pharmacol \u00b7 November 2007 PURPOSE: The DNA repair protein, O (6)-alkylguanine-DNA alkyltransferase (AGT), is a primary source of tumor resistance to agents such as temozolomide and chloroethylnitrosoureas that form DNA lesions at the O (6)-position of guanines. To increase item](https://www.ncbi.nlm.nih.gov/pubmed/17333191) [Cite](/publication/722162#cite) Oncol \u00b7 October 20, 2007 PURPOSE: The prognosis for patients with recurrent glioblastoma multiforme is poor, with a median survival of 3 to 6 months. We performed a phase II trial of bevacizumab, a monoclonal antibody to vascular endothelial growth factor, in [Cite](/publication/732154#cite) Journal Blood & Cancer \u00b7 October 1, 2007 [Cyclophosphamide (CPM) and melphalan (MEL) for recurrent Manag \u00b7 October 2007 Malignant gliomas represent the majority of primary brain tumors, and the prognosis of the patients afflicted with these tumors has been historically dismal, with almost uniform progressive neurologic impairment and rapid death. Even with multimodal treatm ... [Interstitial chemotherapy with biodegradable BCNU of malignant gliomas. ](/publication/768347) [Link to item](https://www.ncbi.nlm.nih.gov/pubmed/18472995) [Cite](/publication/768347#cite) Journal Article Cancer \u00b7 October 1, 2007 BACKGROUND: Effective chemotherapy is lacking for most types of central nervous system (CNS) tumors in children. Temozolomide, an agent with activity against adult brain tumors, was investigated in children and adolescents with recurrent CNS tumors. METHOD ... [Phase 2 study of temozolomide in children and adolescents with recurrent central nervous system tumors: a report from the Ther \u00b7 September 2007 Monotherapies have proven largely ineffective for the treatment of glioblastomas, suggesting that increased patient benefit may be achieved by combining therapies. Two protumorigenic pathways known to be active in glioblastoma include RAS/RAF/mitogen-activ ... [The combination of novel low molecular weight inhibitors of RAF (LBT613) and target of rapamycin (RAD001) decreases item](https://www.ncbi.nlm.nih.gov/pubmed/17766837) Journal Article Oncology Report \u00b7 September 1, 2007 [Dendritic cell vaccine shows promise in glioblastoma: Commentary ](/publication/772081) [Cite](/publication/772081#cite) Journal Article Oncology Report \u00b7 September 1, 2007 [Motexafin gadolinium delays progression in NSCLC brain metastases: Commentary ](/publication/772082) [Cite](/publication/772082#cite) Journal Article Oncology Report \u00b7 September 1, 2007 [Bevacizumab plus irinotecan stalls recurrent gliomas: Commentary ](/publication/772083) [Cite](/publication/772083#cite) Journal Oncology Report \u00b7 September 1, 2007 inhibitor cediranib active in recurrent glioblastoma: Commentary ](/publication/772084) [Cite](/publication/772084#cite) Journal Article Oncology Report \u00b7 September 1, 2007 [Temozolomide and vaccination can work together to treat GBM: Commentary ](/publication/772085) [Cite](/publication/772085#cite) Journal Article Psycho Oncology \u00b7 September 1, 2007 [Stress levels and sources of stress in an adult brain tumor population ](/publication/878337) [Link to item](http://gateway.webofknowledge.com/gateway/Gateway.cgi?GWVersion=2&SrcApp=PARTNER_APP&SrcAuth=LinksAMR&KeyUT=WOS:000249687400253&DestLinkType=FullRecord&DestApp=ALL_WOS&UsrCustomerID=47d3190e77e5a3a53558812f597b0b92) [Cite](/publication/878337#cite) Journal Article J Clin Oncol \u00b7 August 10, 2007 [The fallacy of cancer. 1,2-bis(methylsulfonyl)-1-(2-choloroethyl)-2-(methylamino)carbonylhydrazine (Cloretazine), is a bifunctional prodrug that belongs to a class of DNA-modifying agents-the sulfonylhydrazines-that has been synthesized and been shown to have activ ... [Activity of VNP40101M (Cloretazine) in of Clinical Oncology \u00b7 June 20, 2007 [Prevalence of osteoporosis in glioma on of Clinical Oncology \u00b7 June 20, 2007 [Radiation and concurrent temozolomide followed rotational [Cite](/publication/1366826#cite) Conference Journal of Clinical Oncology \u00b7 June 20, 2007 [Overall survival of primary glioblastoma (GBM) patients (pts) receiving carmustine (BCNU) wafers followed by and rotational multi-agent Oncology \u00b7 June 20, 2007 [Dynamic contrast-enhanced magnetic resonance imaging (DCE-MRI) evaluation in of Clinical Oncology \u00b7 June 20, 2007 [Phase II trial of Gliadel plus O-6-benzylguanic (O-6-BG) item](http://gateway.webofknowledge.com/gateway/Gateway.cgi?GWVersion=2&SrcApp=PARTNER_APP&SrcAuth=LinksAMR&KeyUT=WOS:000455043700345&DestLinkType=FullRecord&DestApp=ALL_WOS&UsrCustomerID=47d3190e77e5a3a53558812f597b0b92) [Cite](/publication/1366907#cite) Conference Journal of Clinical Oncology \u00b7 June 20, 2007 [Phase I trial of imatinib mesylate, hydroxyurea item](http://gateway.webofknowledge.com/gateway/Gateway.cgi?GWVersion=2&SrcApp=PARTNER_APP&SrcAuth=LinksAMR&KeyUT=WOS:000455043700336&DestLinkType=FullRecord&DestApp=ALL_WOS&UsrCustomerID=47d3190e77e5a3a53558812f597b0b92) [Cite](/publication/1366982#cite) Clinical Oncology \u00b7 June 20, 2007 [Phase II trial of imatinib [Cite](/publication/1366983#cite) Clinical Oncology \u00b7 June 20, 2007 [Phase I trial of VNP40101M in children with recurrent brain tumors-A Pediatric Brain Tumor Consortium (PBTC) study ](/publication/1366984) [Link to item](http://gateway.webofknowledge.com/gateway/Gateway.cgi?GWVersion=2&SrcApp=PARTNER_APP&SrcAuth=LinksAMR&KeyUT=WOS:000455043700368&DestLinkType=FullRecord&DestApp=ALL_WOS&UsrCustomerID=47d3190e77e5a3a53558812f597b0b92) [Cite](/publication/1366984#cite) Conference Journal of Clinical Oncology \u00b7 June 20, 2007 [Pilot study of dronabinol for adult patients with primary malignant gliomas ](/publication/1366985) [Link to item](http://gateway.webofknowledge.com/gateway/Gateway.cgi?GWVersion=2&SrcApp=PARTNER_APP&SrcAuth=LinksAMR&KeyUT=WOS:000455043705062&DestLinkType=FullRecord&DestApp=ALL_WOS&UsrCustomerID=47d3190e77e5a3a53558812f597b0b92) [Cite](/publication/1366985#cite) Conference Journal of Clinical Oncology \u00b7 June 20, 2007 [Phase II trial of bevacizumab and irinotecan in the treatment of malignant gliomas ](/publication/1366986) [Link to item](http://gateway.webofknowledge.com/gateway/Gateway.cgi?GWVersion=2&SrcApp=PARTNER_APP&SrcAuth=LinksAMR&KeyUT=WOS:000455043700312&DestLinkType=FullRecord&DestApp=ALL_WOS&UsrCustomerID=47d3190e77e5a3a53558812f597b0b92) [Cite](/publication/1366986#cite) Conference Journal of Clinical Oncology \u00b7 June 20, 2007 [Tinzaparin prophylaxis in brain tumor ](/publication/1366987) [Link to Journal Article Mol Carcinog \u00b7 June 2007 Glioblastomas are highly lethal cancers that resist current therapies. Novel therapies under development target molecular mechanisms that promote glioblastoma growth. In glioblastoma patient \u00b7 May 2007 INTRODUCTION: The neurohistological findings in patients treated with targeted beta emitters such as (131)I are poorly described. We report a histopathologic analysis from patients treated with combined external beam therapy and a brachytherapy consisting ... [Tumor resection cavity \u00b7 May 2007 Five different human melanoma xenografts were used in a xenograft model of extremity melanoma to evaluate the variability of tumor response to regionally administered melphalan or temozolomide and to determine if various components of pertinent drug resist ... [Defining regional infusion treatment strategies for extremity melanoma: comparative analysis of melphalan J Neurooncol \u00b7 May 2007 PURPOSE: Recent reports demonstrate the activity imatinib with recurrent glioblastoma multiforme. We performed the current phase 2 s ... [Phase II study of imatinib mesylate and Oncol \u00b7 April 2007 We conducted a phase II study to assess the efficacy of oral temozolomide (TMZ) in children with progressive low-grade glioma. Thirty eligible patients were enrolled on this study. Median age at enrollment was 10 years (range, 4-18 years). Eligible patient ... [Temozolomide Oncol \u00b7 April 2007 This study estimated the maximum tolerated dose (MTD) of imatinib with irradiation in children with newly diagnosed brainstem gliomas, and those with recurrent malignant intracranial gliomas, stratified according to use of enzyme-inducing anticonvulsant dr ... [Phase I trial of imatinib in children with newly diagnosed brainstem and recurrent malignant gliomas: a Pediatric Brain Tumor Consortium to 2007 [Pilot phase II study of metrenomic oral cyclophosphamide plus thalidomide in children with recurrent malignant tumors ](/publication/878374) [Link to item](http://gateway.webofknowledge.com/gateway/Gateway.cgi?GWVersion=2&SrcApp=PARTNER_APP&SrcAuth=LinksAMR&KeyUT=WOS:000245489300161&DestLinkType=FullRecord&DestApp=ALL_WOS&UsrCustomerID=47d3190e77e5a3a53558812f597b0b92) [Cite](/publication/878374#cite) Conference Neuro Oncology \u00b7 April and intravenous O-6-benzylguanine (O-6-BG), a methylguanine methyltransferase tumors ](/publication/878379) [Link to item](http://gateway.webofknowledge.com/gateway/Gateway.cgi?GWVersion=2&SrcApp=PARTNER_APP&SrcAuth=LinksAMR&KeyUT=WOS:000245489300098&DestLinkType=FullRecord&DestApp=ALL_WOS&UsrCustomerID=47d3190e77e5a3a53558812f597b0b92) [Cite](/publication/878379#cite) Journal Article Psychooncology \u00b7 March 2007 The purpose of the present study was to examine the demographic, medical, and social cognitive determinants of exercise intentions in a institution-based cohort of primary brain tumor patients. Using a cross-sectional survey, 100 primary brain tumor patien ... [Using the theory of planned behavior to understand the determinants of exercise intention in patients diagnosed with primary brain cancer. ](/publication/744059) [Full text](https://dx.doi.org/10.1002/pon.1077) [Link to item](https://www.ncbi.nlm.nih.gov/pubmed/16929468) [Cite](/publication/744059#cite) Journal Article Clin \u00b7 February 15, 2007 PURPOSE: Recurrent grade III-IV gliomas have a dismal prognosis with minimal improvements in survival seen following currently available salvage therapy. This study was conducted to determine if the combination of a novel antiangiogenic therapy, bevacizuma ... [Phase II trial February 2007 OBJECTIVE: Convection-enhanced delivery (CED) holds tremendous potential for drug delivery to the brain. However, little is known about the volume of distribution achieved within human brain tissue or how target anatomy and catheter positioning influence d ... [Intracerebral infusate distribution by convection-enhanced delivery in humans with malignant gliomas: descriptive effects of target anatomy and catheter positioning. ](/publication/722134) text](https://dx.doi.org/10.1227/01.NEU.0000249256.09289.5F) [Link to Cloretazine (VNP40101M) is a newly synthesized alkylating agent belonging to a novel class of alkylating agents called 1,2-bis(sulfonyl)hydrazines. Agents that belong to this class do not produce vinylating and chloroethylating species, and hence this clas ... [Phase II study of Cloretazine for the [Full text](https://dx.doi.org/10.1215/15228517-2006-022) [Link to item](https://www.ncbi.nlm.nih.gov/pubmed/17108065) [Cite](/publication/722185#cite) Journal Article Support Care Cancer \u00b7 January 2007 GOALS OF THE WORK: The purpose of the present investigation was to examine the interest and exercise preferences of an institution-based sample of brain tumor patients. Secondary aims were to examine potential differences in participant's interest and pref ... [Exercise interest and preferences among patients diagnosed with brain cancer. ](/publication/744012) [Full text](https://dx.doi.org/10.1007/s00520-006-0096-8) [Link to item](https://www.ncbi.nlm.nih.gov/pubmed/16819629) [Cite](/publication/744012#cite) Journal Article Support Care Cancer \u00b7 December 2006 BACKGROUND: Despite advances in diagnosis, treatment, and management of brain tumors, a brain tumor (BT) can significantly disrupt a person's life and create stress. To design effective stress reduction interventions, it is essential to have an understandi ... [Stress and intervention preferences of patients ](/publication/669542) [Full text](https://dx.doi.org/10.1007/s00520-006-0087-9) [Link to item](https://www.ncbi.nlm.nih.gov/pubmed/16733656) [Cite](/publication/669542#cite) Journal Article Support Care Cancer \u00b7 December 2006 OBJECTIVE: Caregivers of patients with brain tumors (BT) experience elevated levels of stress. Using pilot data, we sought to determine which caregivers are at risk for experiencing elevated levels of stress based on caregiver-demographic and patient-medic ... [Differential levels of stress in caregivers of brain tumor patients--observations from a pilot study. ](/publication/772088) [Full text](https://dx.doi.org/10.1007/s00520-006-0090-1) [Link to item](https://www.ncbi.nlm.nih.gov/pubmed/16775683) [Cite](/publication/772088#cite) Journal Article European Journal of Cancer Supplements \u00b7 November 2006 [322 POSTER Pediatric Preclinical Testing Program (PPTP) [Cite](/publication/878369#cite) Journal Journal of Cancer Supplements \u00b7 November 2006 [313 POSTER Pediatric preclinical testing program (PPTP) 1, 2006 [Neurocognitive deficits according to hemisphere and diagnosis among patients with high-grade CNS tumors ](/publication/1106237) [Link to 2006 [Development duke inventory-brain tumor Neurol October The topoisomerase is highly tumoricidal against (GBM) in vitro. However, systemic administration of 9NC has not shown the expected efficacy in clinical trials. This failure may be due to the ... Ther \u00b7 October 2006 Promoter hypermethylation of the DNA repair protein O(6)-alkylguanine-DNA alkyltransferase (AGT) has been associated with an enhanced response to chloroethylating and methylating agents in patients with malignant glioma. The purpose of this study was to co ... [Quantitative analysis 1, 2006 [AAL881, a novel small molecule inhibitor of RAF and VEGFR activities, blocks growth of ](/publication/865316) [Link to [Cite](/publication/865316#cite) Conference Neuro 1, 2006 [The combination of novel low-molecular-weight inhibitors of Raf (LBT 613) and TOR (RAD001, everolimus) glioma [Phase I trial of Temodar plus O-6-benzylguanine 5-day regimen trial of temozolomide plus dose-escalating imatinib Conference Neuro Oncology I trial of imatinib (GLEEVEC), hydroxyurea and RAD001 to [Cite](/publication/874937#cite) Conference Neuro 2006 [Overall survival of primary glioblastoma (GBM) patients receiving radiation and concurrent temozolomide multi-agent chemotherapy ](/publication/927781) [Link to item](http://gateway.webofknowledge.com/gateway/Gateway.cgi?GWVersion=2&SrcApp=PARTNER_APP&SrcAuth=LinksAMR&KeyUT=WOS:000240877301180&DestLinkType=FullRecord&DestApp=ALL_WOS&UsrCustomerID=47d3190e77e5a3a53558812f597b0b92) [Cite](/publication/927781#cite) Journal Article Cancer Res \u00b7 September 1, 2006 Malignant gliomas are highly proliferative and angiogenic cancers resistant to conventional therapies. Although RAS and RAF mutations are uncommon in gliomas, RAS activity is increased in gliomas. Additionally, vascular endothelial growth factor and its co ... [AAL881, a novel small molecule inhibitor of RAF and vascular endothelial growth factor receptor activities, blocks the growth glioma. ](/publication/694071) [Full text](https://dx.doi.org/10.1158/0008-5472.CAN-06-0284) [Link to item](https://www.ncbi.nlm.nih.gov/pubmed/16951188) Report \u00b7 September 1, 2006 [Spontaneous necrosis influences the accuracy of glioma grading: Comment ](/publication/772089) [Cite](/publication/772089#cite) Journal Article Oncology Report \u00b7 September 1, 2006 [Bevacizumab-irinotecan combination shows activity in recurrent glioma: Comment ](/publication/772090) [Cite](/publication/772090#cite) Journal Article Oncology Report \u00b7 September 1, 2006 [Chromosomal translocation confers favorable prognosis in brain tumors: Comment ](/publication/772091) [Cite](/publication/772091#cite) Journal Article Oncology Report \u00b7 September 1, 2006 [Age, resection status fail to define risk in glioma: Comment ](/publication/772092) [Cite](/publication/772092#cite) Journal Article Oncology Report \u00b7 September 1, 2006 [Modafinil improves neurocognitive function in brain tumor patients: Comment ](/publication/772093) [Cite](/publication/772093#cite) Journal Article European Journal of Nuclear Medicine and Molecular Imaging \u00b7 September 1, 2006 [Chimeric murine/human IgG(2) anti-tenascin 81C6 monoclonal antibody: phase I trial in patients with malignant glioma of a construct with improved stability ](/publication/865396) [Link to item](http://gateway.webofknowledge.com/gateway/Gateway.cgi?GWVersion=2&SrcApp=PARTNER_APP&SrcAuth=LinksAMR&KeyUT=WOS:000202967400530&DestLinkType=FullRecord&DestApp=ALL_WOS&UsrCustomerID=47d3190e77e5a3a53558812f597b0b92) [Cite](/publication/865396#cite) Journal Article European Journal of Nuclear Medicine and Molecular Imaging \u00b7 September 1, 2006 [Radioimmunotherapy of patients with malignant brain tumors: patient-specific dosing of I-131-labeled anti-tenacin antibody to achieve to resection cavity margins ](/publication/865502) [Link to item](http://gateway.webofknowledge.com/gateway/Gateway.cgi?GWVersion=2&SrcApp=PARTNER_APP&SrcAuth=LinksAMR&KeyUT=WOS:000202967400527&DestLinkType=FullRecord&DestApp=ALL_WOS&UsrCustomerID=47d3190e77e5a3a53558812f597b0b92) [Cite](/publication/865502#cite) Conference Journal of Clinical Oncology \u00b7 June 20, 2006 [A phase II study of temozolomide and oral VP-16 for adults with recurrent glioma - Final results. ](/publication/1106246) [Link to item](http://gateway.webofknowledge.com/gateway/Gateway.cgi?GWVersion=2&SrcApp=PARTNER_APP&SrcAuth=LinksAMR&KeyUT=WOS:000239009400288&DestLinkType=FullRecord&DestApp=ALL_WOS&UsrCustomerID=47d3190e77e5a3a53558812f597b0b92) [Cite](/publication/1106246#cite) Journal June 20, 2006 11505 Background: Glioblastomas are highly lethal cancers that resist current therapies. Focal adhesion kinase (FAK) is a non-receptor tyrosine kinase overexpressed in glioblastoma patient specimens that may promote glioma growth and invasion by increasing ... [A novel low molecular weight inhibitor of focal Oncol 20, 2006 11522 Background: The prognosis for glioblastoma multiforme remains poor. Survival is generally limited to less than 1 year. Currently available standard treatments have not allowed, thus far, to prolong survival significantly. Response rates observed in c ... [Combination of bevacizumab, a monoclonal antibody to vascular of to item](http://www.ncbi.nlm.nih.gov/pubmed/27954538) [Cite](/publication/1162341#cite) Journal J Clin Oncol \u00b7 June 20, 2006 11504 Background: Treatment of patients with newly diagnosed malignant glioma using Gliadel wafer implantation at initial surgery has been shown to increase survival (Westphal et al 2003). Similarly, administration of temozolomide during and after radiothe ... [Acute toxicity analysis of patients receiving surgery, Gliadel wafer implantation, and postoperative daily temozolomide with radiation primary high-grade item](http://www.ncbi.nlm.nih.gov/pubmed/27954360) [Cite](/publication/1162342#cite) \u00b7 June 20, 2006 1580 Background: This study attempts to extend the anti-glioma activity of imatinib mesylate (Gleevec, IM) plus hydroxyurea (H), adding RAD001 an orally bioavailable inhibitor of mTOR, a critical intracellular mediator of signal transduction and me ... [A phase I trial of imatinib, hydroxyurea and RAD001 with recurrent malignant to item](http://www.ncbi.nlm.nih.gov/pubmed/27952508) [Cite](/publication/1162343#cite) Journal \u00b7 June 20, 2006 1573 Background: We evaluated the combination of imatinib mesylate (Gleevec) and hydroxyurea in WHO grade III malignant gliomas following the encouraging response of this combination demonstrated in glioblastoma multiforme. METHODS: malignant item](http://www.ncbi.nlm.nih.gov/pubmed/27952528) [Cite](/publication/1162344#cite) Journal June 20, 2006 1565 Background: Although temozolomide has proven activity in patients with high and low grade gliomas, many patients do not respond, and for those who do, responses are often short-lived. We therefore undertook a trial of temozolomide in combination with ... [A phase II study of temozolomide and oral VP-16 for adults with recurrent glioma-Final results. [Link to item](http://www.ncbi.nlm.nih.gov/pubmed/27952501) [Cite](/publication/1162345#cite) Journal kinase inhibitor of the PDGF receptor has been shown to decrease tumor interstitial pressure resulting in enhanced delivery of cytotoxic therapy. Recent phase II trial demonstrated promising anti-glioma activity of ima ... [An update on phase I study of dose-escalating imatinib mesylate plus standard-dosed temozolomide for the malignant glioma. [Link to item](http://www.ncbi.nlm.nih.gov/pubmed/27952499) [Cite](/publication/1162346#cite) Journal Article J Clin Oncol \u00b7 June 20, 2006 1568 Background. The major mechanism of resistance to alkylnitrosourea therapy involves the DNA repair protein O(6)-alkylguanine-DNA alkyltransferase (AGT) which removes chloroethylation or methylation of guanine. O(6)-BG [Phase II trial [Cite](/publication/1162347#cite) \u00b7 June 20, 2006 1506 Background: The prognosis for recurrent malignant gliomas is poor, with a median survival <12 months, median progression-free survival <12 weeks and response rates <20%. Malignant gliomas have high concentrations of VEGF receptors, and the higher the ... [Bevacizumab, a monoclonal antibody to vascular endothelial growth item](http://www.ncbi.nlm.nih.gov/pubmed/27952313) [Cite](/publication/1162348#cite) Journal June 20, 2006 1539 Background: Thromboembolic complications are common in brain tumor patients, contribute to the morbidity and mortality and complicate treatment. Twenty to 40% of brain tumor patients develop a deep venous thrombosis and/or pulmonary embolus during the ... [Tinzaparin tumor patients. [Link to item](http://www.ncbi.nlm.nih.gov/pubmed/27952290) [Cite](/publication/1162349#cite) Conference Journal of Clinical Oncology \u00b7 June 20, 2006 [A phase I trial of imatinib, hydroxyurea and RAD001 for with recurrent malignant glioma. [Link to item](http://gateway.webofknowledge.com/gateway/Gateway.cgi?GWVersion=2&SrcApp=PARTNER_APP&SrcAuth=LinksAMR&KeyUT=WOS:000239009400303&DestLinkType=FullRecord&DestApp=ALL_WOS&UsrCustomerID=47d3190e77e5a3a53558812f597b0b92) [Cite](/publication/874873#cite) Conference Journal of Clinical Oncology \u00b7 June 20, 2006 [Phase II trial of Gliadel plus 0(6)-benzylguanine item](http://gateway.webofknowledge.com/gateway/Gateway.cgi?GWVersion=2&SrcApp=PARTNER_APP&SrcAuth=LinksAMR&KeyUT=WOS:000239009400291&DestLinkType=FullRecord&DestApp=ALL_WOS&UsrCustomerID=47d3190e77e5a3a53558812f597b0b92) [Cite](/publication/874885#cite) Conference Journal of Clinical Oncology \u00b7 June 20, 2006 [An update on phase I study of dose-escalating imatinib mesylate plus standard-dosed temozolomide for the malignant glioma. ](/publication/874912) [Link to item](http://gateway.webofknowledge.com/gateway/Gateway.cgi?GWVersion=2&SrcApp=PARTNER_APP&SrcAuth=LinksAMR&KeyUT=WOS:000239009400283&DestLinkType=FullRecord&DestApp=ALL_WOS&UsrCustomerID=47d3190e77e5a3a53558812f597b0b92) [Cite](/publication/874912#cite) Conference Journal of Clinical Oncology \u00b7 June 20, 2006 [Phase II trial of imatinib mesylate and hydroxyurea malignant gliomas. to item](http://gateway.webofknowledge.com/gateway/Gateway.cgi?GWVersion=2&SrcApp=PARTNER_APP&SrcAuth=LinksAMR&KeyUT=WOS:000239009400296&DestLinkType=FullRecord&DestApp=ALL_WOS&UsrCustomerID=47d3190e77e5a3a53558812f597b0b92) [Cite](/publication/874928#cite) Conference Journal of Clinical Oncology \u00b7 June 20, 2006 [Bevacizumab, a monoclonal antibody to vascular endothelial growth factor ](/publication/874940) [Link to item](http://gateway.webofknowledge.com/gateway/Gateway.cgi?GWVersion=2&SrcApp=PARTNER_APP&SrcAuth=LinksAMR&KeyUT=WOS:000239009400229&DestLinkType=FullRecord&DestApp=ALL_WOS&UsrCustomerID=47d3190e77e5a3a53558812f597b0b92) [Cite](/publication/874940#cite) Journal Article J Nucl Med \u00b7 June 2006 UNLABELLED: Results from animal experiments have shown that human IgG2/mouse chimeric antitenascin 81C6 (ch81C6) monoclonal antibody exhibited higher tumor accumulation and enhanced stability compared with its murine parent. Our objective was to determine ... [Novel chimeric antitenascin monoclonal antibody construct 131I and administered into the surgically created resection cavity of patients with malignant glioma: phase I trial results. ](/publication/732182) [Link to item](https://www.ncbi.nlm.nih.gov/pubmed/16741299) [Cite](/publication/732182#cite) Journal Article Cancer \u00b7 May 15, 2006 BACKGROUND: Exercise may represent a supportive intervention that may complement existing neurooncologic therapies and address a multitude of therapy-induced debilitating side effects in patients with brain tumors. Given the limited evidence, the authors c ... [Patterns of exercise across the cancer trajectory in patients. ](/publication/744052) [Full text](https://dx.doi.org/10.1002/cncr.21858) [Link to item](https://www.ncbi.nlm.nih.gov/pubmed/16586497) [Cite](/publication/744052#cite) 1, 2006 [O-6-alkylguanine-DNA alkyltransferase (AGT) and microsatellite instability ](/publication/1365210) [Link to item](http://gateway.webofknowledge.com/gateway/Gateway.cgi?GWVersion=2&SrcApp=PARTNER_APP&SrcAuth=LinksAMR&KeyUT=WOS:000454608803060&DestLinkType=FullRecord&DestApp=ALL_WOS&UsrCustomerID=47d3190e77e5a3a53558812f597b0b92) [Cite](/publication/1365210#cite) Conference Cancer Research 1, 2006 [Constitutive phosphorylation of Chk1 at serine 317 in a medulloblastoma cell line is sensitive to the inhibition of kinase (PIKK) pathway ](/publication/1365214) [Link to [Cite](/publication/1365214#cite) April 1, 2006 [Evaluation of 17-dimethylaminoethylamino-17-demethoxygeldanamycin (17-DMAG, KOS-1022) against Childhood Cancer Models by the Pediatric Preclinical Testing Program (PPTP) ](/publication/1365275) [Link to item](http://gateway.webofknowledge.com/gateway/Gateway.cgi?GWVersion=2&SrcApp=PARTNER_APP&SrcAuth=LinksAMR&KeyUT=WOS:000454608802482&DestLinkType=FullRecord&DestApp=ALL_WOS&UsrCustomerID=47d3190e77e5a3a53558812f597b0b92) [Cite](/publication/1365275#cite) Conference Cancer Research \u00b7 April 1, 2006 [Characterization of membrane transport of the novel acid Biol Phys \u00b7 April 1, 2006 PURPOSE: To evaluate the potential influence of radiotherapy quality on survival in high-risk pediatric medulloblastoma patients. METHODS AND MATERIALS: Trial 9031 of the Pediatric Oncology Group (POG) aimed to study the relative benefit of cisplatin and e ... [Radiotherapy in pediatric medulloblastoma: quality Journal Article J Neurooncol \u00b7 April 2006 The role of chemotherapy in the treatment of high-grade gliomas in children is unclear. Early reports were suggestive of improved outcome in children with high-grade glioma with the addition of chemotherapy after surgery and radiation therapy. Subsequent s ... [A phase II window trial of procarbazine and topotecan in children with high-grade glioma: J Neurooncol \u00b7 April 2006 PURPOSE: We performed a retrospective study of patients with diffuse pontine glioma (DPG) who suffered neuraxis metastasis (NM) and characterized the incidence, clinical features, radiologic findings, and patterns of disease dissemination. METHODS: Magneti ... [Incidence and patterns Biol \u00b7 April 2006 PURPOSE: An inverse correlation has been established between tumor levels of the DNA repair protein alkylguanine-DNA alkyltransferase (AGT) and a positive outcome after alkylator chemotherapy. Quantitative imaging of AGT could provide important information ... [Molecular imaging of alkylguanine-DNA Oncol \u00b7 March 10, 2006 Malignant gliomas, including the most common subtype, glioblastoma multiforme (GBM), are among the most devastating of neoplasms. Their aggressive infiltration in the CNS typically produces progressive and profound disability--ultimately leading to death i ... [Recent advances in the Cancer Ther \u00b7 March 2006 This study investigated whether the therapeutic index of regional melanoma therapy using parenteral temozolomide could be improved by chemomodulation with O6-benzylguanine ... [Modulation of chemotherapy resistance in therapy: a novel therapeutic approach to advanced extremity melanoma using item](https://www.ncbi.nlm.nih.gov/pubmed/16546988) [Cite](/publication/713214#cite) Cancer Res \u00b7 March 1, 2006 PURPOSE: A phase I trial of intrathecal Spartaject Busulfan (SuperGen, Inc., San Ramon, CA) was conducted in children with neoplastic meningitis following recurrent primary brain tumors to describe toxicities, estimate the maximum tolerated dose (MTD), and ... [Phase I trial of intrathecal spartaject busulfan in children with neoplastic meningitis: text](https://dx.doi.org/10.1158/1078-0432.CCR-05-2094) [Link to item](https://www.ncbi.nlm.nih.gov/pubmed/16533779) [Cite](/publication/732155#cite) Journal Article Current Medical Research and Opinion \u00b7 February 2006 OBJECTIVE: Antibiotics are clinically indicated for acute bacterial rhinosinusitis, but they may be prescribed inappropriately. This retrospective study examined how labeled recommendations for duration of moxifloxacin and levofloxacin treatment of acute b ... [Moxifloxacin versus levofloxacin for treatment of acute rhinosinusitis: a retrospective database analysis of treatment duration, outcomes, and charges. ](/publication/669550) [Cite](/publication/669550#cite) Journal Article Clin Cancer Res \u00b7 February 1, 2006 PURPOSE: To determine the maximum tolerated dose (MTD) and dose-limiting toxicity (DLT) of gefitinib, a receptor tyrosine inhibitor the epidermal growth factor receptor, plus sirolimus, an inhibitor of the mammalian target of rapamycin, among pat ... [Phase 1 trial of gefitinib plus to item](https://www.ncbi.nlm.nih.gov/pubmed/16467100) [Cite](/publication/732175#cite) Oncology \u00b7 February 1, 2006 [The role of chemoresistance in regional infusion therapy for [Link to item](http://gateway.webofknowledge.com/gateway/Gateway.cgi?GWVersion=2&SrcApp=PARTNER_APP&SrcAuth=LinksAMR&KeyUT=WOS:000235085500267&DestLinkType=FullRecord&DestApp=ALL_WOS&UsrCustomerID=47d3190e77e5a3a53558812f597b0b92) [Cite](/publication/878364#cite) Journal Article Psycho February 1, 2006 [Caregivers of brain tumor patients: Stress and intervention preferences ](/publication/878370) [Link to item](http://gateway.webofknowledge.com/gateway/Gateway.cgi?GWVersion=2&SrcApp=PARTNER_APP&SrcAuth=LinksAMR&KeyUT=WOS:000235659000095&DestLinkType=FullRecord&DestApp=ALL_WOS&UsrCustomerID=47d3190e77e5a3a53558812f597b0b92) [Cite](/publication/878370#cite) Journal Article Psycho Oncology \u00b7 February 1, 2006 [Brain tumor patients: Stress and intervention preferences ](/publication/878376) [Link to item](http://gateway.webofknowledge.com/gateway/Gateway.cgi?GWVersion=2&SrcApp=PARTNER_APP&SrcAuth=LinksAMR&KeyUT=WOS:000235659000145&DestLinkType=FullRecord&DestApp=ALL_WOS&UsrCustomerID=47d3190e77e5a3a53558812f597b0b92) [Cite](/publication/878376#cite) Journal Article Clin Cancer Res \u00b7 January 1, 2006 PURPOSE: Previous preclinical studies have shown that regional temozolomide therapy via isolated limb infusion is more effective than melphalan, the current drug of choice for regional chemotherapy for advanced extremity melanoma. The aim of this study was ... [Optimizing a novel regional Oncol \u00b7 January 1, 2006 PURPOSE: To assess the efficacy and toxicity of intraresection cavity iodine-131-labeled murine antitenascin monoclonal antibody 81C6 (131I-m81C6) among recurrent malignant brain tumor patients. PATIENTS AND METHODS: In this phase II trial, 100 mCi with recurrent primary and metastatic malignant brain tumors: phase II study results. [Link 2006 Carbohydration of N-terminus and substitution of a threonine for the threoninol residue at the C-terminus of Tyr3-octreotide (TOC) has resulted in improved pharmacokinetics and tumor targeting of its radioiodinated derivatives. Yet, these peptides are very ... [Synthesis and evaluation of glycosylated octreotate analogues labeled [Cite](/publication/736678#cite) Oncol \u00b7 December 20, 2005 PURPOSE: We performed a phase II study to evaluate the combination of imatinib study of to item](https://www.ncbi.nlm.nih.gov/pubmed/16361636) Cancer Research \u00b7 December 15, 2005 [A phase I trial of AP23573, a novel mTOR inhibitor, in patients (Pts) with recurrent malignant glioma. ](/publication/864165) [Link to item](http://gateway.webofknowledge.com/gateway/Gateway.cgi?GWVersion=2&SrcApp=PARTNER_APP&SrcAuth=LinksAMR&KeyUT=WOS:000234382700197&DestLinkType=FullRecord&DestApp=ALL_WOS&UsrCustomerID=47d3190e77e5a3a53558812f597b0b92) [Cite](/publication/864165#cite) Conference Clinical Cancer Research \u00b7 December 15, 2005 [Evaluation of bortezomib against childhood tumor models by the pediatric preclinical testing program (PPTP) ](/publication/878378) [Link to item](http://gateway.webofknowledge.com/gateway/Gateway.cgi?GWVersion=2&SrcApp=PARTNER_APP&SrcAuth=LinksAMR&KeyUT=WOS:000234382700098&DestLinkType=FullRecord&DestApp=ALL_WOS&UsrCustomerID=47d3190e77e5a3a53558812f597b0b92) [Cite](/publication/878378#cite) ](/publication/965093) [Full text](https://dx.doi.org/10.1016/B978-0-7216-8148-1.50028-0) [Cite](/publication/965093#cite) Journal Article Clin Cancer Res \u00b7 November 15, 2005 PURPOSE: Primary central nervous system (CNS) tumors represent a diverse group of tumor types with heterogeneous molecular mechanisms that underlie their formation and maintenance. CNS tumors depend on angiogenesis and often display increased activity of E ... [ZD6474, a novel tyrosine kinase inhibitor of vascular endothelial growth factor receptor and epidermal growth factor receptor, inhibits tumor growth of multiple nervous system tumors. ](/publication/694084) [Full text](https://dx.doi.org/10.1158/1078-0432.CCR-05-0319) [Link to item](https://www.ncbi.nlm.nih.gov/pubmed/16299247) [Cite](/publication/694084#cite) Journal Article J Med \u00b7 November 10, 2005 [Glioblastoma multiforme and the epidermal [Link to item](https://www.ncbi.nlm.nih.gov/pubmed/16282174) [Cite](/publication/675370#cite) Journal Article Social Science & Medicine \u00b7 November 2005 An archival prospective design was used to study mediating and moderating variables for the association between parental divorce and increased mortality risk, using a sub-group (n = 1183) of individuals from the US Terman Life Cycle Study covering the peri ... [Longevity following the experience of parental divorce. ](/publication/669501) [Cite](/publication/669501#cite) Journal Article Cancer \u00b7 October 15, 2005 BACKGROUND: Allelic losses of 1p and 19q arms correlate with the oligodendroglial phenotype as well as with sensitivity to radiotherapy and chemotherapy. Furthermore, the DNA repair gene, methylguanine methyltransferase (MGMT), is diminished October 15, 2005 BACKGROUND: Brainstem gliomas (BSGs) are resistant to all therapy. Based on their imaging characteristics, we postulated that inhibition of P-glycoprotein (P-gp) associated with endothelial cells of the barrier enhance penetration of xeno ... [Etoposide, vincristine, and cyclosporin A with standard-dose radiation therapy in newly diagnosed diffuse intrinsic brainstem gliomas: a pediatric oncology group text](https://dx.doi.org/10.1002/pbc.20382) [Link to item](https://www.ncbi.nlm.nih.gov/pubmed/16110498) [Cite](/publication/750839#cite) Journal Article Cancer \u00b7 October 1, 2005 BACKGROUND: The authors determined the maximum tolerated dose (MTD) and dose-limiting toxicity (DLT) of irinotecan (CPT-11), a topoisomerase I inhibitor, when administered with temozolomide with recurrent malignant glioma (MG). METHODS: Pati ... [Phase I trial of \u00b7 October 1, 2005 PURPOSE: We conducted a two-phase clinical trial in patients with progressive malignant glioma (MG). The first phase of this trial was designed to determine the dose of O6-BG effective in producing complete depletion of tumor AGT activity for 48 hours. The ... [Phase I trial of temozolomide plus O6-benzylguanine for patients recurrent or September 2005 Temozolomide is a DNA-methylating agent used in the treatment of malignant gliomas. In this study, we have examined if inhibition of poly(ADP-ribose) polymerase (PARP) could increase the cytotoxicity of temozolomide, particularly in cells deficient in DNA ... [Poly(ADP-ribose) polymerase-1 inhibition reverses temozolomide September 1, 2005 Glial neoplasms represent 0.5-1% of all cancers in most Western countries. Malignant gliomas are among the most devastating cancers, leading to death in most cases. They present unique challenges due to their location, aggressive biological behavior and di ... [Chemotherapy and novel therapeutic approaches [Link to item](https://www.ncbi.nlm.nih.gov/pubmed/15970525) \u00b7 September 1, 2005 [Can PFS predict overall survival. Comment ](/publication/750840) [Cite](/publication/750840#cite) Journal Article Oncology Report \u00b7 September 1, 2005 [Peritumoral administration best way to deliver ILI3PE. Comment ](/publication/750841) [Cite](/publication/750841#cite) Journal Article Oncology Report \u00b7 September 1, 2005 [Thalidomide does not improve survival. Comment ](/publication/750842) [Cite](/publication/750842#cite) Journal Article J Nucl Med \u00b7 June 2005 UNLABELLED: The objective was to perform dosimetry and evaluate dose-response relationships in newly diagnosed patients with malignant brain tumors treated with direct injections of (131)I-labeled anti-tenascin murine 81C6 antibody in newly diagnosed patients with malignant gliomas: a phase II study. ](/publication/730634) [Link to item](https://www.ncbi.nlm.nih.gov/pubmed/15937318) [Cite](/publication/730634#cite) Conference Journal of Clinical Oncology \u00b7 June 1, 2005 [A phase I trial of gefitinib (ZD1 839) plus rapamycin for patients with recurrent malignant glioma. ](/publication/865491) [Link to item](http://gateway.webofknowledge.com/gateway/Gateway.cgi?GWVersion=2&SrcApp=PARTNER_APP&SrcAuth=LinksAMR&KeyUT=WOS:000230326600516&DestLinkType=FullRecord&DestApp=ALL_WOS&UsrCustomerID=47d3190e77e5a3a53558812f597b0b92) [Cite](/publication/865491#cite) Conference Journal of June 1, 2005 [Efficacy of imatinib mesylate plus hydroxyurea regimen in the treatment of recurrent malignant glioma: Phase II study results ](/publication/874868) [Link to item](http://gateway.webofknowledge.com/gateway/Gateway.cgi?GWVersion=2&SrcApp=PARTNER_APP&SrcAuth=LinksAMR&KeyUT=WOS:000230326600465&DestLinkType=FullRecord&DestApp=ALL_WOS&UsrCustomerID=47d3190e77e5a3a53558812f597b0b92) [Cite](/publication/874868#cite) Conference Journal of Clinical Oncology \u00b7 June 1, 2005 [A phase 1 dose escalation study of imatinib mesylate plus standard-dosed temozolomide in the treatment glioma ](/publication/874931) [Link to item](http://gateway.webofknowledge.com/gateway/Gateway.cgi?GWVersion=2&SrcApp=PARTNER_APP&SrcAuth=LinksAMR&KeyUT=WOS:000230326600490&DestLinkType=FullRecord&DestApp=ALL_WOS&UsrCustomerID=47d3190e77e5a3a53558812f597b0b92) [Cite](/publication/874931#cite) Journal Article Oncology Report \u00b7 March 1, 2005 [Radiation sensitizer shows promise in breast cancer patients with brain metastases ](/publication/750843) [Cite](/publication/750843#cite) Journal Article Oncology Report \u00b7 March 1, 2005 ['Encouraging news': Vaccine increases survival in phase I brain cancer trial ](/publication/750844) [Cite](/publication/750844#cite) Journal Article Oncology Report \u00b7 March 1, 2005 [Promising results in overcoming temozolomide resistance ](/publication/750845) [Cite](/publication/750845#cite) Journal Article Oncology Report \u00b7 March 1, 2005 [Adding temozolomide to radiation improves survival in patients with glioblastoma ](/publication/750846) [Cite](/publication/750846#cite) Journal Article The New England Journal of Medicine \u00b7 February 2005 [Carotid-artery stenting versus endarterectomy. ](/publication/669510) [Cite](/publication/669510#cite) Journal Article J Clin Oncol \u00b7 January 20, 2005 PURPOSE: A phase I trial of intrathecal (IT) mafosfamide was performed to determine the optimal dose, dose-limiting toxicities, and incidence and severity of other toxicities when administered in association with concomitant multiagent systemic chemotherap ... [Phase I clinical trial of mafosfamide in infants and children aged 3 years or younger with newly diagnosed embryonal tumors: a pediatric brain tumor text](https://dx.doi.org/10.1200/JCO.2005.06.544) [Link to item](https://www.ncbi.nlm.nih.gov/pubmed/15659498) [Cite](/publication/750847#cite) Journal Article Cancer \u00b7 January 15, 2005 BACKGROUND: In the current study, the authors report a Phase II trial of irinotecan (CPT-11), a topoisomerase I inhibitor active against malignant glioma (MG), with celecoxib, a selective COX-2 inhibitor, among MG patients with recurrent disease. METHODS: ... [Phase II trial of irinotecan plus 2005 BACKGROUND: Valuable correlations could be made between serum prostate specific antigen (PSA) and prostate histopathology by the use of autopsy sampling if post-mortem PSA data were informative. However, PSA forms and levels in autopsy sera have not been i ... [Comparison of ante- and 2005 Glioblastoma multiforme remains refractory to conventional therapy, and novel therapeutic modalities are desperately needed. TP-38 is a recombinant chimeric protein containing a genetically engineered form of the cytotoxic Pseudomonas exotoxin fused to tra ... [Sustained radiographic in patient with bifrontal recurrent glioblastoma multiforme with intracerebral infusion of the study. [Full Ther \u00b7 January 2005 Malignant gliomas are highly lethal tumors that display striking genetic heterogeneity. Novel therapies that inhibit a single molecular target may slow tumor progression, but tumors are likely not dependent on a signal transduction pathway. Rather, maligna ... [Combination therapy of inhibitors of epidermal growth factor receptor/vascular endothelial growth factor receptor 2 (AEE788) and the mammalian target of rapamycin (RAD001) offers tumor growth item](https://www.ncbi.nlm.nih.gov/pubmed/15657358) [Cite](/publication/694188#cite) Journal Article J Biol Chem \u00b7 December 10, 2004 Secreted protein acidic, rich in cysteine (SPARC), is an extracellular matrix protein expressed in many advanced cancers, including malignant gliomas. We and others have previously shown that human glioma cell lines engineered to overexpress SPARC adopt an ... [Secreted protein acidic, rich in cysteine (SPARC), mediates [Full [Link to item](https://www.ncbi.nlm.nih.gov/pubmed/15469933) Journal Article Am J Surg \u00b7 November 2004 BACKGROUND: Regional infusion therapy with melphalan (LPAM) is an accepted treatment for advanced extremity melanoma. However, much room exists for improving the therapeutic index of this type of therapy. METHODS: Isolated limb infusion (ILI) with temozolo ... [Temozolomide is a novel regional infusion agent Park) \u00b7 November 2004 Central nervous system (CNS) cancers are the second most frequent malignancy (and the most common solid tumor) in childhood. In recent years, significant advances in surgery, radiotherapy, and chemotherapy have improved survival in children with these tumo ... [Recent advances in the treatment of pediatric brain tumors. ](/publication/732169) [Link to item](https://www.ncbi.nlm.nih.gov/pubmed/15648297) [Cite](/publication/732169#cite) Journal Article Eur J Nucl Med Mol Imaging \u00b7 October 2004 PURPOSE: As a part of our efforts to develop a meta-iodobenzylguanidine (MIBG) analogue with improved characteristics for the diagnosis and treatment of neuroendocrine tumours, 3-[131I]iodo-4-methyl-benzylguanidine ([131I]MeIBG) has been developed. The pur ... 4-methyl-substituted meta-iodobenzylguanidine analogue with vascular endothelial growth factor receptor 2 (VEGFR2) inhibitor, inhibits growth of multiple primary central nervous system tumor types ](/publication/865437) [Link to item](http://gateway.webofknowledge.com/gateway/Gateway.cgi?GWVersion=2&SrcApp=PARTNER_APP&SrcAuth=LinksAMR&KeyUT=WOS:000224332400373&DestLinkType=FullRecord&DestApp=ALL_WOS&UsrCustomerID=47d3190e77e5a3a53558812f597b0b92) [Cite](/publication/865437#cite) Conference Neuro 2004 [Inhibition of receptor tyrosine kinases and mammalian target of rapamycin offers combinatorial benefit control ](/publication/865489) [Link to 2004 [Extraosseous Ewings sarcoma (EES) of the central nervous system (CNS) - Case reports and molecular diagnosis ](/publication/873161) [Link to item](http://gateway.webofknowledge.com/gateway/Gateway.cgi?GWVersion=2&SrcApp=PARTNER_APP&SrcAuth=LinksAMR&KeyUT=WOS:000224332400561&DestLinkType=FullRecord&DestApp=ALL_WOS&UsrCustomerID=47d3190e77e5a3a53558812f597b0b92) [Cite](/publication/873161#cite) Conference Neuro Oncology \u00b7 October 1, 2004 [Phase I trial of adults with primary malignant glioma 2004 [Phase (Temodar) plus irinotecan (CPT-11) plus O6-benzylguanine (O6-BG) in ](/publication/874917) [Link to trial of temozolomide (Temodar) plus O6-benzylguanine (O6-BG) in treatment [Link to 2004 [Phase II study of oral temozolomide (TMZ) in [Incidence and patterns of neuraxis metastasis (NM) 2004 The chemotherapeutic activity of 1,3-bis(2-chloroethyl)-1-nitrosourea (BCNU or carmustine) may be improved by the addition of O6-benzylguanine (O6-BG). The reaction of O6-BG with the repair of O6-chloroet ... [Brain cell lines resistant to alkyltransferase mutations. ](/publication/675367) Coll \u00b7 September 2004 BACKGROUND: Regional perfusion treatments for melanoma, using the alkylating agent melphalan, show variable responses in magnitude and duration. Surprisingly, the potential contribution of alkylating-agent resistance mechanisms to diminish tumor responses, ... [In-transit melanoma: the role of alkylating-agent Diagn \u00b7 August 2004 Astrocytoma is comprised of a group of common intracranial neoplasms that are classified into four grades based on the World Health Organization histological criteria and patient survival. To date, histological grade, patient age, and clinical performance, ... [Comparative genomic [Link [Cite](/publication/709759#cite) Journal Article Surgery \u00b7 August 2004 BACKGROUND: The presence of resistance to chemotherapy is associated with poor tumor response and patient survival in a variety of tumors. Attempts to modulate resistance in conjunction with systemic chemotherapy have been limited by the toxicity of combin ... [Modulation of resistance to regional ](/publication/713191) \u00b7 July 15, 2004 1569 Background: In a prior phase I study we established the dose of 100mCi as the maximum tolerated dose of iodine 131-labeled murine anti-tenascin antibody 81C6 (131I-81C6) injected into a surgically created resection cavity (SCRC) for the treatment of r ... (M81C6) via surgically created resection cavity in the treatment of patients with recurrent malignant brain tumors. ](/publication/1163158) [Link to item](http://www.ncbi.nlm.nih.gov/pubmed/28015735) [Cite](/publication/1163158#cite) Journal Article J Clin Oncol \u00b7 July 15, 2004 1554 Background: We performed a phase II study to determine the activity and toxicity of thalidomide plus daily cyclophosphamide in patients with recurrent anaplastic astrocytomas (AO). [Phase II study of thalidomide daily cyclophosphamide with malignant glioma. ](/publication/1163240) [Link to item](http://www.ncbi.nlm.nih.gov/pubmed/28015449) [Cite](/publication/1163240#cite) Conference Journal of Clinical Oncology \u00b7 July 15, 2004 [Phase II (M81C6) via surgically created resection cavity in the treatment of patients with recurrent malignant brain tumors. ](/publication/865447) [Link to item](http://gateway.webofknowledge.com/gateway/Gateway.cgi?GWVersion=2&SrcApp=PARTNER_APP&SrcAuth=LinksAMR&KeyUT=WOS:000223512400491&DestLinkType=FullRecord&DestApp=ALL_WOS&UsrCustomerID=47d3190e77e5a3a53558812f597b0b92) [Cite](/publication/865447#cite) Conference Journal of Clinical Oncology \u00b7 July 15, 2004 [Phase II study of thalidomide and daily cyclophosphamide for adults with malignant glioma. to item](http://gateway.webofknowledge.com/gateway/Gateway.cgi?GWVersion=2&SrcApp=PARTNER_APP&SrcAuth=LinksAMR&KeyUT=WOS:000223512400474&DestLinkType=FullRecord&DestApp=ALL_WOS&UsrCustomerID=47d3190e77e5a3a53558812f597b0b92) [Cite](/publication/878361#cite) Journal Article \u00b7 June 2004 Transforming growth factor-beta (TGF-beta) is a multifunctional cytokine that promotes malignant and immunosuppression. Antisense oligonucleotide suppression of TGF-beta(2) expression has shown promise in preclinical a ... [SB-431542, a small molecule transforming growth factor-beta-receptor antagonist, inhibits human glioma cell line proliferation [Link to item](https://www.ncbi.nlm.nih.gov/pubmed/15210860) [Cite](/publication/675348#cite) Journal Article Clin Cancer Res \u00b7 May 1, 2004 PURPOSE: We have reported previously that tumors expressing wild-type epidermal growth factor receptor (EGFR) in a murine sensitive to the EGFR tyrosine kinase inhibitor gefitinib, whereas [Resistance to tyrosine kinase inhibition by mutant epidermal growth factor receptor variant 2004 Irinotecan is a topoisomerase I inhibitor previously shown to be active in the treatment of malignant glioma. We now report the results of a phase 1 trial of irinotecan plus BCNU, or 1,3-bis(2-chloroethyl)-1-nitrosourea, for patients with recurrent or prog ... [Phase 1 trial of irinotecan plus BCNU in progressive or In BCNU, or 1,3-bis(2-chloroethyl)-1-nitrosourea, plus CPT-11 (irinotecan) exhibits schedule-dependent, synergistic activity against malignant glioma (MG). We previously established the maximum tolerated dose of CPT-11 when administere ... [Phase 2 trial of [Link item](https://www.ncbi.nlm.nih.gov/pubmed/15134628) [Cite](/publication/730639#cite) Journal Article The American Journal of Cardiology \u00b7 March 2004 The purpose of this investigation was to determine whether heart rate variability (HRV) in atrial fibrillation (AF) can be related to any echocardiographic-derived measurements of cardiac dimensions or function. AF is characterized by marked HRV. Although ... [Heart rate variability in atrial fibrillation related to left atrial size. ](/publication/669487) [Cite](/publication/669487#cite) Journal Article The New England Journal of Medicine \u00b7 March 2004 [Conditions associated with ST-segment elevation. ](/publication/669489) [Cite](/publication/669489#cite) Journal Article J Clin Oncol \u00b7 January 1, 2004 PURPOSE: To evaluate the efficacy and tolerability of gefitinib (ZD1839, Iressa; AstraZeneca, Wilmington, growth receptor tyrosine kinase inhibitor, in patients with recurrent glioblastoma. PATIENTS AND METHODS: This was an op ... [Phase \u00b7 2004 O(6)-Benzylguanine derivatives with suitable radionuclides attached to the benzyl ring are potentially useful in the noninvasive imaging of the DNA repair protein, alkylguanine-DNA alkyltransferase (AGT). Previously, O(6)-3-[(131)I]iodobenzylguanine ([(131 ... [O6-3-[131I]iodobenzylguanine: improved synthesis and further evaluation of for imaging item](https://www.ncbi.nlm.nih.gov/pubmed/15025538) Cancer Research \u00b7 December 1, 2003 [Combination therapy of inhibitors of the epidermal growth factor/vascular endothelial growth factor receptor 2 (AEE788) and the mammalian target of rapamycin (RAD001) offers tumor growth inhibition. ](/publication/865400) [Link to item](http://gateway.webofknowledge.com/gateway/Gateway.cgi?GWVersion=2&SrcApp=PARTNER_APP&SrcAuth=LinksAMR&KeyUT=WOS:000187467300089&DestLinkType=FullRecord&DestApp=ALL_WOS&UsrCustomerID=47d3190e77e5a3a53558812f597b0b92) [Cite](/publication/865400#cite) Conference Clinical Cancer Research \u00b7 December 1, 2003 [ZD6474, a vascular endothelial growth factor receptor 2 (VEGFR-2) inhibitor, inhibits growth of multiple primary central nervous system tumor types. ](/publication/865422) [Link to item](http://gateway.webofknowledge.com/gateway/Gateway.cgi?GWVersion=2&SrcApp=PARTNER_APP&SrcAuth=LinksAMR&KeyUT=WOS:000187467300298&DestLinkType=FullRecord&DestApp=ALL_WOS&UsrCustomerID=47d3190e77e5a3a53558812f597b0b92) [Cite](/publication/865422#cite) Journal Article Clin Cancer Res 15, 2003 PURPOSE: The monoclonal (MAb) trastuzumab (Herceptin) such macromolecule therapeutic agents to intracerebral metastases, however, is limited by the tight junctions ... [Efficacy of intracerebral microinfusion of trastuzumab in breast cancer. ](/publication/694196) [Link to item](https://www.ncbi.nlm.nih.gov/pubmed/14654531) [Cite](/publication/694196#cite) Am J 2003 BACKGROUND: Hyperthermic isolated limb perfusion (HILP) with melphalan as treatment for locally recurrent or in-transit malignant melanoma is frequently performed but the principle for calculating drug dosage remains poorly understood. METHODS: This study ... [Marked variability of melphalan plasma 2003 Idarubicin (IDA), the 4-demethoxy analog of daunomycin, has had significant cytotoxicity in many malignancies. In previous reports, the alcohol metabolite of IDA, 4-demethoxydaunorubicinol (idarubicinol, or IDOL), had cytotoxic activity and the ability to ... [Phase 2 study of idarubicin in pediatric \u00b7 October 2003 TP-38 is a recombinant chimeric targeted toxin composed of the EGFR binding ligand TGF-alpha and a genetically engineered form of the Pseudomonas exotoxin, PE-38. After in vitro and in vivo animal studies that showed specific activity and defined the maxim ... [Progress report of a Phase I study of the intracerebral microinfusion of a recombinant chimeric protein composed of transforming growth factor (TGF)-alpha and a mutated form of the Pseudomonas exotoxin termed PE-38 (TP-38) for the treatment text](https://dx.doi.org/10.1023/a:1026290315809) [Link to item](https://www.ncbi.nlm.nih.gov/pubmed/14649883) [Cite](/publication/709787#cite) Journal Article Res \u00b7 September 15, 2003 PURPOSE: The epidermal growth factor receptor (EGFR) is often amplified and structurally rearranged in malignant gliomas and other tumors such as breast and lung, with the most common mutation being EGFRvIII. In the study described here, we tested in mouse ... [Epidermal growth factor receptor VIII peptide vaccination is established intracerebral tumors. to item](https://www.ncbi.nlm.nih.gov/pubmed/14519652) [Cite](/publication/678252#cite) Journal Article Cancer Chemother Pharmacol \u00b7 September 2003 BACKGROUND: Most solid human tumors exist in an acidic microenvironment, due in part to inefficient vasculature and a higher intrinsic rate of glycolysis. This leads to a tumor-selective pH gradient, which can be exploited therapeutically with antitumor ag ... [The activity of camptothecin analogues is enhanced in histocultures of human tumors and human tumor xenografts by Oncol \u00b7 June 1, 2003 PURPOSE: We evaluated the usefulness of a treatment regimen that included high-dose chemotherapy (HDC) with autologous stem-cell rescue (ASCR) in patients with newly diagnosed pineoblastoma (PBL). PATIENTS AND METHODS: Twelve patients with PBL were initial ... [High-dose chemotherapy with autologous stem-cell rescue in children ](/publication/710406) [Full text](https://dx.doi.org/10.1200/JCO.2003.10.096) [Link to item](https://www.ncbi.nlm.nih.gov/pubmed/12775745) [Cite](/publication/710406#cite) Journal \u00b7 May 1, 2003 Irinotecan is a water-soluble derivative of camptothecin, an alkylator originally extracted from the Chinese tree Camptotheca acuminata. Laboratory studies have demonstrated the activity of irinotecan in a broad panel of pediatric and adult central nervous ... [The emerging role of irinotecan (CPT-11) in the treatment malignant glioma Journal Article Park) \u00b7 May 2003 Patients with malignant glioma continue to have a dismal outcome. Those with glioblastoma multiforme, the most common type of malignant glioma, have a median survival of 40 to 60 weeks following diagnosis and only 16 to 24 weeks after recurrence. While sta ... [Irinotecan: promising activity in the treatment of malignant glioma. ](/publication/669523) [Link to item](https://www.ncbi.nlm.nih.gov/pubmed/12800600) [Cite](/publication/669523#cite) Journal Article Clin Cancer Res \u00b7 May 2003 PURPOSE: The objective of this study was to determine the feasibility of exploiting the overexpression of somatostatin subtype-2 receptors (sstr(2)) on human medulloblastoma cells to develop targeted radiodiagnostics and radiotherapeutics for this ... [Specific Article Cancer [Introduction: Irinotecan in brain tumors ](/publication/772095) [Full text](https://dx.doi.org/10.1002/cncr.11303) [Cite](/publication/772095#cite) Journal Article Cancer \u00b7 May 1, 2003 Two studies were performed to evaluate the safety, tolerability, and efficacy of irinotecan (CPT-11) in the treatment of adults with malignant glioma. Patients with progressive or recurrent malignant gliomas were enrolled. In the first study, CPT-11 was ad ... [Two studies evaluating irinotecan treatment for Experimental Neurology \u00b7 May 1, 2003 [Sub-classification of glioblastoma defined genomic hybridization alterations. ](/publication/865424) [Link to item](http://gateway.webofknowledge.com/gateway/Gateway.cgi?GWVersion=2&SrcApp=PARTNER_APP&SrcAuth=LinksAMR&KeyUT=WOS:000182959100029&DestLinkType=FullRecord&DestApp=ALL_WOS&UsrCustomerID=47d3190e77e5a3a53558812f597b0b92) [Cite](/publication/865424#cite) Journal Article Cancer \u00b7 April 15, 2003 BACKGROUND: Although temozolomide is active against recurrent malignant glioma, responses in many patients are modest and short-lived. Temozolomide may prove more effective in combination with other agents. Therefore, combination oral chemotherapy for thes ... [Phase I study of temozolomide and escalating doses of oral etoposide for adults with malignant glioma. ](/publication/772097) [Full text](https://dx.doi.org/10.1002/cncr.11260) [Link to item](https://www.ncbi.nlm.nih.gov/pubmed/12673724) [Cite](/publication/772097#cite) Journal Article The Journal of Physiology \u00b7 April 2003 Psychophysical studies indicate that perception of the colour and brightness of a surface depends on neural signals evoked by the borders of the surface rather than its interior. The visual cortex emphasizes contrast borders, but it is unclear whether colo ... [The coding of uniform colour figures in monkey visual cortex. ](/publication/669520) [Cite](/publication/669520#cite) Journal Article J Clin Oncol Featured Publication PURPOSE: Schering-Plough Corp, Kenilworth, NJ) is an imidazole undergoes chemical conversion to the active 5-(3-methyltriazen-1yl)imidazole-4-carboximide under physiologic conditions. Previous studi ... \u00b7 January 2003 Featured Publication OBJECT: The prognostic value of differentiating between recurrent malignant glioma and a lesion due to radiation effect by performing stereotactic biopsy has not been assessed. Thus, this study was undertaken to determine such value. METHODS: Between 1995 ... [Prognostic value of magnetic resonance imaging-guided stereotactic biopsy in the evaluation of recurrent malignant astrocytoma compared with a lesion due to radiation effect. [Cite](/publication/680300#cite) Journal Article Neuroimaging Clin N Am \u00b7 November 2002 Effectiveness of chemotherapy in patients with brain tumors is hampered by the presence of the blood-brain barrier and drug resistance. In recent years, significant progress has been made in devising innovative methods of design and delivery of chemotherap ... [Innovations in design and delivery of chemotherapy tumors. ](/publication/669529) [Full text](https://dx.doi.org/10.1016/s1052-5149(02)00031-x) [Link to item](https://www.ncbi.nlm.nih.gov/pubmed/12687913) [Cite](/publication/669529#cite) Journal Article Res \u00b7 November 2002 Featured Publication Iressa (ZD1839) is a p.o.-active, selective, epidermal growth inhibitor (EGFR-TKI) that blocks signal transduction pathways implicated in cancer cell proliferation, survival, and host-dependent processes promoting cancer gro ... [Brain tumors in mice are susceptible to blockade of epidermal growth factor receptor (EGFR) with October 2002 Featured Publication Temozolomide is a novel second-generation oral alkylating agent with demonstrated efficacy and safety in patients with recurrent glioblastoma multiforme (GBM) and anaplastic astrocytoma (AA). A multicenter phase trial was conducted to determine the effi ... [A phase II study of temozolomide in patients with newly diagnosed supratentorial malignant glioma therapy. ](/publication/669217) item](https://www.ncbi.nlm.nih.gov/pubmed/12356356) [Cite](/publication/669217#cite) Journal \u00b7 October 2002 Featured Publication Neoplastic meningitis, which is the diffuse involvement of the leptomeninges by infiltrating cancer cells, may be caused by many systemic tumors. The treatment options for neoplastic meningitis disease remain unsatisfactory. In this review article, we disc ... [Current options the Cancer Res \u00b7 September 2002 Featured Publication Irofulven is a novel, small molecular weight semisynthetic compound, derived from a family of mushroom toxins known as illudins. This DNA alkylating agent has a chemical structure unlike any other chemotherapeutic agent in clinical use. The molecule is cur ... [Relation between Irofulven (MGI-114) systemic exposure and tumor response human solid tumor xenografts. ](/publication/669315) [Link to item](https://www.ncbi.nlm.nih.gov/pubmed/12231547) [Cite](/publication/669315#cite) Journal Article Mol Cancer Ther \u00b7 September 2002 Featured Publication We have previously demonstrated (A. E. Pegg, Cancer Res., 50: 6119-6129, 1990) that O6-benzylguanine in malignant glioma xenografts growing in athymic nude mice. More recently, we ha ... [O6-benzylguanine-mediated enhancement of chemotherapy. ](/publication/674965) [Link to item](https://www.ncbi.nlm.nih.gov/pubmed/12481416) [Cite](/publication/674965#cite) Journal Article Mol Cancer Ther 2002 Featured Publication Medulloblastoma (D-341 MED) and rhabdomyosarcoma (TE-671) cell lines, which are resistant to either 1,3-bis(2-chloroethyl)-1-nitrosourea (BCNU) or the combination of BCNU and O6-benzylguanine (O6-BG), were generated by serial escalation of BCNU. The activi ... [Mechanisms of Journal Article Clin Oncol \u00b7 July 1, 2002 Featured Publication PURPOSE: To assess the rate of tumor response and activity of carboplatin in stabilizing the growth of progressive low-grade gliomas. PATIENTS AND METHODS: Eligible patients received carboplatin 560 mg/m(2) intravenously every 4 weeks for 1 year after maxi ... [Phase II study of to item](https://www.ncbi.nlm.nih.gov/pubmed/12089224) [Cite](/publication/709847#cite) Journal Article Cancer Res \u00b7 June 15, 2002 Featured Publication The gene most commonly altered in human glioblastomas is the epidermalgrowth factor receptor (EGFR). We profiled transcripts induced by mutantEGFR to better understand its role in tumor progression. The pattern found suggested enhanced tumor invasion. The ... [Mutant epidermal growth factor receptor up-regulates invasion. ](/publication/669982) [Link to item](https://www.ncbi.nlm.nih.gov/pubmed/12067969) [Cite](/publication/669982#cite) Journal Article Cancer \u00b7 May 15, 2002 Featured Publication BACKGROUND: Astrocytoma is a primary brain tumor that affects 20,000 Americans each year. To date, only age and histologic grade stand out as independent predictors of survival. There is now increased interest in the use of molecular markers as objective s ... [Molecular markers of prognosis to item](https://www.ncbi.nlm.nih.gov/pubmed/12173338) [Cite](/publication/709876#cite) Journal Article J Neurosurg \u00b7 May 2002 Featured Publication Adjuvant use of 1,3-bis(2-chloroethyl)-1-nitrosourea (BCNU) wafers with surgical resection is becoming common for the treatment of malignant gliomas. Cyst formation in the tumor resection cavity is a recently described complication associated with the use ... [Management of tumor bed cysts after chemotherapeutic wafer implantation. four cases. ](/publication/678319) text](https://dx.doi.org/10.3171/jns.2002.96.5.0941) [Link to item](https://www.ncbi.nlm.nih.gov/pubmed/12005403) [Cite](/publication/678319#cite) Journal Article Arch Pathol Lab Med \u00b7 May 2002 Featured Publication CONTEXT: Brain tumors are the most common solid tumor in childhood, and medulloblastoma is the most common malignant brain tumor in this age group. Cytogenetic abnormalities that have been described in childhood medulloblastoma include loss of 17p, amplifi hybridization Oncol \u00b7 May 1, 2002 Featured Publication PURPOSE: We conducted a phase II trial of carmustine (BCNU) plus the O(6)-alkylguanine-DNA alkyltransferase inhibitor O(6)-benzylguanine (O(6)-BG) to define the activity and toxicity of this regimen in the treatment of adults with progressive or recurrent ... [Phase II trial of carmustine plus O(6)-benzylguanine for patients recurrent Oncol \u00b7 April 2002 Featured Publication A phase II study of irinotecan (CPT-11) was conducted at Duke University Medical Center, Durham, NC, to evaluate the activity of this agent in children with high-risk malignant brain tumors. A total of 22 children were enrolled in this study, including 13 ... [Phase II study of irinotecan (CPT-11) in children with high-risk malignant brain tumors: experience. ](/publication/694076) Journal Article Neuro \u00b7 April 2002 Featured Publication Cell lines and xenografts derived from medulloblastomas are useful tools to investigate the chromosomal changes in these tumors. Here we used G-banding, fluorescence in situ hybridization (FISH), spectral hybridiz ... molecular cytogenetic investigation of J Clin Oncol \u00b7 April 2002 This phase II study was designed to evaluate the safety, tolerability, and efficacy of irinotecan (CPT-11) in the treatment of adults with malignant glioma. Patients with progressive or recurrent malignant gliomas were enrolled. CPT-11 was administered as ... [Irinotecan treatment for recurrent Oncol \u00b7 March 1, 2002 Featured Publication PURPOSE: To assess the efficacy and toxicity of intraresection cavity (131)I-labeled murine antitenascin monoclonal antibody 81C6 and determine its true response rate among patients with newly diagnosed malignant glioma. PATIENTS AND METHODS: In this phase ... of murine administered into surgically created with text](https://dx.doi.org/10.1200/JCO.2002.20.5.1389) [Link to item](https://www.ncbi.nlm.nih.gov/pubmed/11870184) [Cite](/publication/730628#cite) Journal \u00b7 January 15, 2002 Featured Publication BACKGROUND: Medulloblastomas are small cell embryonal tumors of the cerebellum found predominantly in children, only slightly more than half of whom survive. Predicting favorable outcome has been difficult, and improved stratification clearly is required t ... [Histopathologic grading [Link to item](https://www.ncbi.nlm.nih.gov/pubmed/11900240) [Cite](/publication/669126#cite) Journal Article Cancer Treat Res \u00b7 2002 Featured Publication [Cellular mechanisms of cyclophosphamide resistance: model studies in [Link to item](https://www.ncbi.nlm.nih.gov/pubmed/12481718) 2002 Featured Publication OBJECTIVE: Dendritic cells (DCs) are specialized cells of the immune system that are capable of generating potent immune responses that are active even within the \"immunologically privileged\" central nervous system. However, immune responses generated by D ... [Dendritic cells pulsed with a tumor-specific peptide \u00b7 December 2001 Elevated levels of choline (trimethyl-2-hydroxyethylammonium) and choline kinase (CK) development of positron-labeled choline analogs for noninvasive detection of cancer using PET. The aim of this study ... [Synthesis and evaluation of (18)F-labeled ](/publication/669465) [Link to item](https://www.ncbi.nlm.nih.gov/pubmed/11752077) [Cite](/publication/669465#cite) Journal Article Clinical Cancer Research \u00b7 November 1, 2001 [A phase I trial of PTK787/ZK 222584 (PTK/ZK), a novel Journal Article Cancer Chemother Pharmacol \u00b7 November 2001 PURPOSE: This study was conducted to define the activity of irofulven in the treatment of a series of xenografts derived from human glioblastoma multiforme growing subcutaneously and [Cite](/publication/675085#cite) Journal Article Clinical Cancer Research \u00b7 November 1, 2001 [Characterization of molecular mechanisms of resistance to 1,3-bis(2-chloroethyl)-1-nitrosourea alone or in combination with O-6-benzylguanine in human medulloblastoma and rhabdomyosarcoma cell lines. ](/publication/872063) [Link to item](http://gateway.webofknowledge.com/gateway/Gateway.cgi?GWVersion=2&SrcApp=PARTNER_APP&SrcAuth=LinksAMR&KeyUT=WOS:000172121800418&DestLinkType=FullRecord&DestApp=ALL_WOS&UsrCustomerID=47d3190e77e5a3a53558812f597b0b92) [Cite](/publication/872063#cite) Journal Article Clinical Cancer Research \u00b7 November 1, 2001 [Pharmacokinetics of CPT-11 in glioma patients: Pooled analysis of data NABTC, Both Gliadel wafers [1,3-bis(2-chloroethyl)-1-nitrosourea] and temozolomide (TEMO) have been shown in independent studies to prolong survival of patients with recurrent malignant glioma following surgery and radiotherapy. On the basis of preclinical eviden ... [Phase I study of Gliadel wafers September 2001 Featured Publication PURPOSE: The in vivo antitumor activity of a novel topoisomerase I inhibitor, J-107088, was tested in athymic nude mice bearing subcutaneous pediatric and adult malignant CNS J-107088 administered I inhibitor J-107088 [6-N-(1-hydroxymethyla-2-hydroxyl) ethylamino-12,13-dihydro-13-(beta-D-glucopyranosyl) -5H-indolo[2,3-a]-pyrrolo[3,4-c]-carbazole-5,7(6H)-dione]] against ](/publication/675169) [Full Pharmacol \u00b7 July 2001 PURPOSE: The purpose of this investigation was to compare the antitumor activities of a series of acyl derivatives of 4-demethylpenclomedine (DM-PEN), the major plasma metabolite of penclomedine (PEN) observed to be an active antitumor agent in vivo and \u00b7 July 2001 PURPOSE: Camptothecins have emerged as an important new class of antitumor drugs. Camptothecin derivatives such as CPT-11 and topotecan are commercially available and approved for the treatment of colorectal (CPT-11) and ovarian and small-cell lung cancer ... [Therapeutic of 7-[(2-trimethylsilyl)ethyl)]-20 (S)-camptothecin [Cite](/publication/675340#cite) Journal Article Cancer \u00b7 May 1, 2001 Even with novel chemotherapeutic agents and external beam radiation therapy, the prognosis of neoplastic meningitis secondary to malignant melanoma is still dismal. The authors report a case study of a 46-year-old white female who presented with progressiv ... [Long term response in a patient with melanoma treated with to item](https://www.ncbi.nlm.nih.gov/pubmed/11335907) [Cite](/publication/718941#cite) Journal Article Journal of Nuclear Medicine \u00b7 May 1, 2001 [Radioimmunotherapy of recurrent glioma patients using item](http://gateway.webofknowledge.com/gateway/Gateway.cgi?GWVersion=2&SrcApp=PARTNER_APP&SrcAuth=LinksAMR&KeyUT=WOS:000168821900455&DestLinkType=FullRecord&DestApp=ALL_WOS&UsrCustomerID=47d3190e77e5a3a53558812f597b0b92) [Cite](/publication/865363#cite) Journal Ann Intern Med \u00b7 February 6, 2001 [Serum homocysteine and stroke Pharmacol \u00b7 2001 PURPOSE: The purpose of this study was to determine the usefulness of various 8-substituted O6-benzylguanine (BG) analogs as modulators of the DNA repair protein. O6-alkylguanine-DNA alkyltransferase (AGT). More specifically, the degree of Oncol \u00b7 2001 PURPOSE: To assess the efficacy and define the toxicity of paclitaxel given at a dosage of 350 mg/m2 every 3 weeks as a 24-hour continuous infusion to children with recurrent or progressive primary brain tumors. PATIENTS AND METHODS: Seventy-three eligible ... [Paclitaxel for the treatment of progressive or recurrent childhood brain tumors: a pediatric oncology phase II study. ](/publication/750848) to item](https://www.ncbi.nlm.nih.gov/pubmed/11464982) [Cite](/publication/750848#cite) Journal Article J Pers \u00b7 December 2000 There is now little doubt that individuals who are well-adjusted, socially stable, and well-integrated into their communities are at significantly lower risk for disease and premature mortality than those who are more unstable, impulsive, isolated, and ali ... [Long-term relations of Article Oncogene \u00b7 November 23, 2000 Homozygous deletions of human chromosome 9p21 occur frequently in malignant cell lines, and are also common in primary gliomas, lung cancers, and leukemias. Moving from the centromere to the telomere, this complex region encodes the tumor suppressor genes ... [A methylthioadenosine phosphorylase (MTAP) fusion transcript identifies a new gene on chromosome 9p21 that is frequently deleted in cancer. ](/publication/750849) [Full to item](https://www.ncbi.nlm.nih.gov/pubmed/11126361) [Cite](/publication/750849#cite) \u00b7 November 15, 2000 PURPOSE: To resection cavities (SCRCs) in malignant glioma patients and to identify any ob ... [Phase I trial results of iodine-131-labeled antitenascin monoclonal antibody 81C6 treatment of ](/publication/709741) [Full text](https://dx.doi.org/10.1200/JCO.2000.18.22.3862) [Link to item](https://www.ncbi.nlm.nih.gov/pubmed/11078500) [Cite](/publication/709741#cite) Journal Article Clinical Cancer Research \u00b7 November 1, 2000 [Oral administration of the specific EGFR tyrosine to item](http://gateway.webofknowledge.com/gateway/Gateway.cgi?GWVersion=2&SrcApp=PARTNER_APP&SrcAuth=LinksAMR&KeyUT=WOS:000165409000338&DestLinkType=FullRecord&DestApp=ALL_WOS&UsrCustomerID=47d3190e77e5a3a53558812f597b0b92) [Cite](/publication/861324#cite) \u00b7 November 1, 2000 [Effect of intracavitary radiation therapy for cerebral gliomas on relative cerebral blood volume in adjacent white matter: Assessment with perfusion MR imaging ](/publication/863610) [Link to item](http://gateway.webofknowledge.com/gateway/Gateway.cgi?GWVersion=2&SrcApp=PARTNER_APP&SrcAuth=LinksAMR&KeyUT=WOS:000090071300799&DestLinkType=FullRecord&DestApp=ALL_WOS&UsrCustomerID=47d3190e77e5a3a53558812f597b0b92) [Cite](/publication/863610#cite) Journal Article N Engl J Med \u00b7 October 19, 2000 [Observational studies and randomized trials. ](/publication/669319) [Link to item](https://www.ncbi.nlm.nih.gov/pubmed/11041760) [Cite](/publication/669319#cite) Article J Clin Oncol \u00b7 October 15, 2000 PURPOSE: The major mechanism of resistance to alkylnitrosourea therapy involves the DNA repair protein O(6)-alkylguanine-DNA alkyltransferase (AGT), which removes chloroethylation or of ... [Phase I trial of carmustine plus O6-benzylguanine recurrent or \u00b7 October 2000 The Pediatric Oncology Group conducted a phase II study to evaluate the activity of carboplatin in children 5 years or younger with progressive optic pathway tumors (OPTs). Of the 51 patients accrued to this study, 1 was not eligible because the child was ... [Carboplatin is effective therapy for young children with progressive optic pathway tumors: a Pediatric Oncology Group phase II study. ](/publication/669073) [Full text](https://dx.doi.org/10.1093/neuonc/2.4.213) [Link to item](https://www.ncbi.nlm.nih.gov/pubmed/11265230) [Cite](/publication/669073#cite) Journal Article Chest \u00b7 October 2000 BACKGROUND: Despite a long history of use in the treatment of paroxysmal atrial fibrillation (AF), the efficacy of cardiac glycosides has not been established. If such drugs are beneficial in this condition, the general view is that the benefit must be rel ... [Effects of cardiac glycosides Article Clin Cancer Res \u00b7 October 2000 The activity of temozolomide combined with irinotecan (CPT-11) was evaluated against eight independent xenografts (four neuroblastomas, three rhabdomyosarcomas, and one glioblastoma). In all studies, temozolomide was administered p.o. daily for 5 consecuti ... [Antitumor activity of temozolomide combined with irinotecan is partly independent of O6-methylguanine-DNA methyltransferase and mismatch in xenograft Exp Neurol \u00b7 October 2000 495 medulloblastomas (MBs) from 6 Pediatric Oncology Group (POG) protocols were reviewed to assess the incidence and prognostic item](https://www.ncbi.nlm.nih.gov/pubmed/11079775) 2000 Temozolomide, an imidazole tetrazinone, and CPT-11, a camptothecin derivative, have previously been shown to have anti-central nervous system tumor activity in laboratory and clinical studies. The current experiments were designed to evaluate the activity ... [Schedule-dependent activity of temozolomide plus CPT-11 against a system ](/publication/675280) [Link to item](https://www.ncbi.nlm.nih.gov/pubmed/11051270) [Cite](/publication/675280#cite) Res \u00b7 October 2000 Intracerebral microinfusion (ICM) is an innovative technique of delivering therapeutic agents throughout large portions of the brain that circumvents the blood-brain barrier, minimizes systemic toxicity, and provides a homogeneous distribution of the infus ... [Temozolomide delivered by intracerebral microinfusion is safe and malignant gliomas in rats. ](/publication/694168) [Link to item](https://www.ncbi.nlm.nih.gov/pubmed/11051269) [Cite](/publication/694168#cite) Journal Article J Neurosci \u00b7 September 1, 2000 Areas V1 and V2 of the visual cortex have traditionally been conceived as stages of local feature representations. We investigated whether neural responses carry information about how local features belong to objects. Single-cell activity was recorded in a ... [Coding of border ownership in text](https://dx.doi.org/10.1523/JNEUROSCI.20-17-06594.2000) [Link to item](https://www.ncbi.nlm.nih.gov/pubmed/10964965) [Cite](/publication/669104#cite) Journal Cancer \u00b7 September 2000 A randomized, multicentre, open-label, phase II study second-generation alkylating agent, and procarbazine 225 patients with glioblastoma multiforme at first relapse. Primary objectives were to determine progre ... [A phase II study of temozolomide vs. August 2000 [Can O6-alkylguanine-DNA alkyltransferase depletion item](https://www.ncbi.nlm.nih.gov/pubmed/10955771) Article J Clin Oncol \u00b7 August 2000 PURPOSE: To evaluate prospectively the effects on survival, relapse-free survival, and patterns of relapse of reduced-dose (23.4 Gy in 13 fractions) compared with standard-dose (36 Gy in 20 fractions) neuraxis irradiation in patients 3 to 21 years of age w ... [Low-stage medulloblastoma: final analysis of 2000 Malignant gliomas (glioblastoma multiforme and anaplastic astrocytoma) occur more frequently than other types of primary central nervous system tumors, having a combined incidence of 5-8/100,000 population. Even with aggressive treatment using surgery, rad ... [Temozolomide and treatment of malignant Journal Article Neuro Oncol Cytogenetic and molecular genetic studies of glioblastoma multiforme (GBM) have shown that the most frequent alterations are gains of chromosome 7, losses of 9p loci and chromosome 10, and gene amplification, primarily of the epidermal growth factor recept ... [Comparative genetic patterns of glioblastoma classification. ](/publication/678266) [Full text](https://dx.doi.org/10.1093/neuonc/2.3.164) [Link to item](https://www.ncbi.nlm.nih.gov/pubmed/11302337) [Cite](/publication/678266#cite) Journal Article Cancer Chemotherapy and Pharmacology \u00b7 July 1, 2000 [Schedule-dependent activity of irinotecan plus BCNU against malignant glioma xenografts 45, pg 345, 1999) ](/publication/865456) [Link to item](http://gateway.webofknowledge.com/gateway/Gateway.cgi?GWVersion=2&SrcApp=PARTNER_APP&SrcAuth=LinksAMR&KeyUT=WOS:000088203400014&DestLinkType=FullRecord&DestApp=ALL_WOS&UsrCustomerID=47d3190e77e5a3a53558812f597b0b92) [Cite](/publication/865456#cite) Journal Article Seminars in Oncology \u00b7 June 30, 2000 Temozolomide is a novel, oral, second-generation alkylating agent. Preclinical and phase I/II studies have demonstrated its efficacy against newly diagnosed high-grade glioma and anaplastic astrocytoma, its antineoplastic effect is accompanied by quality o ... [Temozolomide in early stages of newly diagnosed malignant meningitis ](/publication/772101) [Cite](/publication/772101#cite) Journal Article Proc Natl Acad Sci U S A \u00b7 June 20, 2000 The epidermal growth factor receptor (EGFR) is often amplified and rearranged structurally in tumors of the brain, breast, lung, and ovary. The most common mutation, EGFRvIII, is characterized by an in-frame deletion of 801 base pairs, resulting in the gen ... [Unarmed, tumor-specific antibody to item](https://www.ncbi.nlm.nih.gov/pubmed/10852962) [Cite](/publication/678308#cite) Journal Article Seminars in Oncology \u00b7 June 1, 2000 [Temozolomide in early stages of newly diagnosed malignant glioma and Temozolomide is a novel, oral, second-generation alkylating agent. Preclinical and phase I/II studies have demonstrated its efficacy against newly diagnosed high-grade glioma and anaplastic astrocytoma. Its antineoplastic effect is accompanied by quality o ... [Temozolomide in early stages of newly diagnosed neoplastic meningitis. ](/publication/669133) Biol Phys \u00b7 June 1, 2000 PURPOSE: To compare the proportion of patients that survive at least 1 year following treatment with hyper-fractionated radiotherapy (HRT) to a dose of 70.2 Gy on Pediatric Oncology Group (POG) study #8495 with that of patients treated with similar radioth ... [A detrimental effect of a combined chemotherapy-radiotherapy approach in children with diffuse intrinsic brain stem gliomas? \u00b7 April 2000 Loss of portions of chromosome 17p, usually through the formation of i(17qp) is a well-known finding in medulloblastomas. Loss of heterozygosity (LOH) studies, however, occasionally demonstrate loss of the more distal portions of 17p, a pattern which is mo ... [Characterization of chromosome to item](https://www.ncbi.nlm.nih.gov/pubmed/10787031) [Cite](/publication/694105#cite) Cancer Res \u00b7 March 2000 The antitumor activity of the methylating agent temozolomide has been evaluated against a panel of 17 xenografts derived from pediatric solid tumors. Temozolomide was administered p.o. daily for five consecutive days at a dose level of 66 mg/kg. Courses of ... [Biochemical correlates of temozolomide sensitivity in solid tumor xenograft models. ](/publication/669154) [Link Biol Phys \u00b7 March 1, 2000 PURPOSE: The objective of this study was to perform the dosimetry and evaluate the dose-response relationships in newly diagnosed patients with malignant brain tumors treated by direct injections of (131)I-labeled 81C6 monoclonal antibody (MAb) into surgic ... [Dosimetry relationships in newly patients malignant gliomas treated Journal Article J Pers \u00b7 February 2000 The goals of this study were: (a) to examine whether personality scales, meaningful in contemporary terms, could be derived from archival data; and (b) to use these scales to aid our understanding of the relation of personality to mortality. NEO PI-R data ... [Comparing personality scales across time: an illustrative study of validity and consistency in data. ](/publication/669170) [Full text](https://dx.doi.org/10.1111/1467-6494.00092) [Link 2000 Cyclophosphamide is an alkylating agent that has shown activity in the treatment of pediatric brain tumors, including high-grade gliomas. This study was designed to evaluate the response of patients with newly diagnosed glioblastoma multiforme to pre-radio ... [Evaluation with newly diagnosed glioblastoma multiforme. Writing Committee for The Brain Tumor Center at Duke. ](/publication/669320) [Full text](https://dx.doi.org/10.1023/a:1006258026274) Oncol \u00b7 2000 PURPOSE: Children with recurrent or progressive central nervous system (CNS) tumors have an unfavorable prognosis. Based on Pediatric Oncology Group (POG) institutional pilot data, low-dose oral methotrexate Eight dosages of ... [Oral methotrexate for recurrent brain tumors study. ](/publication/669392) Electrophysiol \u00b7 January 2000 The number and intensity of stimuli that set basic cycle length in cardiac electrophysiological studies can influence the electrical properties assessed by extrastimuli. The relative contribution of drive (S1) and test (S2) stimulus intensity in defining m ... [The comparative effects of drive and test stimulus intensity on myocardial excitability and vulnerability. ](/publication/669425) [Full text](https://dx.doi.org/10.1111/j.1540-8159.2000.tb00653.x) [Link to item](https://www.ncbi.nlm.nih.gov/pubmed/10666757) [Cite](/publication/669425#cite) Journal Article Vision Res \u00b7 2000 Form perception in random-dot stereograms is based on information that resides in the correlation between the two images, but is not present in either image alone. We have studied the coding of stereoscopic figures in the neural activity of areas V1 and V2 ... 2000 PURPOSE: evaluate the role of 1,3-bis(2-chloroethyl)-1-nitrosourea (BCNU) plus O6-benzylguanine (O6-BG) in the treatment of both Mer+ and Mer- tumors. METHODS: The effect of pretreatment with O6-BG on the activity of BCNU against Mer- human central nerv ... [O6-benzylguanine-mediated enhancement of nitrosourea activity in Mer- central tumor xenografts--implications trials. ](/publication/675018) Pharmacol \u00b7 2000 PURPOSE: To further evaluate the activity of irinotecan (CPT-11) plus 1,3-bis-(chloroethyl)-1-nitrosourea (BCNU) in the treatment of central nervous system tumor-derived xenografts in athymic nude mice. METHODS: We report studies the schedule-de ... [Schedule-dependent radiolabeled analogues of 6-benzyloxy-9H-purin-2-ylamine (O(6)-benzylguanine; BG) potentially mapping of O(6)-alkylguanine-DNA alkyltransferase (AGT) were the ... [Radiolabeled guanine and Pharmacology \u00b7 January 1, 2000 [Erratum: Schedule-dependent activity of irinotecan plus BCNU against malignant Chemotherapy and Pharmacology 45 (345- 349)) ](/publication/760918) [Cite](/publication/760918#cite) Journal Article Cancer Chemotherapy and Pharmacology \u00b7 2000 Purpose: To evaluate the role of 1,3-bis(2-chloroethyl)-l-nitrosourea (BCNU) plus O6-benzylguanine (O6-BG) in the treatment of both Mer+ and Mer- tumors. Methods: The effect of pretreatment with O6-BG on the activity of BCNU against Mer- human central nerv ... [O6-benzylguanine-mediated enhancement of nitrosourea activity in Mer- central nervous system tumor xenografts - Implications for clinical trials ](/publication/760919) [Cite](/publication/760919#cite) Journal Article Clinical Cancer Research \u00b7 2000 [Can O6-Alkylguanine-DNA alkyltransferase depletion enhance alkylator activity in the clinic? [Cite](/publication/772102#cite) Journal Article Psychol Aging \u00b7 December 1999 Age-related changes in the associations of social network ties with mortality risk were investigated using data from the Terman Life-Cycle Study (L. M. Terman, 1925; L. M. Terman & M. H. Oden, 1947, 1959). Marital status, number of living children, number ... [Age-related changes in the associations of social network ties with mortality risk. ](/publication/669308) [Full text](https://dx.doi.org/10.1037/0882-7974.14.4.564) [Link to item](https://www.ncbi.nlm.nih.gov/pubmed/10632145) \u00b7 September 1999 PURPOSE: To determine the antitumor efficacy and safety profile of temozolomide in patients with malignant astrocytoma at first relapse. PATIENTS AND METHODS: This open-label, multicenter, 162 patients [ITT] populat ... [Multicenter phase II astrocytoma or anaplastic [Cite](/publication/678279#cite) Journal Article Clin Res \u00b7 September 1999 The incidence of neoplastic meningitis is on the rise. Neoplastic meningitis can result from a direct seeding of the neuraxis by primary brain tumors or by hematogeneous spread of systemic solid tumors. A frequent genetic alteration in primary brain tumors ... [Regional treatment of epidermal growth [Cite](/publication/694157#cite) Journal Article European Journal of Nuclear Medicine \u00b7 September 1, 1999 [Astatine-211 labeled chimeric anti-tenascin antibody: Phase I trial in resection cavity patients ](/publication/865349) [Link to item](http://gateway.webofknowledge.com/gateway/Gateway.cgi?GWVersion=2&SrcApp=PARTNER_APP&SrcAuth=LinksAMR&KeyUT=WOS:000082614101020&DestLinkType=FullRecord&DestApp=ALL_WOS&UsrCustomerID=47d3190e77e5a3a53558812f597b0b92) [Cite](/publication/865349#cite) Journal Article Am J Pathol \u00b7 August 1999 Oligodendroglial neoplasms are a subgroup of gliomas with distinctive morphological characteristics. In the present study we have evaluated a series of these tumors to define their molecular profiles and to determine whether there is a relationship between ... [Molecular genetic aspects of oligodendrogliomas Med \u00b7 July 1999 BACKGROUND: Verapamil is an effective drug to slow ventricular rate in atrial fibrillation (AF). Clinically, however, i.v. verapamil enhances AF despite experimental evidence suggesting favorable effects of the drug on AF-induced electrical remodeling of t ... [Verapamil prolongs atrial fibrillation by evoking ](/publication/669377) [Link to item](https://www.ncbi.nlm.nih.gov/pubmed/10431484) [Cite](/publication/669377#cite) Journal Article J Neurooncol \u00b7 May 1999 Topotecan was studied as a 72 h infusion given every 3 weeks. Treatment began at a dose of 1.0 mg/m2/day and was increased to 1.25 mg/m2/day after the first 6 patients tolerated this higher dose without excessive toxicities. Eighty-eight evaluable children ... [Topotecan for the treatment of recurrent or progressive central nervous system tumors - a pediatric oncology group phase II study. ](/publication/669372) [Full text](https://dx.doi.org/10.1023/a:1006294102611) [Link to item](https://www.ncbi.nlm.nih.gov/pubmed/10448870) [Cite](/publication/669372#cite) May 1999 Neoplastic meningitis (NM) results from leptomeningeal dissemination of cancers arising within the central nervous system or metastasizing to the leptomeninges from systemic neoplasms. The inability to produce therapeutic drug levels intrathecally Oncol \u00b7 May 1999 PURPOSE: To determine the activity, toxicity, and pharmacokinetics of irinotecan (CPT-11, Camptosar; Pharmacia & Upjohn, Kalamazoo, MI) in the treatment of adults with progressive, persistent, or recurrent malignant glioma. PATIENTS AND METHODS: Patients w ... [Irinotecan therapy in adults with recurrent \u00b7 April 1999 [The treatment of malignant brain tumors in infants and very young children: an update of the Pediatric Oncology Group experience. ](/publication/669257) text](https://dx.doi.org/10.1093/neuonc/1.2.152) [Link to item](https://www.ncbi.nlm.nih.gov/pubmed/11554387) Article J Nucl Med \u00b7 April 1999 UNLABELLED: The objective of this study was to perform the dosimetry of 131I-labeled 81C6 monoclonal antibody (MAb) in patients with recurrent malignant brain tumors, treated by direct injections of MAb into surgically created into surgically created resection cavities in patients with malignant brain tumors. ](/publication/686857) [Link [Cite](/publication/686857#cite) Journal Article Int Biol Phys \u00b7 March 15, 1999 PURPOSE: In June 1992, POG began accrual to a phase III study, POG-9239, designed to compare the time to disease progression, overall survival, and toxicities observed in children with newly diagnosed brainstem tumor treated with 100 mg/m2 of infusional ci ... [There is no role for hyperfractionated radiotherapy in the management of children with newly diagnosed diffuse intrinsic brainstem tumors: results of a Pediatric Oncology Group phase III comparing conventional [Full text](https://dx.doi.org/10.1016/s0360-3016(98)00501-x) [Link to \u00b7 March 1, 1999 BACKGROUND: Topotecan activity was evaluated for the treatment of malignant glioma. METHODS: Sixty-three patients with newly diagnosed (n = 25) or recurrent (n = 38) malignant glioma were treated with topotecan [AU: Please verify all dosages here and throu ... [Topotecan treatment of adults with primary malignant glioma. The Brain Tumor Center at Duke. ](/publication/694092) [Link to item](https://www.ncbi.nlm.nih.gov/pubmed/10091802) [Cite](/publication/694092#cite) Journal Article J Neurosci Methods \u00b7 February 1, 1999 Stimulus response latency is the delay between stimulus onset and the evoked modulation in neural activity. A common technique to estimate latencies involves binning the spike arrival times to form histogram smoothed AIMS: We have reviewed immunohistochemically 17 paediatric medulloblastomas in order to determine if correlations exist that might be useful in subclassifying these tumours. METHODS AND RESULTS: The patient group included 11 children who had died (mean sur ... [Diagnostic markers in Journal Article Anticancer Res \u00b7 1999 Evidence has been presented that tumor suppressor genes p53 and Rb play a crucial role in the development of both human prostate and bladder cancer. Patients with either cancer are at an increased risk for developing the other malignancy as compared to the ... [Expression of p53 and pRb in bladder and prostate cancers of patients having both cancers. ](/publication/1505873) [Link to item](https://www.ncbi.nlm.nih.gov/pubmed/10697570) [Cite](/publication/1505873#cite) Journal Article J Pediatr Hematol Oncol \u00b7 1999 PURPOSE: Results of a phase II trial of cyclophosphamide (CPM) for children with progressive low-grade astrocytoma are reported. PATIENTS AND METHODS: Fifteen patients with a median age of 39 months (range, 2 to 71) were included in this study. The tumors ... [Cyclophosphamide for the treatment of progressive low-grade astrocytoma: a Oncology Group [Link to item](https://www.ncbi.nlm.nih.gov/pubmed/10363852) [Cite](/publication/669226#cite) Res \u00b7 January 1999 O6-benzylguanine (BG) is a potent, specific inactivator of the DNA repair protein O6-alkylguanine-DNA alkyltransferase (AGT), which enhances sensitivity to nitrosoureas in cells and tumor-bearing animals. BG is presently undergoing clinical trials for deve ... [Lack of evidence for a polymorphism at codon 160 of human O6-alkylguanine-DNA alkyltransferase gene in normal tissue and cancer. ](/publication/669260) [Link to item](https://www.ncbi.nlm.nih.gov/pubmed/9918221) [Cite](/publication/669260#cite) Journal Article Perception \u00b7 1999 Color filling-in is a phenomenon in which the color of an object appears to be filled-in by the color of the surrounding field. We have studied the question of whether monkeys perceive color filling-in with near-foveal stimuli under steady fixation. Two mo ... [Color filling-in under steady fixation: behavioral demonstration ](/publication/669334) [Full to PURPOSE: The human medulloblastoma cell line D283 Med (4-HCR), a line resistant to 4-hydroperoxycyclophosphamide (4-HC), displays enhanced repair of DNA interstrand crosslinks induced by phosphoramide mustard. D283 Pharmacol \u00b7 1999 PURPOSE: We have previously reported preferential repair of DNA interstrand crosslinks in the 4-hydroperoxycyclophosphamide-resistant human medulloblastoma cell line D-283 Med (4-HCR). We now report further studies that explored the potential mechanisms un ... [Multiple DNA repair mechanisms and alkylator resistance in the cell Article for malignant glioma. ](/publication/678306) item](https://www.ncbi.nlm.nih.gov/pubmed/10225006) [Cite](/publication/678306#cite) Journal Article J Neurooncol \u00b7 1999 The current study was designed to evaluate the toxicity and activity of Spartaject Busulfan, a microcrystalline preparation of busulfan, following its intrathecal administration into a nude rat model of human neoplastic meningitis. Animals were treated thr 1999 [Temozolomide ](/publication/772104) [Full text](https://dx.doi.org/10.2165/00023210-199912030-00007) [Cite](/publication/772104#cite) Journal Article Laboratory Investigation \u00b7 January 1, 1999 [Gliomas of the optic nerve in children and adults. ](/publication/873146) [Link to item](http://gateway.webofknowledge.com/gateway/Gateway.cgi?GWVersion=2&SrcApp=PARTNER_APP&SrcAuth=LinksAMR&KeyUT=WOS:000078376601011&DestLinkType=FullRecord&DestApp=ALL_WOS&UsrCustomerID=47d3190e77e5a3a53558812f597b0b92) [Cite](/publication/873146#cite) Journal Article J Clin Oncol \u00b7 December 1998 PURPOSE: We evaluated the response to Temodal (Schering-Plough Research Institute, Kenilworth, NJ) of patients with newly diagnosed malignant glioma, as well as the predictive value of quantifying tumor DNA mismatch repair activity and O6-alkylguanine-DNA ... [DNA mismatch repair and O6-alkylguanine-DNA alkyltransferase analysis and in item](https://www.ncbi.nlm.nih.gov/pubmed/9850030) [Cite](/publication/730624#cite) Journal 24, 1998 Clinical results with irinotecan (CPT-11 [Camptosar]) and other camptothecin derivatives in various cancers, although encouraging, have fallen short of the expectations predicted by preclinical models. One proposed explanation for this is that preclinical ... [Preclinical and clinical results with irinotecan: Extending principles learned in model systems to clinical trials design ](/publication/750851) [Cite](/publication/750851#cite) Journal Article Eur J Cancer \u00b7 ](/publication/678221) [Full Oncol \u00b7 November 1998 PURPOSE: The major mechanism of resistance to alkylnitrosourea therapy is the DNA repair protein O6-alkylguanine-DNA alkyltransferase (AGT), which removes chlorethylation guanine. is an ... [Phase I trial of undergoing glioma. ](/publication/709889) [Link to item](https://www.ncbi.nlm.nih.gov/pubmed/9817277) [Cite](/publication/709889#cite) Journal Article Neurosci Methods \u00b7 September 1, 1998 Stimulus response latency is the delay in the onset of stimulus-evoked neuronal activity. We develop maximum likelihood and least squares estimators of stimulus response latency and present a comparison of the performance of these methods with estimators c ... [Estimating Journal Article Ann Neurol \u00b7 September 1998 Between 1986 and 1990, the Pediatric Oncology Group conducted a study in which 198 children younger than 3 years of age with malignant brain tumors were treated with prolonged postoperative chemotherapy in an effort to delay irradiation and reduce long-ter ... [Second malignancies in young children with primary brain tumors following treatment with prolonged postoperative chemotherapy and delayed irradiation: a Pediatric [Full \u00b7 September 1998 Fifty-five patients with atypical teratoid/rhabdoid tumors of the central nervous system were studied to define the clinical and pathologic features of this newly described neoplasm. The lesion occurred primarily in children younger than 2 (mean age at dia ... [Atypical teratoid/rhabdoid tumor of the central nervous system: a highly malignant tumor of infancy and childhood frequently mistaken for medulloblastoma: a Pediatric Oncology Group study. Article August 1998 Clinical results with irinotecan (CPT-11 [Camptosar]) and other camptothecin derivatives in various cancers, although encouraging, have fallen short of the expectations predicted by preclinical models. One proposed explanation for this is that preclinical ... [Extending principles learned in model systems to clinical trials design. ](/publication/669481) [Link to item](https://www.ncbi.nlm.nih.gov/pubmed/9726098) [Cite](/publication/669481#cite) Journal Article Oncology New York \u00b7 August 1, 1998 [Preclinical and clinical results with irinotecan - Extending principles learned in model systems to clinical trials design ](/publication/878368) [Link to item](http://gateway.webofknowledge.com/gateway/Gateway.cgi?GWVersion=2&SrcApp=PARTNER_APP&SrcAuth=LinksAMR&KeyUT=WOS:000075568500014&DestLinkType=FullRecord&DestApp=ALL_WOS&UsrCustomerID=47d3190e77e5a3a53558812f597b0b92) [Cite](/publication/878368#cite) Journal Article Med Pediatr Oncol \u00b7 July 1998 BACKGROUND: Exploration of the role of chemotherapy in the treatment of low grade glioma, including oligodendroglioma, has been limited to the pediatric population, reflecting the sensitivity of young patients to radiation-induced toxicity and a desire to ... [Treatment of adults with progressive oligodendroglioma with carboplatin (CBDCA): preliminary results. Writing Committee for The Brain Tumor Center at Duke. ](/publication/678313) [Full text](https://dx.doi.org/10.1002/(sici)1096-911x(199807)31:1<16::aid-mpo3>3.0.co;2-2) [Link to item](https://www.ncbi.nlm.nih.gov/pubmed/9607424) June 1998 PURPOSE: To determine the maximum-tolerated (MTD) of iodine 131 (131I)-labeled 81C6 monoclonal antibody (mAb) in brain tumor patients with surgically created resection cavities (SCRCs) and to identify any objective responses to this treatment. METHODS ... [Iodine-131-labeled antitenascin monoclonal antibody 81C6 treatment of patients with gliomas: phase I trial results. ](/publication/709767) [Full text](https://dx.doi.org/10.1200/JCO.1998.16.6.2202) [Link to item](https://www.ncbi.nlm.nih.gov/pubmed/9626222) [Cite](/publication/709767#cite) Journal Article Clinical Cancer Research : an Official Journal of the American Association for Cancer Research \u00b7 June 1998 During replication, the primary function of the eukaryotic DNA mismatch repair (MMR) system is to recognize and correct mismatched base pairs within the DNA helix. Deficiencies in MMR have been reported previously in cases of hereditary nonpolyposis colore ... [Analysis of DNA mismatch repair proteins medulloblastoma. ](/publication/724133) [Cite](/publication/724133#cite) Journal Article J Clin Oncol \u00b7 May 1998 PURPOSE: The purpose of this study was to test the hypothesis that survivors of medulloblastoma who were younger at diagnosis and those who received standard-dose cranial irradiation (SRT) of 36 Gy would have a lower performance on standardized tests of co ... [Neuropsychologic functioning of survivors of childhood medulloblastoma randomized to receive conventional or reduced-dose to item](https://www.ncbi.nlm.nih.gov/pubmed/9586884) [Cite](/publication/669225#cite) Journal Article Lab Invest \u00b7 May 1998 [Immunohistochemical detection of the DNA Journal Article Nuclear Medicine \u00b7 May 1, 1998 [N.C.A. 5-Iodo-1(2-deoxy,2-fluoro-beta-D-arabinofuranosyl)uracil (FIAU): Tissue uptake in ](/publication/878343) [Link to item](http://gateway.webofknowledge.com/gateway/Gateway.cgi?GWVersion=2&SrcApp=PARTNER_APP&SrcAuth=LinksAMR&KeyUT=WOS:000073560300408&DestLinkType=FullRecord&DestApp=ALL_WOS&UsrCustomerID=47d3190e77e5a3a53558812f597b0b92) [Cite](/publication/878343#cite) Journal Article Neurosurg Focus \u00b7 April 15, 1998 In this study, the authors sought to investigate the response rate and toxicity of carboplatin in patients with progressive low-grade glioma (LGG). Thirty-two patients with progressive LGG were treated with carboplatin at a dosage of 560 mg/m(2). Treatment ... [Phase April 1998 The Pediatric Oncology Group (1986-1990) conducted a study in which 48 children <3 years of age with intracranial ependymomas were treated with prolonged postoperative chemotherapy (CT) and delayed RT. Thirty-one children, 0-23 months of age at diagnosis ( ... [Prognostic factors in infants and ](/publication/669080) Pediatr Oncol \u00b7 February 1998 Seventeen patients less than or equal to 20 years of age with newly diagnosed (n = 10) or recurrent (n = 7) malignant gliomas (anaplastic astrocytoma and glioblastoma multiforme) ... [Activity of activity of vinorellbine, a new semisynthetic vinca alkaloid, was evaluated against a battery of human tumor xenografts derived from adult and pediatric CNS malignancies. METHODS: Tumors c ... [Therapeutic efficacy of vinorelbine against pediatric and adult central system tumors. ](/publication/675033) [Full text](https://dx.doi.org/10.1007/s002800050848) [Link to item](https://www.ncbi.nlm.nih.gov/pubmed/9788574) [Cite](/publication/675033#cite) Journal Article Cancer Chemother Pharmacol \u00b7 1998 Two major obstacles in the treatment of patients with central nervous system malignancies are drug resistance and host toxicity. The goal of combination chemotherapy is to achieve therapeutic effects that are more favorable than using a single drug alone, ... [Enhancement of irinotecan (CPT-11) activity against central ](/publication/675332) [Full text](https://dx.doi.org/10.1007/s002800050771) [Link to item](https://www.ncbi.nlm.nih.gov/pubmed/9554593) Journal Article Modern Pathology \u00b7 January 1, 1998 [DNA mismatch repair enzyme detection in 1998 [Patterns of CNS involvement and clinical outcome in trilateral retinoblastoma ](/publication/889618) [Link to item](https://www.webofscience.com/api/gateway?GWVersion=2&SrcApp=PARTNER_APP&SrcAuth=LinksAMR&KeyUT=WOS:000076659700250&DestLinkType=FullRecord&DestApp=ALL_WOS&UsrCustomerID=47d3190e77e5a3a53558812f597b0b92) [Cite](/publication/889618#cite) Journal Article Cancer Research \u00b7 November 1, 1997 [Methylator resistance mediated by mismatch repair deficiency in a glioblastoma multi forme xenograft (vol 57, pg 2933, 1997) ](/publication/1106239) [Link to item](http://gateway.webofknowledge.com/gateway/Gateway.cgi?GWVersion=2&SrcApp=PARTNER_APP&SrcAuth=LinksAMR&KeyUT=WOS:A1997YD35800049&DestLinkType=FullRecord&DestApp=ALL_WOS&UsrCustomerID=47d3190e77e5a3a53558812f597b0b92) [Cite](/publication/1106239#cite) Journal Article Clinical Chemistry \u00b7 November 1, 1997 [Pten gene mutations are seen in high grade, but not in low grade gliomas. ](/publication/878328) [Link to item](http://gateway.webofknowledge.com/gateway/Gateway.cgi?GWVersion=2&SrcApp=PARTNER_APP&SrcAuth=LinksAMR&KeyUT=WOS:A1997YE07200064&DestLinkType=FullRecord&DestApp=ALL_WOS&UsrCustomerID=47d3190e77e5a3a53558812f597b0b92) [Cite](/publication/878328#cite) Journal Article Cancer Res \u00b7 October 1, 1997 The PTEN gene, located on 10q23, has recently been implicated as a candidate tumor suppressor gene in brain, breast and prostate tumors. In the present study, 123 brain tumors, including various grades and histological types of gliomas occurring in childre ... [PTEN gene mutations are low-grade gliomas. Journal Article Cytogenet \u00b7 September 1997 In the present cytogenetic analysis of 116 pediatric brain tumors, chromosomal abnormalities were demonstrated in 44 cases, 48 cases revealed only 46,XX or 46,XY cells, and 24 cases were nonproductive. In contrast to studies of adult brain tumors in which ... [Chromosomal characteristics of childhood brain tumors. ](/publication/719204) item](https://www.ncbi.nlm.nih.gov/pubmed/9283596) [Cite](/publication/719204#cite) Journal Article J Pers Soc Psychol \u00b7 August 1997 Using an archival prospective design, the authors studied associations among parental divorce occurring during participants' childhood, adult psychosocial mediators, and mortality over the life span of a subgroup of participants (N = 1,261) in the Terman L ... [Parental divorce: text](https://dx.doi.org/10.1037//0022-3514.73.2.381) [Link to item](https://www.ncbi.nlm.nih.gov/pubmed/9248055) [Cite](/publication/669176#cite) Journal Article Cancer 15, 1997 A methylator-resistant human glioblastoma multiforme xenograft, D-245 MG (PR), in athymic nude mice was established by serially treating the parent xenograft D-245 MG with temozolomide, N-me ... [Methylator resistance Med \u00b7 June 1997 [Chronic CSF leak into the peritoneal cavity shown by radionuclide cisternography. Successful treatment with an text](https://dx.doi.org/10.1097/00003072-199706000-00010) [Link to item](https://www.ncbi.nlm.nih.gov/pubmed/9193811) [Cite](/publication/719189#cite) Journal Article J Med Chem \u00b7 May 23, 1997 Peripheral benzodiazepine receptors (PBRs) are located on the outer membrane of mitochondria, and their density is increased in brain tumors. Thus, they may serve as a unique intracellular and selective target for antineoplastic agents. A PBR ligand-melpha ... [Modulation of melphalan Lab Med \u00b7 May 1997 OBJECTIVE: Malignant neoplasms exhibiting mixed populations of neuronal and glial cells occurring in the cerebral hemispheres of young adults and children are well recognized, but rare. A confusing array of diagnostic terms has arisen. We describe two pati ... [Malignant supratentorial glial-neuronal neoplasms: report of two of the literature. ](/publication/694166) [Link to item](https://www.ncbi.nlm.nih.gov/pubmed/9167602) [Cite](/publication/694166#cite) Journal Article J Clin Oncol \u00b7 May 1997 PURPOSE: We treated 49 patients with recurrent or poor-prognosis CNS malignancies with high-dose chemotherapy regimens followed rescue with or without peripheral-blood stem-cell augmentation to determine the toxicity of and event-free ... [High-dose chemotherapy with autologous stem-cell rescue in patients with recurrent and high-risk pediatric brain tumors. ](/publication/709779) [Full text](https://dx.doi.org/10.1200/JCO.1997.15.5.1814) [Link to item](https://www.ncbi.nlm.nih.gov/pubmed/9164190) [Cite](/publication/709779#cite) Journal Article Med Pediatr Oncol \u00b7 February 1997 In recent years, major advances in the diagnosis and treatment of patients with brain tumors have been seen. Today, evaluation of the central nervous system almost always includes magnetic resonance imaging (MRI). The appearance of a new lesion on the MRI ... [False positive images in the follow-up of patients tumors. ](/publication/724136) [Full text](https://dx.doi.org/10.1002/(sici)1096-911x(199702)28:2<127::aid-mpo6>3.0.co;2-m) [Link to item](https://www.ncbi.nlm.nih.gov/pubmed/8986148) [Cite](/publication/724136#cite) Journal Article January 8, 1997 [Effectiveness of right heart catheterization: time for [Full text](https://dx.doi.org/10.1001/jama.277.2.111b) [Link to item](https://www.ncbi.nlm.nih.gov/pubmed/8990329) [Cite](/publication/669111#cite) Journal Article Cancer Research \u00b7 January 1, 1997 [Erratum: (Cancer Research (July 15, 1997) (2933-2936)) ](/publication/1505874) [Cite](/publication/1505874#cite) Journal Article Cancer Chemother Pharmacol \u00b7 1997 Therapy of patients with malignant central nervous system tumors is frequently unsuccessful, reflecting limitations of current surgical, radiotherapeutic, and pharmacotherapeutic treatments. The camptothecin derivative irinotecan (CPT-11) has been shown ... [Therapeutic efficacy of the topoisomerase I inhibitor 7-ethyl-10-(4-[1-piperidino]-1-piperidino)-carbonyloxy-camptothecin against pediatric and adult central ](/publication/675027) [Full Chemother Pharmacol \u00b7 1997 These studies evaluated the efficacy of sequential pretreatment with L-amino acid oxidase (LOX) and against intracranial glioma in athymic nude mice. LOX produced statistically significant < 0.01) de ... [L-amino 1997 Busulfan is an alkylating agent commonly used in the treatment of chronic myelogenous leukemia and in combination with cyclophosphamide in preparation for allogeneic bone marrow transplantation. Serial treatment of a childhood high-grade glioma xenograft ( ... [Characterization of Chemother Pharmacol \u00b7 1997 The prognosis for patients with malignant gliomas continues to be dismal. The high degree of resistance of gliomas to nitrosourea-based chemotherapy is one major factor in poor treatment outcome. The identification of O6-alkylguanine-DNA alkyltransferase ( ... [Intraarterial Journal Article N Y Acad Sci \u00b7 December 13, 1996 [Treatment of central nervous [Link to \u00b7 September 15, 1996 BACKGROUND: Bradycardia is commonly found in individuals at risk for paroxysmal atrial fibrillation (AF). However, a clear relationship between lengthening of basic cyclic length (BCL) and AF has not been demonstrated. METHODS AND RESULTS: In 20 open-chest ... [Zones of atrial text](https://dx.doi.org/10.1161/01.cir.94.6.1456) [Link to item](https://www.ncbi.nlm.nih.gov/pubmed/8823006) [Cite](/publication/669423#cite) Journal Article J Nucl Med \u00b7 September 1996 UNLABELLED: The purpose of this study was to investigate the potential role of FDG-PET in the monitoring of neoadjuvant therapy of soft-tissue and musculoskeletal sarcomas. METHODS: Nine patients studied. consisted of either chemot ... [Monitoring of ](/publication/736048) [Link to [Cite](/publication/736048#cite) Journal Article Cancer \u00b7 August 15, 1996 BACKGROUND: Does a \"delay in diagnosis\" lead to a child being diagnosed with advanced stage as opposed to early stage medulloblastoma? Correlation between the duration of a patient's presenting symptoms and stage at diagnosis was examined. METHODS: The pop ... [Is there a correlation between duration of presenting symptoms and stage of medulloblastoma at the time of diagnosis? ](/publication/669380) [Full text](https://dx.doi.org/10.1002/(SICI)1097-0142(19960815)78:4<874::AID-CNCR26>3.0.CO;2-R) [Link to item](https://www.ncbi.nlm.nih.gov/pubmed/8756384) [Cite](/publication/669380#cite) Journal Article R Soc Med \u00b7 August 1996 [Streptokinase versus alteplase August 1996 A paired-label biodistribution was performed in athymic mice bearing SK-N-SH human neuroblastoma xenografts to compare the tissue uptake of meta-[211At]astatobenzylguanidine ([211At]MABG) and [131I]MIBG. Significantly higher (p < 0.05) uptake of [211At]MAB ... [Evaluation of meta-[211At]astatobenzylguanidine July 1996 Leptomeningeal dissemination of childhood pilocytic astrocytoma (PA) is a rare event with little information available regarding therapy. We report here four children with disseminated PA whom we treated with high doses of cyclophosphamide with clinical be ... [Successful treatment of Oncol \u00b7 June 1996 PURPOSE: The outcome for patients with recurrent medulloblastoma has historically been poor, with most patients dying of disseminated disease. Here, we report on seven patients with recurrent medulloblastoma, most heavily pretreated with a variety of chemo ... Article Clin Cancer Res \u00b7 June 1996 We aimed to determine the maximum tolerated dose (MTD) of 131I-labeled 81C6 in patients with leptomeningeal neoplasms or brain tumor resection cavities with subarachnoid communication and to identify any primary brain tumor resection cavities with I trial item](https://www.ncbi.nlm.nih.gov/pubmed/9816257) [Cite](/publication/709820#cite) Journal Article Med Pediatr Oncol \u00b7 June 1996 The outcome for patients with pineoblastoma has historically been very poor, with most patients dying of disseminated disease despite irradiation. Furthermore, the low incidence of this tumor has hindered progress toward defining better treatment strategie ... [Treatment of patients [Cite](/publication/724146#cite) Journal Med \u00b7 May 23, 1996 [Tissue item](https://www.ncbi.nlm.nih.gov/pubmed/8614437) [Cite](/publication/669376#cite) Journal Article Br May 1996 The biodistribution of no-carrier-added (n.c.a.) meta-[131I]iodobenzylguanidine ([131I]MIBG) and that prepared by the standard isotopic exchange method were compared in athymic mice bearing SK-N-SH human neuroblastoma xenografts. No advantage in tumour upt ... in nude mice bearing ependymomas exhibit epidemiologic, anatomic, histologic, and biologic features and distinguish them from other gliomas. Because of their propensity to grow in functionally sensitive regions of the brain, adequate tumor sampling for basic and ther ... [Production to item](https://www.ncbi.nlm.nih.gov/pubmed/8627345) [Cite](/publication/694121#cite) Journal of Nuclear Medicine \u00b7 May 1, 1996 [Meta-[At-211]astatobenzylguanidine (MABG): In vivo evaluation in an [Link to item](http://gateway.webofknowledge.com/gateway/Gateway.cgi?GWVersion=2&SrcApp=PARTNER_APP&SrcAuth=LinksAMR&KeyUT=WOS:A1996UL62500236&DestLinkType=FullRecord&DestApp=ALL_WOS&UsrCustomerID=47d3190e77e5a3a53558812f597b0b92) [Cite](/publication/878344#cite) Journal Article Health Psychol \u00b7 March 1996 The association between marital history at midlife (in 1950) and mortality (as of 1991) was studied in a group of intelligent, educated men and women (N = 1,077) who participated in the Terman Life-Cycle Study initiated by Lewis Terman in 1921. Results con ... [Marital history at midlife as a predictor of longevity: alternative explanations to the protective effect of marriage. ](/publication/669435) [Full text](https://dx.doi.org/10.1037//0278-6133.15.2.94) [Link to item](https://www.ncbi.nlm.nih.gov/pubmed/8681925) [Cite](/publication/669435#cite) Journal Article J Med Chem \u00b7 February 16, 1996 A series of 7,8-dialkylpyrrolo[3,2-f]quinazolines were prepared as inhibitors of dihydrofolate reductase (DHFR). On the basis of an apparent inverse relationship between compound size and antifungal activity, the compounds were designed to be relatively sm ... [High-affinity inhibitors of dihydrofolate reductase: antimicrobial Oncol \u00b7 February 1996 Carboplatin is the drug of choice for the treatment of nonresectable astrocytomas in children, but patients who are intolerant may require cranial irradiation which is associated with significant morbidity. Hypersensitivity reactions, including urticaria, ... [Successful desensitization text](https://dx.doi.org/10.1002/(SICI)1096-911X(199602)26:2<105::AID-MPO7>3.0.CO;2-P) [Link to item](https://www.ncbi.nlm.nih.gov/pubmed/8531847) [Cite](/publication/669151#cite) Journal Article Cancer \u00b7 February 1, 1996 BACKGROUND: Over the past decade, the principal focus of research in pediatric brain stem gliomas has been on the use of hyperfractionated radiotherapy (HRT). The purpose of this study was to evaluate the clinical characteristics and treatment related toxi ... [Long term survivors of childhood brain stem gliomas treated with hyperfractionated radiotherapy. Clinical characteristics and treatment ](/publication/669272) \u00b7 February 1996 PURPOSE: To determine the maximum-tolerated dose of cyclophosphamide (CTX) when administered sequentially with melphalan 60 mg/m2/d for 3 days, followed by autologous bone marrow rescue (ABMR), in children with recurrent or progressive malignant brain tumo ... [High-dose melphalan and cyclophosphamide with autologous bone marrow rescue for recurrent/progressive malignant brain tumors in children: a pilot pediatric study. to item](https://www.ncbi.nlm.nih.gov/pubmed/8636747) Article Biophysical Journal \u00b7 February 1, 1996 [A structural basis for phosphoramide Journal Article Biochemistry \u00b7 January 30, 1996 In this study, we investigated the role of ubiquitination in the disposition of the inactivated O6-methylguanine-DNA methyltransferase in human (HT-29 and CEM) murine (ts85) tumor cells. Using a and imm ... [Ubiquitination-dependent proteolysis of O6-methylguanine-DNA methyltransferase in human and 1996 PURPOSE: The pharmacokinetic parameters and maximal tolerated systemic exposure were determined for carboplatin in young children given in combination with cyclophosphamide and etoposide. PATIENTS AND METHODS: Carboplatin was administered as part of a mult ... [Carboplatin pharmacokinetics in young [Link to item](https://www.ncbi.nlm.nih.gov/pubmed/8765431) [Cite](/publication/669094#cite) Journal Article Ann Epidemiol \u00b7 January 1996 The objective of this study was to determine whether birth order is associated with total or cause-specific adult mortality and whether the association differed by sex, was confounded by age, number of siblings, or socioeconomic status, or was mediated by ... [Is birth order associated to Neurooncol \u00b7 1996 Although survivals of infants with malignant brain tumors are worse than any other age group, one possible exception to this rule are the malignant gliomas. Eighteen children less than 3 years of age with malignant gliomas (glioblastoma multiforme, anaplas ... [Treatment of ](/publication/669273) Article J Neurooncol \u00b7 January 1996 PURPOSE/OBJECTIVE: Some malignant brain tumors shed cells into the cerebrospinal fluid (CSF). These tumors may implant throughout the neuroaxis via the CSF. With the placement of a ventriculoperitoneal (VP) or ventriculoatrial (VA) shunt, tumor cells free- ... [Fabrication and testing of a device capable of reducing the incidence of ventricular Pharmacol \u00b7 1996 Cyclophosphamide is one of the most active agents in the treatment of medulloblastoma. However, development of resistance to this alkylator frequently occurs and is the harbinger of tumor progression and death. In order to understand the biochemical basis ... [Repair analysis of 4-hydroperoxycyclophosphamide-induced DNA Article Pharmacol \u00b7 1996 Our previous studies exploring melphalan resistance in the human rhabdomyosarcoma xenograft TE-671 MR revealed elevation of DNA polymerase-alpha and DNA polymerase-beta. The present study evaluated the alteration of melphalan activity in TE-671 (melphalan- ... [Enhancement of to item](https://www.ncbi.nlm.nih.gov/pubmed/8674158) [Cite](/publication/675308#cite) Journal Article Genes Chromosomes Cancer \u00b7 January 1996 Loss of heterozygosity at specific chromosomal locations has been taken as evidence of a tumor suppressor gene located in that area. We performed a genomic allelotyping study on 46 childhood brain tumors of different histopathological types in order to ide ... [Microsatellite analysis of brain tumors. U S \u00b7 December 19, 1995 Phosphoramide mustard-induced DNA interstrand cross-links were studied both in vitro and by computer simulation. The local determinants for the formation of phosphoramide mustard-induced DNA interstrand cross-links were defined by using different pairs of ... [A structural basis for \u00b7 December 1995 LMB-1 (B3-LysPE38) is an immunotoxin composed of the tumor-reactive monoclonal antibody B3 and a engineered form of exotoxin. Monoclonal antibody B3 reacts with a carbohydrate epitope that is found on a number of solid tumors (e.g., ... [Efficacy of compartmental administration of immunotoxin item](https://www.ncbi.nlm.nih.gov/pubmed/9815955) [Cite](/publication/709904#cite) Journal Article Pediatr November 1995 We report two cases of papillary meningioma in children. The MRI appearance of this special type of meningioma is described for the first time. Both lesions were dura based and associated with cystic components. We review the literature pertaining to this ... [MRI of papillary meningiomas in children. ](/publication/719207) [Link to item](https://www.ncbi.nlm.nih.gov/pubmed/8577564) [Cite](/publication/719207#cite) Journal Article Cell Growth Differ \u00b7 October 1995 The type III deletion-mutant gene for the epidermal growth factor receptor (EGFRvIII) is frequently expressed in glioblastomas and in breast and non-small cell lung carcinomas. To understand its contribution to the malignant phenotype in humans, we transfe ... [Epidermal growth factor ligand-independent, unregulated, cell-transforming potential of a naturally occurring human mutant EGFRvIII gene. ](/publication/675276) [Link to item](https://www.ncbi.nlm.nih.gov/pubmed/8845302) [Cite](/publication/675276#cite) Journal Article Health Psychol \u00b7 September 1995 The relationship between mental health status and longevity was examined in an archival prospective cohort study (N = 1,103) derived from work begun by Lewis Terman in the 1920s. Degree of psychological maladjustment, cumulatively rated by Terman and his c ... [An archival prospective study of mental health and longevity. ](/publication/669082) [Full text](https://dx.doi.org/10.1037//0278-6133.14.5.381) [Link to item](https://www.ncbi.nlm.nih.gov/pubmed/7498108) [Cite](/publication/669082#cite) Journal Article Am Public Health \u00b7 September 1995 OBJECTIVES: Childhood sociodemographic, psychosocial, and environmental factors are often assumed to affect adult health and longevity. These relationships were prospectively tested by using the 7-decade Terman Life Cycle Study of Children With High Abilit ... [Sociodemographic and psychosocial factors in ](/publication/669470) [Full text](https://dx.doi.org/10.2105/ajph.85.9.1237) [Link to item](https://www.ncbi.nlm.nih.gov/pubmed/7661231) [Cite](/publication/669470#cite) Journal Article Cancer Res \u00b7 September 1, 1995 Malignant gliomas will affect 15,000-17,000 Americans each year and carry a dismal prognosis. Adjuvant chemotherapy is hampered by inadequate drug delivery, systemic toxicity, and a markedly variable biological sensitivity. Intraarterial (i.a.) therapy may ... [Intraarterial administration of Article Med Pediatr Oncol \u00b7 September 1995 Thirteen patients with recurrent medulloblastoma were treated with cyclophosphamide in association with Sargramostim. Cyclophosphamide was given at doses ranging between 1.0-2.5 g/m2 daily for two doses. Sargramostim was given at a fixed dose of 250 microg ... [Cyclophosphamide in combination with Oncol \u00b7 July 1995 Eleven infants with pineoblastomas were treated with prolonged postoperative chemotherapy in an attempt to delay radiation and reduce neurotoxicity. These infants were part of the Pediatric Oncology Group infant brain tumor study but the outcome of infants ... [Lack of efficacy of postoperative chemotherapy and delayed radiation in very young children with pineoblastoma. Pediatric Oncology Group. ](/publication/669304) Med Pediatr Oncol \u00b7 July 1995 The purpose of this work was to determine the frequency of hematologic toxicity during craniospinal radiation (CSI) and the impact of preirradiation chemotherapy on this frequency. The charts of 37 patients who received CSI were reviewed. Twenty did not ha ... [Hematologic toxicity during craniospinal irradiation: the [Full text](https://dx.doi.org/10.1002/mpo.2950250110) [Link to item](https://www.ncbi.nlm.nih.gov/pubmed/7753002) [Cite](/publication/669358#cite) Journal Article Cancer Res \u00b7 July 1, 1995 The activity of 8-carbamoyl-3-methylimidazo[5,1-d]-1,2,3,5-tetrazin- 4(3H)-one (temozolomide) in the treatment of a panel of xenografts derived from ependymoma, medulloblastoma, and childhood and adult high-grade glioma was evaluated in athymic nude mice b ... [Activity of temozolomide in the treatment of central nervous system tumor xenografts. ](/publication/674999) [Link to item](https://www.ncbi.nlm.nih.gov/pubmed/7796412) [Cite](/publication/674999#cite) Journal Article Cancer \u00b7 June 1, 1995 BACKGROUND: Chemotherapy may be used to delay the need for cranial irradiation in infants and young children with malignant central nervous system (CNS) tumors. The polyfunctional alkylator thiotepa (TT) possesses significant in vitro and in vivo activity ... [A phase II evaluation of thiotepa followed by other multiagent chemotherapy regimens in infants and young children with malignant brain tumors. ](/publication/669442) [Full text](https://dx.doi.org/10.1002/1097-0142(19950601)75:11<2762::aid-cncr2820751121>3.0.co;2-2) [Link to item](https://www.ncbi.nlm.nih.gov/pubmed/7743483) [Cite](/publication/669442#cite) Journal Article Br J Cancer \u00b7 June 1995 Flunarizine, a diphenylpiperazine calcium channel blocker, is known to increase tumor blood flow. It also interferes with calmodulin function, repair of DNA damage and drug resistance associated with P-glycoprotein. Flunarizine was tested for its ability t ... [Cite](/publication/675184#cite) Other Oncogene \u00b7 June 1, 1995 The high incidence of loss of chromosome 10 alleles in glioblastoma multiforme suggests the presence on this chromosome of a tumor suppressor gene that is important in glioma tumorigenesis and progression. Our initial deletion mapping studies using restric ... [Chromosome 10 deletion mapping in human gliomas: a deletion region in 10q25. ](/publication/694137) [Link to item](https://www.ncbi.nlm.nih.gov/pubmed/7784070) [Cite](/publication/694137#cite) Journal Article Neurosurgery \u00b7 May 1995 A new model for human brain tumor uses the intracranial placement of tumor xenografts under transparent glass cranial windows in nude rats, which require no immunosuppression for tumor engraftment. Adult male nude rats underwent implantation of human anapl ... [A pial window model for J Neuroradiol \u00b7 May 1995 PURPOSE: To determine the sensitivity of contrast MR versus myelography followed by CT in the detection of cerebrospinal fluid metastases in children with primary central nervous system tumors. METHODS: Thirty-three patients who had primary central nervous Article Med Pediatr Oncol \u00b7 April 1995 We conducted a dose escalation trial of cyclophosphamide plus Sargramostim in the therapy of patients with newly diagnosed or recurrent central nervous system tumors. Cyclophosphamide was administered at doses ranging between 1.0 and 2.5 g/m2 daily for two ... [Dose escalation trial of cyclophosphamide with Sargramostim in the central Pers Soc Psychol \u00b7 April 1995 Previous research showed that conscientiousness (social dependability) in childhood predicted longevity in an archival prospective cohort study of bright children first studied by Terman in the 1920s (H. S. Friedman et al., 1993). Possible behavioral mecha ... [Childhood conscientiousness and longevity: U S A \u00b7 March 28, 1995 LMB-7 [B3(Fv)-PE38] is a single-chain immunotoxin constructed from the from PE38. Antibody B3 recognizes a carbohydrate epitope found on solid tumors that frequently invade the intrathec ... [Intrathecal administration item](https://www.ncbi.nlm.nih.gov/pubmed/7708720) [Cite](/publication/709681#cite) Journal Article Psychol Aging \u00b7 March 1995 Models of the relations between contact with pets and better health are examined in an archival prospective study using data derived from the longitudinal study initiated by Terman in 1921 (current N = 343 men, 300 women). In survival analyses of documente ... [Playing with pets and longevity [Link to item](https://www.ncbi.nlm.nih.gov/pubmed/7779313) [Cite](/publication/669290#cite) Journal Article Alcohol Clin Exp Res \u00b7 February 1995 The objective of this study was to determine the relations between the hallmark circulatory finding of decompensated cirrhosis, a reduced systemic vascular resistance (SVR), and the indices of hepatic decompensation, the accumulation of ascites, and the co ... state of decompensated Am Psychol \u00b7 February 1995 Impulsive, undercontrolled personalities and major family stresses are known predictors of impaired adjustment, but long-term health effects are unclear. In an archival prospective cohort design, we followed up on L. M. Terman's (Terman & Oden, 1947) sampl ... [Psychosocial and behavioral predictors of longevity. the \"termites\". ](/publication/669285) [Full text](https://dx.doi.org/10.1037//0003-066x.50.2.69) [Link to item](https://www.ncbi.nlm.nih.gov/pubmed/7879989) [Cite](/publication/669285#cite) Journal Engl J Med \u00b7 January 19, 1995 [More on surveillance of children with medulloblastoma. ](/publication/669137) to item](https://www.ncbi.nlm.nih.gov/pubmed/7800019) 1995 Uptake of radioiodinated meta-iodobenzylguanidine (MIBG) has been demonstrated in the neural crest tumors, including neuroblastoma, pheochromocytoma, and carcinoid tumors, and is presently in use diagnostically and therapeutically in these settings. Cells ... [Meta-[131I]iodobenzylguanidine uptake and meta-[211At]astatobenzylguanidine in Brainstem gliomas are an important oncologic problem in the pediatric age group, constituting between 10 and 15% of childhood central nervous system neoplasms. A new classification scheme based on magnetic resonance imaging (MRI) has recently been proposed ... [Prognostic value of contrast-enhanced J Neurooncol \u00b7 1995 Despite reported activity in many other solid tumors, high-dose ifosfamide produces few objective responses in recurrent pediatric brain tumors. Alkylating agents such as cyclophosphamide (CYCLO) possess good activity in many of solid tumors, including bra ... [A phase II study of every other day high-dose ifosfamide in pediatric brain tumors: a Article Cancer Chemother Pharmacol \u00b7 1995 The efficacy of protracted schedules of therapy of the topoisomerase I inhibitors 9-dimethyl-aminomethyl-10-hydroxycamptothecin (topotecan) and 7-ethyl-10-[4-(1-piperidino)-1-piperidino]-carbonyloxycamptothecin of topoisomerase I inhibitors, topotecan and irinotecan, administered at low dose levels in protracted schedules to mice bearing xenografts of human tumors. ](/publication/669355) [Full Journal Article Cancer Chemother Pharmacol \u00b7 1995 We have previously shown that diet restriction-induced depletion of large neutral amino acids (LNAAs) in murine plasma to 46% of control significantly enhances intracranial delivery of melphalan without enhancing delivery to other organs. Studies have now ... [The effect of L-amino acid oxidase Neurooncol \u00b7 1995 Medulloblastoma, the most common malignancy of childhood, was originally shown to be sensitive to cyclophosphamide in 1981. We have used combined laboratory and clinical investigations to demonstrate the synergy of cyclophosphamide and vincristine in the t ... [Cyclophosphamide therapy of medulloblastoma: from the laboratory to the clinic and back again (and again and again). ](/publication/675153) [Full text](https://dx.doi.org/10.1007/BF01052667) [Link to item](https://www.ncbi.nlm.nih.gov/pubmed/8523066) [Cite](/publication/675153#cite) Journal Article Int J Hyperthermia \u00b7 1995 These experiments investigate the biodistribution of radiolabelled MAb in a human glioma xenograft model after 4 h of local hyperthermia (HT) with a twofold purpose: to maximize the ratio of cumulative isotope activity in tumour relative to normal tissues, ... [Hyperthermic modulation of radiolabelled antibody uptake in ](/publication/686836) [Cite](/publication/686836#cite) Journal Article J Neurooncol \u00b7 1995 DNA derived from medulloblastoma biopsies was analyzed to determine if deletions of the 17p region, mutations of the TP53 gene, or amplification of the c-myc, was indica ... [Prognostic [Cite](/publication/694195#cite) \u00b7 1995 The advent of monoclonal antibody (MAb) technology has made Ehrlich's postulate of the 'magic bullet' an attainable goal. Although specific localization of polyvalent antibodies to human gliomas was demonstrated in the 1960s, the lack of specific, high aff ... [Phase I studies of treatment of malignant Eight infants with choroid plexus carcinomas were treated with surgery, prolonged postoperative chemotherapy and delayed radiation. The results suggest that some infants with choroid plexus carcinomas can be successfully treated with multimodality therapy, ... [Postoperative chemotherapy and delayed radiation in infants and very young children with choroid plexus carcinomas. 1, 1994 [Drugs of abuse and immunosuppression ](/publication/1293492) [Cite](/publication/1293492#cite) Journal Article Lancet \u00b7 October 29, 1994 [Effect of coronary artery bypass graft surgery on survival. ](/publication/669162) [Link to item](https://www.ncbi.nlm.nih.gov/pubmed/7934555) [Cite](/publication/669162#cite) Journal Article Cancer Res \u00b7 October 1, 1994 O6-Benzylguanine effectively inactivates the DNA repair protein, O6-alkylguanine-DNA alkyltransferase, leading to an increase in the therapeutic index of 1,3-bis(2-chloroethyl)-1-nitrosourea in nude mouse xenograft studies. To investigate the fate of this ... Journal Article Phys Part Fields \u00b7 October 1, 1994 [Stage-two spin-correlation functions: Tests for non-CKM-type leptonic text](https://dx.doi.org/10.1103/physrevd.50.4544) [Link to item](https://www.ncbi.nlm.nih.gov/pubmed/10018093) [Cite](/publication/669454#cite) Journal Article Am J Public Health \u00b7 September 1994 OBJECTIVES: The purpose of the study was to determine whether breast-feeding is associated with increased longevity or cause-specific survival. METHODS: Teachers throughout California identified intellectually gifted children as part of a prospective study ... [Is breast-feeding in infancy [Link to item](https://www.ncbi.nlm.nih.gov/pubmed/8092371) [Cite](/publication/669167#cite) Journal Article Cancer Res \u00b7 September 1, 1994 We report the activity and toxicity of intrathecal melphalan in the treatment of human neoplastic meningitis in the subarachnoid space of athymic nude rats. Animals received injections via chronic indwelling subarachnoid catheters with 5 x 10(5) or 5 x 10( ... [Intrathecal melphalan therapy ](/publication/694097) [Link to item](https://www.ncbi.nlm.nih.gov/pubmed/8062269) [Cite](/publication/694097#cite) Journal Article Journal of the National Cancer Institute \u00b7 July 6, 1994 We would like to correct a mistake in this report. We have recently discovered that the human medulloblastoma line D341 Med was cross-contaminated in our laboratory with the human rhabdomyosarcoma line TE-671. Accordingly, enhancement of nitrosourea text](https://dx.doi.org/10.1093/jnci/86.13.1027) [Cite](/publication/1004001#cite) Journal Article Cancer Res \u00b7 July 1, 1994 Previous investigations have revealed that the human TE-671 MR human rhabdomyosarcoma xenograft selected in vivo for melphalan resistance (M. C. Rosenberg, et al., Cancer Res., 49: 6917-6922, 1989) is cross-resistant to a wide variety of alkylating agents ... [Elevated DNA polymerase alpha, DNA polymerase beta, and DNA topoisomerase II in a melphalan-resistant rhabdomyosarcoma Natl [Cite](/publication/675105#cite) Journal Journal of Nuclear Medicine \u00b7 May 1, 1994 [MONITORING OF RESPONSE TO NEOADJUVANT THERAPY OF SOFT-TISSUE [Link to item](http://gateway.webofknowledge.com/gateway/Gateway.cgi?GWVersion=2&SrcApp=PARTNER_APP&SrcAuth=LinksAMR&KeyUT=WOS:A1994NK90900143&DestLinkType=FullRecord&DestApp=ALL_WOS&UsrCustomerID=47d3190e77e5a3a53558812f597b0b92) [Cite](/publication/867101#cite) Journal Article Journal of Nuclear Medicine \u00b7 May 1, 1994 [METABOLIC CHARACTERIZATION OF PEDIATRIC PRIMARY BRAIN-TUMORS USING FDG-PET ](/publication/871773) [Link to item](http://gateway.webofknowledge.com/gateway/Gateway.cgi?GWVersion=2&SrcApp=PARTNER_APP&SrcAuth=LinksAMR&KeyUT=WOS:A1994NK90900169&DestLinkType=FullRecord&DestApp=ALL_WOS&UsrCustomerID=47d3190e77e5a3a53558812f597b0b92) [Cite](/publication/871773#cite) Journal Article Chest \u00b7 April 1994 This study was undertaken to determine whether patients with silent ischemia (SI) (a positive thallium stress test without chest pain) have nonchest-pain symptoms that might serve as \"anginal equivalents.\" Two hundred ninety-four individuals on completing ... [Symptoms of patients with silent ischemia as detected testing. Article Ajnr Am J Neuroradiol \u00b7 April 1994 A patient had severe hydrocephalus and diffuse leptomeningeal enhancement on MR which mimicked leptomeningeal spread of a primary brain tumor. The leptomeningeal enhancement resolved completely after decompression of the hydrocephalus. Data suggest that th ... [Gadolinium enhancement of the leptomeninges caused by hydrocephalus: of leptomeningeal metastasis. ](/publication/772110) [Link to item](https://www.ncbi.nlm.nih.gov/pubmed/8010263) [Cite](/publication/772110#cite) Journal Article Cancer Res \u00b7 March 1, 1994 Glial tumors of all grades and histological types from 72 adults and 48 children were analyzed for mutations of the TP53 gene, loss of heterozygosity (LOH) for 17p, and accumulation of TP53 protein to determine whether the incidence and type of TP53 altera ... [Alterations of item](https://www.ncbi.nlm.nih.gov/pubmed/8118823) [Cite](/publication/709783#cite) Article Ajr Am J Roentgenol \u00b7 March 1994 OBJECTIVE: The purpose of this study was to evaluate the usefulness of diffusion-weighted echoplanar MR imaging in the examination of high-grade brain gliomas compared with that of conventional spin-echo (SE) or fast spin-echo (FSE) MR imaging. We hypothes Engl J Med \u00b7 February 17, 1994 [Thrombolytic therapy for acute myocardial [Link to Article 1994 Ifosfamide, a nitrogen mustard derived alkylating agent commonly used in the treatment of solid tumors, has been associated with neurotoxicity in 5-33% of treated patients. Encephalopathy most often occurs during or shortly following drug administration, w ... [Cerebral atrophy in an infant \u00b7 1994 A phase I Pediatric Oncology Group Study was performed combining 7,020 cGy hyperfractionated irradiation (117 cGy twice daily separated by 6 h) with increasing concurrent doses of cisplatin given with the intent of radiosensitization as treatment for child ... [Hyperfractionated irradiation and concurrent cisplatin in brain stem tumors: Oncology \u00b7 1994 [Ellen, a 12-year-old girl, was given a diagnosis of a primitive neuroectodermal tumor. ](/publication/669240) [Link to item](https://www.ncbi.nlm.nih.gov/pubmed/7697078) [Cite](/publication/669240#cite) dihydrochloride)) is a water-soluble, heat-labile azo compound which undergoes thermal decomposition to produce carbon-centred free radicals. These carbon-centred radicals might be directly cytotoxic or may react with ox ... radical inactivates the DNA-repair protein O6-alkylguanine-DNA alkyltransferase in tumor cells and has been shown to increase the cytotoxicity of chloroethylnitrosoureas. This study was undertaken to ascertain the optimal vehicle for f ... [Biodistribution of O6-benzylguanine and its effectiveness against human brain tumor xenografts when given in polyethylene Oncol \u00b7 1994 A 16-year-old white male presented with multiple abnormal extraocular movements secondary to an enhancing pineal tumor. Subtotal resection of the lesion revealed a mixed malignant germ cell tumor. The preoperative serum alpha-fetoprotein (AFP) was markedly ... [Management of pineal \u00b7 1994 We evaluated the antitumor activity of busulfan against a panel of tumor cell lines and xenografts in athymic nude mice derived from \u00b7 1994 The activity of dimethylaminomethyl-10-hydroxycamptothecin (topotecan) was evaluated against a panel of ... [Activity of 9-dimethylaminomethyl-10-hydroxycamptothecin xenografts. 1994 Conventional treatment for medulloblastoma includes surgical resection followed by craniospinal irradiation, with the potential risk of subsequent radiotherapy-induced secondary neoplasms. We report a 23-year-old woman previously irradiated nine years earl ... [Well differentiated astrocytoma occurring nine years after radiation therapy for medulloblastoma. ](/publication/694062) [Link to item](https://www.ncbi.nlm.nih.gov/pubmed/7805312) [Cite](/publication/694062#cite) Journal Article Med Pediatr Oncol \u00b7 1994 Magnetic resonance imaging (MRI) is becoming the method of choice for evaluation of central nervous system tumors. However, the sensitivity of this modality raises concern that new lesions in patients previously diagnosed with a brain tumor may not Journal Article Journal of the National Cancer Institute \u00b7 January 1, 1994 [Erratum: Enhancement of nitrosourea activity in medulloblastoma and glioblastoma multiforme (Journal of the National Cancer Institute (1992) 84 (1926-1931)) ](/publication/772109) [Cite](/publication/772109#cite) Journal Article Laboratory Investigation \u00b7 January NEUROBLASTOMA MALIGNANT GLIOMA ](/publication/878360) [Link to item](http://gateway.webofknowledge.com/gateway/Gateway.cgi?GWVersion=2&SrcApp=PARTNER_APP&SrcAuth=LinksAMR&KeyUT=WOS:A1994MW42600823&DestLinkType=FullRecord&DestApp=ALL_WOS&UsrCustomerID=47d3190e77e5a3a53558812f597b0b92) [Cite](/publication/878360#cite) Journal Article Cancer \u00b7 November 1, 1993 BACKGROUND: Children diagnosed with medulloblastoma whose tumor involves the brain stem or has spread through the cerebrospinal fluid pathways to other areas of the brain or spinal cord have a poor prognosis despite therapy with surgery, craniospinal irrad ... [Preradiation chemotherapy in advanced Journal Article Nucl October 1993 The potential utility of N-succinimidyl 5-iodo-3-pyridinecarboxylate (SIPC) for the radioiodination of monoclonal antibodies was investigated. Paired-label studies were performed using the anti-tenascin antibody 81C6 in athymic mice bearing subcutaneous neuroepithelial tumors are undifferentiated neoplasms. We have used this term in preference to the controversial classification primitive neuroectodermal tumors (PNET). These lesions in children are malignant neoplasms which are us ... [Surgery, hyperfractionated craniospinal irradiation, and chemotherapy in Biol Phys \u00b7 September 30, 1993 PURPOSE: In September 1984, the Pediatric Oncology Group began accrual to a Phase I/II study designed to assess the efficacy and toxicity of sequentially escalated doses of hyperfractionated (twice daily) radiotherapy in children with poor-prognosis brain ... [Final results of a study of escalating doses of hyperfractionated radiotherapy in brain stem tumors in children: a study. ](/publication/669344) item](https://www.ncbi.nlm.nih.gov/pubmed/8407392) [Cite](/publication/669344#cite) Journal Article N Engl J Med \u00b7 August [Treatment \u00b7 August 1993 9-beta-D-Arabinofuranosylguanine (araG), an analog of deoxyguanosine which is not degraded by purine nucleoside phosphorylase, has been previously shown in in vitro studies by our laboratory to be effective in purging malignant T cells from human bone marr ... [Efficacy and toxicity of 9-beta-D-arabinofuranosylguanine (araG) as an agent to purge malignant T cells from murine bone marrow: application to an in vivo T-leukemia [Link to item](https://www.ncbi.nlm.nih.gov/pubmed/8350627) [Cite](/publication/669193#cite) Journal Article J Neurosurg \u00b7 August 1993 Six patients with optic pathway gliomas who were previously managed with surgery and/or chemotherapy were treated with carboplatin (560 mg/sq m) after radiographic evidence of disease progression. The median age at diagnosis was 2 years (range 4 months to ... [Carboplatin treatment of progressive optic pathway Roentgenol \u00b7 August 1993 OBJECTIVE: Astrocytomas are classified as either fibrillary or pilocytic on the basis of their histologic appearance. The imaging features of the fibrillary astrocytoma correlate closely with the tumor's clinical aggressiveness and are, therefore, useful i ... [Pilocytic astrocytoma: correlation between the initial imaging features aggressiveness. ](/publication/669335) [Full text](https://dx.doi.org/10.2214/ajr.161.2.8333380) [Link Oncol \u00b7 August 1993 PURPOSE: Hyperleukocytosis secondary to acute leukemia is a medical emergency. Intracranial hemorrhage often leads to death in this setting. Early efforts to prevent this serious complication have included emergent cranial irradiation, with its associated ... 1993 OBJECTIVE: Cardiac myocytes were exposed to 4-hydroperoxycyclophosphamide (4-HC, an activated derivative of cyclophosphamide) to assess whether early ionic events are associated with the dose limiting toxicity of this chemotherapeutic agent. METHODS: Prima ... Pers Soc Psychol \u00b7 July 1993 Key models relating personality and health predict that personality in childhood is indicative of later health and longevity. Longevity predictions are tested using data derived from the 7-decade longitudinal study initiated by L. M. Terman 1921 (L. M. Ter [Cite](/publication/669417#cite) Journal Engl J Med \u00b7 June 17, 1993 BACKGROUND: Among patients with malignant brain tumors, infants and very young children have the worst prognosis and the most severe treatment-related neurotoxic effects. Therefore, in 1986, the Pediatric Oncology Group began a study in which postoperative ... [Postoperative chemotherapy and delayed radiation in children less than three years of age with malignant brain tumors. ](/publication/669102) [Full text](https://dx.doi.org/10.1056/NEJM199306173282401) [Link to item](https://www.ncbi.nlm.nih.gov/pubmed/8388548) [Cite](/publication/669102#cite) Journal May 15, 1993 BACKGROUND: Although pilocytic astrocytomas (PA) generally are considered benign, a subset of patients with PA have disease progression despite standard treatment with surgery and radiation therapy. The authors report their experience with chemotherapy in ... Journal Article Cancer Res \u00b7 May 15, 1993 The addition of chemotherapy, notably using nitrosoureas, in the treatment of patients with glioblastoma multiforme has resulted in only modest improvements in long-term patient survival over the use of surgical intervention and irradiation alone. Intraart ... [Intraarterial therapy of Roentgenol \u00b7 May 1993 OBJECTIVE: Mesenrhombencephalitis is a serious form of brainstem inflammation predominantly involving the deep and vital portions of the brain, that is, the mesencephalon (midbrain) and rhombencephalon (pons, medulla). Mesenrhombencephalitis is difficult ](/publication/772113) item](https://www.ncbi.nlm.nih.gov/pubmed/8470582) [Cite](/publication/772113#cite) Conference and Experimental Neurology \u00b7 May 1993 [NEUROPATHOLOGY OF MULTIPLE VERSUS SINGLE DOSE INTRATHECAL MELPHALAN IN RATS ](/publication/861329) [Full text](https://dx.doi.org/10.1097/00005072-199305000-00152) [Cite](/publication/861329#cite) Journal Article of Neuropathology and Article Chest \u00b7 OBJECTIVE: To determine the relation between urinary digoxin-like immunoreactive substance (DLIS) and cardiac performance. DESIGN: Cohort Assist Tomogr \u00b7 1993 Cerebellar necrosis associated with therapy of primary gliomas is unusual. We present the MR findings in a patient with postradiation multifocal cerebellar \u00b7 1993 Both elevated glutathione levels and increased activity of the enzyme glutathione S-transferase have been associated with the resistance of cells to alkylating agents. We have demonstrated that one mechanism of this resistance is the inactivation of the al ... [Role of glutathione in cellular Med Pediatr Oncol \u00b7 1993 Profound clinical deficits may be associated with insults to the brainstem, making management of patients with brainstem gliomas very complex. Small changes in the radiographic appearance of a brainstem tumor may be associated with significant clinical det ... [Comparison of serial PET and MRI scans in a pediatric patient with a brainstem glioma. ](/publication/669283) \u00b7 1993 Gadolinium-DTPA enhanced MRI is the modality of choice when imaging central nervous system infratentorial tumors in the pediatric population. The detection of a new enhancing lesion following initiation of therapy is typically considered pathognomonic for ... [False-positive MRI detection of Pharmacol \u00b7 1993 The tolerated dose of melphalan is limited by bone marrow suppression; when this complication is ameliorated by bone marrow transplantation, the dose-limiting toxicity becomes gastrointestinal mucositis. No intervention to date has been successful in modul ... [Development of a model [Full text](https://dx.doi.org/10.1007/BF00686151) [Link to item](https://www.ncbi.nlm.nih.gov/pubmed/8431971) [Cite](/publication/675238#cite) Journal Article Cancer Res \u00b7 January 1, 1993 Two monoclonal antibodies, DMAb-21 and DMAb-22, directed against the lactotetraose series ganglioside-associated epitope IV3NeuAc,III6-NeuAcLcOse4Cer (3',6'-isoLD1), in tumors of central nervous and other systems in vitro and in vivo. ](/publication/694113) [Link to item](https://www.ncbi.nlm.nih.gov/pubmed/8416736) [Cite](/publication/694113#cite) Other \u00b7 1993 Gangliocytomas are rare CNS tumors that occur in children and young adults. We present a case of a cerebellar gangliocytoma with invasion of the cervical spinal cord demonstrated on MR. Radiographic differentiation of gangliocytomas from other ganglion cel ... [MRI \u00b7 1993 O6-Alkylguanine-DNA alkyltransferase (AT) is a cellular protein that protects cells from the cytotoxic effects of nitrosoureas by repairing alkyl lesions at the O6 position of guanine. We have studied the ability of O6-benzylguanine to deplete AT activity ... [Treatment of subcutaneous [Cite](/publication/729602#cite) Journal Article Cancer Research \u00b7 January 1, 1993 The addition of chemotherapy, notably using nitrosoureas, in the treatment of patients with glioblastoma multiforme has resulted in only modest improvements in long-term patient survival over the use of surgical intervention and irradiation alone. Intraart ... [Intraarterial Therapy of ](/publication/757995) [Cite](/publication/757995#cite) Journal J Natl Cancer Inst \u00b7 December 16, 1992 BACKGROUND: Although chemotherapy offers promise of increased survival for children with medulloblastoma and glioblastoma multiforme, drug resistance occurs frequently, resulting in tumor progression and death. Resistance to nitrosoureas and methylating ag ... J Ophthalmol \u00b7 November 15, 1992 [Successful therapy for trilateral retinoblastoma. ](/publication/762691) [Full text](https://dx.doi.org/10.1016/s0002-9394(14)74509-x) [Link to item](https://www.ncbi.nlm.nih.gov/pubmed/1443039) [Cite](/publication/762691#cite) Other Am J Ophthalmol \u00b7 November 15, 1992 [Successful therapy for trilateral retinoblastoma. ](/publication/762692) [Full text](https://dx.doi.org/10.1016/s0002-9394(14)74507-6) [Link to item](https://www.ncbi.nlm.nih.gov/pubmed/1443038) [Cite](/publication/762692#cite) Journal Article October 15, 1992 Melphalan (L-phenylalanine mustard, L-PAM, alkeran; molecular weight, 305,000) is transported across tumor cell membranes and the blood-brain barrier by the large neutral amino acid (LNAA) transport system. Normally, plasma LNAA levels are high enough and ... [The effect of an amino acid-lowering diet on the rate of melphalan entry into brain and xenotransplanted glioma. ](/publication/674966) [Link to item](https://www.ncbi.nlm.nih.gov/pubmed/1394182) [Cite](/publication/674966#cite) Journal October 1992 [Back paraplegia Exp Res \u00b7 October 1992 UNLABELLED: The purpose of this study was to determine the relation of the circulatory findings of cirrhosis to hepatic decompensation. Twenty individuals with biopsy-proven cirrhosis and aged-matched controls underwent echocardiographic evaluation of c ... [Ascites as a marker [Cite](/publication/669475#cite) Journal Article Cancer Res \u00b7 October 1, 1992 Mechanisms of tumor resistance to 4-hydroperoxycyclophosphamide (4-HC) were studied by using a panel of human medulloblastoma cell lines either passaged in the laboratory for resistance to 4-HC or established from tumors showing clinical resistance to cycl [Cyclophosphamide resistance in medulloblastoma. October 1992 [Methylphenidate in neuropsychological sequelae of radiotherapy and chemotherapy of childhood leukemia. ](/publication/679883) [Full text](https://dx.doi.org/10.1177/088307389200700425) [Link to item](https://www.ncbi.nlm.nih.gov/pubmed/1469256) [Cite](/publication/679883#cite) Journal Article Am J Ophthalmol \u00b7 July 15, 1992 Trilateral retinoblastoma, the intracranial malignancy associated with bilateral retinoblastoma, is an uncommon and clinically aggressive malignancy with a uniformly fatal outcome. Three children with newly diagnosed trilateral retinoblastoma were treated ... [Successful therapy for trilateral retinoblastoma. [Cite](/publication/669180#cite) Journal Article Oncology (Williston Park) \u00b7 May 1992 With only about 1,500 new cases a year of pediatric brain tumors, as many cases as possible must be enrolled in ongoing multicenter trials if therapeutic advances are to continue. To date, such trials have identified chemotherapeutic agents active against ... [New therapeutic options in the management of childhood brain tumors. ](/publication/669174) [Link to item](https://www.ncbi.nlm.nih.gov/pubmed/1534675) [Cite](/publication/669174#cite) Journal Article Crit March 1992 [The uses text](https://dx.doi.org/10.1016/1040-8428(92)90085-5) [Link to item](https://www.ncbi.nlm.nih.gov/pubmed/1590942) [Cite](/publication/669449#cite) Journal Article Cancer Res \u00b7 March 1, 1992 Six well characterized human medulloblastoma cell lines (D283 Med, Daoy, D341 Med, D384 Med, D425 Med, and D458 Med) were examined for the expression of O6-methylguanine-DNA methyltransferase (MGMT) by activity and Western and Northern blot analysis. High ... [Expression of O6-methylguanine-DNA methyltransferase in [Link to item](https://www.ncbi.nlm.nih.gov/pubmed/1737373) [Cite](/publication/669466#cite) Journal Article N Engl J Med \u00b7 February 20, 1992 [Is there sex bias in the management of coronary artery disease? ](/publication/669352) [Link to item](https://www.ncbi.nlm.nih.gov/pubmed/1732799) [Cite](/publication/669352#cite) Journal Article February 1992 PURPOSE: The Pediatric Oncology Group (POG) conducted a randomized phase II study to evaluate the activity of carboplatin and iproplatin in children with progressive or recurrent brain tumors. PATIENTS AND METHODS: The study was designed to evaluate the ac ... [Treatment of children with progressive or recurrent brain tumors with carboplatin or iproplatin: a Pediatric Oncology Group item](https://www.ncbi.nlm.nih.gov/pubmed/1732426) [Cite](/publication/669476#cite) Journal Article Radiat Res \u00b7 February 1992 The effects of regional hyperthermia (42 degrees C for 70 min) on the antitumor activity of melphalan were examined in athymic mice bearing melphalan-resistant human rhabdomyosarcoma (TE-671 MR) xenografts growing in the right hind limb, and results were c ... [Hyperthermia-induced enhancement of melphalan activity 1992 Myelosuppression is a common sequelae of radiotherapy, occasionally delaying the completion of treatment. In this report, we describe successful reversal of radiation-induced neutropenia in a child receiving Twenty-two pediatric patients with known CNS neoplasms underwent magnetic resonance (MR) imaging before and after intravenous injection of 0.1 mmol/kg gadoteridol injection as part of a Phase IIIB open label multicenter clinical trial. Intravenous administ ... [Phase clinical evaluation Article J Tomogr \u00b7 1992 Seventeen pediatric patients with posterior fossa brain tumors were studied with 2-[18F]fluoro-2-deoxy-D-glucose (FDG) and positron emission tomography (PET). The FDG uptake was ranked by two observers, and the results were correlated with tumor histology. ... of medulloblastoma. Oncol Biol Phys \u00b7 1992 We have used an extensively characterized human glioma cell line in an athymic mouse model to evaluate new therapeutic approaches for human supratentorial high grade gliomas. The tumor, D-54MG, is a subline of a human anaplastic glioma. Eight days after ho ... [The radiation dose-response relationship in a human glioma xenograft and an evaluation of the influence Chemother Pharmacol \u00b7 1992 On the basis of response rates of up to 50%, BCNU [1,3-bis(2-chloroethyl)-1-nitrosourea] is the primary drug used in the chemotherapy of anaplastic gliomas. Preclinical data obtained in several experimental systems show that the cytotoxicity of chloroethyl ... [Phase I study Hyperthermia \u00b7 1992 Investigations with the melphalan-sensitive and -resistant human rhabdomyosarcoma xenografts TE-671 and TE-671 MR were performed to examine effect of glutathione and polyamine modulation on Hyperthermia \u00b7 1992 Both hyperthermia and glutathione depletion have been shown to increase the antineoplastic activity of melphalan. Investigations were carried out to define the toxicity and activity of melphalan given in conjunction with local (right hind limb) hyperthermi ... [Enhancement of melphalan-induced gastrointestinal toxicity in Article International Journal of Radiation Oncology, Biology, Physics \u00b7 1992 We have used an extensively characterized human glioma cell line in an athymic mouse model to evaluate new therapeutic approaches for human supratentorial high grade gliomas. The tumor, D-54MG, is a subline of a human anaplastic glioma. Eight days after ho ... [The radiation dose-response relationship in a human glioma xenograft and an evaluation of the influence of glutathione depletion by buthionine sulfoximine ](/publication/760920) [Cite](/publication/760920#cite) Journal Article J Pers Soc Psychol \u00b7 November 1991 Individual differences in the expression and regulation of emotion are important components of social skill. The present study focused on the concealing of spontaneous expressions of happiness after winning in a competitive situation against peers. In a re ... [Nonverbal display of emotion in public and in private: self-monitoring, personality, and expressive cues. [Cite](/publication/669412#cite) Journal Article Neurosurgery \u00b7 October 1991 A 2.5-year-old child who had undergone nearly total resection of an infratentorial ependymoma demonstrated a new enhancing lesion on the undersurface of the right cerebellar hemisphere 7 weeks after the initiation of adjuvant chemotherapy. The residual pri Cancer Res \u00b7 September 1, 1991 Cytogenetic and molecular studies of medulloblastomas have demonstrated frequent loss of sequences from the short arm of chromosome 17, possibly implicating loss or inactivation of the p53 tumor suppressor gene. We amplified exons 5 through 8 of the p53 ge ... [Infrequent p53 gene mutations in Journal Article Biochem August 15, 1991 Malignant human glioma D-298 MG amplifies a rearranged epidermal growth factor receptor (EGFR) gene (c-erbB proto-oncogene), resulting in an in-frame deletion of 83 amino acids in domain IV of the extracellular domain of the EGFR. EGF and transforming grow ... [Deletion-mutant epidermal growth factor receptor in human gliomas: effects of type II mutation on receptor function. ](/publication/674957) [Full text](https://dx.doi.org/10.1016/0006-291x(91)91051-d) [Link to item](https://www.ncbi.nlm.nih.gov/pubmed/1678600) [Cite](/publication/674957#cite) Journal Article J Neurooncol \u00b7 August 1991 Medulloblastoma is the most common central nervous system malignancy of childhood, with approximately 350 new cases seen in the United States each year. Although the low incidence of this tumor, compared with adult neoplasms such as breast or colon carcino ... [Medulloblastoma: tumor [Link to item](https://www.ncbi.nlm.nih.gov/pubmed/1919642) [Cite](/publication/675224#cite) Journal Article Cancer Res \u00b7 August 1, 1991 Investigations with the melphalan-resistant human rhabdomyosarcoma xenograft TE-671 MR were carried out to identify patterns of cross-resistance and collateral sensitivity and to define the mechanism(s) mediating melphalan resistance. TE-671 Journal Article Am J Ophthalmol \u00b7 June 15, 1991 We treated three children with optic pathway gliomas who had progressive disease associated with metastatic spread to the leptomeninges. One patient had radiographic resolution of leptomeningeal disease after treatment with intravenous carmustine and oral ... [Leptomeningeal dissemination of [Full text](https://dx.doi.org/10.1016/s0002-9394(14)76778-9) [Link to item](https://www.ncbi.nlm.nih.gov/pubmed/2039043) [Cite](/publication/709067#cite) Journal Article Chest \u00b7 June 1991 OBJECTIVE: to determine the relation of serum theophylline concentrations (STC) to the occurrence of cardiac arrhythmias in a population of hospitalized patients. STUDY DESIGN: A cross-sectional study of 100 patients receiving theophylline who had electroc ... [The to item](https://www.ncbi.nlm.nih.gov/pubmed/2036824) [Cite](/publication/669324#cite) Journal Article Lab Invest \u00b7 June 1991 Three new human medulloblastoma (MB) cell lines (D384 Med, D425 Med, and D458 Med) and their transplantable xenografts were examined for antigenic expression with antibodies antigens, cytoskeletal proteins, neuroendocrine markers, g ... [Differentiation newly established medulloblastoma cell lines (D384 Med, D425 Med, and Journal Article Neurol Clin \u00b7 May 1991 Virtually all brain tumor models studied to date have demonstrated the activity of the nitrosoureas, an observation confirmed in a cohort of adult patients with high-grade gliomas. However, studies with animal brain tumor models have not led to the selecti ... [Therapeutic analysis of in vitro and in vivo brain tumor models. ](/publication/675337) [Link to item](https://www.ncbi.nlm.nih.gov/pubmed/1944106) [Cite](/publication/675337#cite) Journal Article J Pharmacol Exp Ther \u00b7 April 1991 To assess the actions of theophylline on coronary blood flow and myocardial energetics, 1 mg/kg/min of this methylxanthine was infused i.v. in the dog for 15 min, producing an average concentration of 18 +/- 3 micrograms/ml. Heart rate increased by 20 +/- ... [Theophylline produces an adverse effect on myocardial lactate metabolism at a therapeutic serum concentration: [Cite](/publication/669229#cite) Journal Article Pediatr Clin North Am \u00b7 April 1991 More children with CNS tumors will continue to be cured of their neoplasms as a result of improved surgical, radiotherapeutic, and chemotherapeutic intervention. The complex problems seen in these patients mandate their treatment at academic centers active ... [Tumors of the central nervous system. Improvement in outcome through a multimodality approach. ](/publication/669233) [Full text](https://dx.doi.org/10.1016/s0031-3955(16)38083-x) [Link to item](https://www.ncbi.nlm.nih.gov/pubmed/2006083) [Cite](/publication/669233#cite) Journal N Engl J Med \u00b7 March 7, 1991 [Medical appropriateness angiograms. February 5, 1991 Medulloblastoma biopsies are heterogenous and might contain normal brain tissue, which limits the usefulness of such tumor material for biochemical analyses. We have, therefore, examined the gangliosides and their metabolism using the medulloblastoma cell ... [Glycolipids and glycosyltransferases in permanent text](https://dx.doi.org/10.1016/0005-2760(91)90279-q) melanosis. \u00b7 A 19-month-old refractory to multi-agent immunosuppressive therapy developed severe platelet alloimmunization following several months of platelet transfusions. She became refractory to human leukocyte antigen Oncol \u00b7 1991 Two patients with brain stem gliomas were treated with hyperfractionated radiation therapy (HFR) (7,020 and 7,560 cGy, respectively). Despite initial clinical improvement during irradiation, both patients demonstrated clinical deterioration approximately 3 ... [Reversible neurotoxicity following hyperfractionated Pediatr Oncol \u00b7 1991 The spread of primary central nervous system (CNS) neoplasms beyond the confines of the neuraxis is a relatively uncommon observation. Extraneural metastases involving bone are quite rare, and have been observed almost exclusively in cases of medulloblasto ... [Osteoblastic metastases from \u00b7 1991 Melphalan-induced toxicity in nude mice following pretreatment with a regimen of L-buthionine sulfoximine (BSO), previously shown to enhance the activity of this alkylating agent against rhabdomyosarcoma and glioma xenografts, was examined. Mice pretr ... 1991 We used human anaplastic glioma xenografts to evaluate the therapeutic efficacy of combinations alkylating drugs, either 1,3-bis(2-chloroethyl)-1-nitrosourea (BCNU), 1-(2-chloroethyl)-3-(2,5-dioxo-3-piperidyl)-1-nitrosourea Metastasis \u00b7 1991 Medulloblastoma, a highly malignant pediatric tumor of the posterior fossa, demonstrates a marked propensity for leptomeningeal dissemination. Although the predominant site of relapse is the posterior fossa, the prevention of subarachnoid spread would be o cell-substrate interaction in vitro. ](/publication/675186) [Link to item](https://www.ncbi.nlm.nih.gov/pubmed/1822845) [Cite](/publication/675186#cite) Journal Article Cancer Res \u00b7 December 15, 1990 Both permanent cultured cell lines and athymic mouse xenografts were established from two human glioblastomas. Biopsies from D-245 MG and D-270 MG contained amplified and rearranged epidermal growth factor receptor (EGFR) genes. Although the gene amplifica ... [Characterization of the epidermal growth factor receptor in cell lines and xenografts. ](/publication/675273) [Link to item](https://www.ncbi.nlm.nih.gov/pubmed/2253244) [Cite](/publication/675273#cite) Journal Article Pediatr Infect Dis J \u00b7 September 1990 [Catheter-related sepsis refractory to antibiotics treated successfully with adjunctive urokinase infusion. ](/publication/669413) [Link to item](https://www.ncbi.nlm.nih.gov/pubmed/2235195) [Cite](/publication/669413#cite) Acad Sci U S A \u00b7 June 1990 We have investigated human gliomas that amplify and rearrange the epidermal growth factor receptor gene, with generation of an in-frame deletion mutation of 802 nucleotides in the external domain. This in-frame deletion mutation generates a local amino aci ... [Anti-synthetic peptide antibody reacting at the fusion junction of deletion-mutant epidermal growth factor receptors [Link to item](https://www.ncbi.nlm.nih.gov/pubmed/1693434) [Cite](/publication/675312#cite) Journal Article Cancer Res \u00b7 May 15, 1990 Despite a considerable amount of information concerning chromosomal and molecular abnormalities found in gliomas in adults, relatively little is known regarding these abnormalities in pediatric brain tumors. We have analyzed DNA from 37 primary brain tumor ... [Oncogene amplification in pediatric brain tumors. ](/publication/675155) [Link to item](https://www.ncbi.nlm.nih.gov/pubmed/2334901) [Cite](/publication/675155#cite) Journal Article J Neurosurg \u00b7 May 1990 The development of the Cavitron ultrasonic surgical aspirator (CUSA) has facilitated neurosurgical intervention for removal of central or peripheral nervous system tumors adjacent to or within vital structures. However, laboratory studies defining the phen ... [Successful laboratory growth and analysis ](/publication/674970) [Full Journal Article and Experimental Neurology \u00b7 May 1990 [NEURON-ASSOCIATED MICROTUBULE PROTEINS GLIOMA CELL LINE ](/publication/865441) [Full text](https://dx.doi.org/10.1097/00005072-199005000-00041) [Cite](/publication/865441#cite) Journal Article Cancer Res \u00b7 April 15, 1990 Administration of cyclophosphamide at a dose which is lethal to 10% of control athymic nude mice resulted in sudden death within 3 h in all mice that had been pretreated with the glutathione synthesis inhibitor L-buthionine-SR-sulfoximine. In Fischer 344 r ... [Glutathione protects cardiac and skeletal muscle from cyclophosphamide-induced toxicity. ](/publication/669461) [Link to item](https://www.ncbi.nlm.nih.gov/pubmed/2317829) [Cite](/publication/669461#cite) Journal Article Cancer Res \u00b7 April 15, 1990 Cultured cell lines and xenografts derived from 7 human medulloblastomas were evaluated for amplification of the c-myc, N-myc, epidermal growth factor receptor, and gli genes by Southern blot analysis. Karyotypes of the original biopsies and early passaged ... [Amplification of the c-myc gene in and xenografts. ](/publication/675135) [Link to item](https://www.ncbi.nlm.nih.gov/pubmed/2180567) [Cite](/publication/675135#cite) Journal Article J Neurosurg \u00b7 April 1990 Seventeen patients with recurrent gliomas were treated with the combination of cyclophosphamide and vincristine. All but one had previously received and failed chemotherapy. Cyclophosphamide was administered at doses ranging from 250 to 1000 mg/sq m by int ... [Treatment of patients [Cite](/publication/669120#cite) Journal Article Cancer Res \u00b7 March 15, 1990 The purpose of this study was to investigate the effects of tumor-localized hyperthermia at 42 degrees C on the tissue distribution of radioiodinated monoclonal antibody F(ab')2 fragments. Paired-label biodistribution measurements ... delivery monoclonal antibody [Link to item](https://www.ncbi.nlm.nih.gov/pubmed/2407344) [Cite](/publication/674985#cite) Journal Article Cancer Res \u00b7 March 15, 1990 The administration of radiolabeled monoclonal antibodies to improve the treatment of malignant gliomas is dependent upon achieving effective tumor radiation dose while sparing normal tissues. We have evaluated the efficacy of 131I-labeled F(ab')2 fragment to item](https://www.ncbi.nlm.nih.gov/pubmed/2407345) [Cite](/publication/675090#cite) Journal Article Cancer Res \u00b7 March 15, 1990 Neoplastic meningitis can result from leptomeningeal dissemination of a variety of cancers. We now report the development of animal models of human neoplastic meningitis and activity of intrathecal ... [Activity of neoplastic meningitis. ](/publication/693693) [Link to item](https://www.ncbi.nlm.nih.gov/pubmed/2306744) [Cite](/publication/693693#cite) Journal February 15, 1990 Buthionine sulfoximine (BSO) is an inhibitor of glutathione synthesis and can be used to potentiate the effects of chemotherapeutic alkylating agents and radiotherapy. We examined the rates of influx and efflux of [35S]BSO administered to athymic mice with ... [Rate to item](https://www.ncbi.nlm.nih.gov/pubmed/2297773) intracranial radiotherapy model D-54 MG human glioma xenografts was developed, allowing evaluation of the therapeutic benefits seen after L-buthionine-S,R-sulfoximine (L-BSO)-mediated depletion of tu MG), sequentially passaged in athymic nude mice and originally derived from a human giant cell glioblastoma, was maintained in an organ culture (matrix) system and studied immunohistochemically after i ... [Kinetics and glial fibrillary acidic (GFA) production in a transplantable human giant cell glioblastoma (D-212 MG) of near haploid karyotype maintained in an culture system. ](/publication/675285) [Full text](https://dx.doi.org/10.1111/j.1365-2990.1990.tb00929.x) [Link to item](https://www.ncbi.nlm.nih.gov/pubmed/2320202) [Cite](/publication/675285#cite) Journal Article Cancer Res \u00b7 January 15, 1990 Based on previous work demonstrating the activity of cyclophosphamide and melphalan in a series of human medulloblastoma and rhabdomyosarcoma cell lines and transplantable xenografts, investigations were conducted to define the effects of combining cycloph ... [Synergistic interactions between cyclophosphamide Journal \u00b7 1990 The chemopreventive effects of beta-carotene are usually attributed to its antioxidant properties. To determine the effects of beta-carotene supplementation on different parameters of oxidative metabolism, 15 normal young male subjects (18-30 yrs) were pla ... [Effects of absorption, item](https://www.ncbi.nlm.nih.gov/pubmed/1964728) [Cite](/publication/1432782#cite) Journal Article Int J Cell Cloning \u00b7 January 1990 This is a review and discussion of studies leading to the first use of human umbilical cord blood, material usually discarded, for the provision of stem/progenitor cells for clinical hematopoietic reconstitution. This prospect arose as a result of extensiv ... [Human umbilical cord blood: a Neuroradiol \u00b7 1990 [False-positive spinal MR findings for subarachnoid spread of primary CNS tumor in postoperative pediatric patients. ](/publication/669172) [Link to item](https://www.ncbi.nlm.nih.gov/pubmed/2124036) [Cite](/publication/669172#cite) Journal Article Ajnr Am J Neuroradiol \u00b7 1990 Three children with known primary brain neoplasms and leptomeningeal disease were evaluated with MR imaging. Two of the patients had medulloblastoma and one had pineoblastoma. The presence of leptomeningeal tumor spread was established by positive CSF cyto ... [Gd-DTPA-enhanced MR imaging of leptomeningeal spread of tumor in children. to MR imaging ](/publication/669403) [Link to item](https://www.ncbi.nlm.nih.gov/pubmed/2114771) [Cite](/publication/669403#cite) Journal Article J Gen Intern Med \u00b7 1990 [Coronary bypass graft surgery: reexamining the assumptions. ](/publication/669444) Journal Article Oncol \u00b7 1990 Tumors of the renal pelvis are not common in adults and are extremely rare in children. Forty-eight cases of adenocarcinoma of the renal pelvis have been reported, with only one patient under 32 years of age. We report the youngest patient (an 11 year old ... [Papillary adenocarcinoma of the renal pelvis in a child: case report and brief review of the literature. ](/publication/674184) text](https://dx.doi.org/10.1002/mpo.2950180118) [Link 1990 [Cytogenetics and molecular genetics: their status and role in understanding the behavior of central nervous system neoplasms. ](/publication/675235) [Link to item](https://www.ncbi.nlm.nih.gov/pubmed/2192278) [Cite](/publication/675235#cite) Journal Article Cancer Res December 15, 1989 A melphalan-resistant human rhabdomyosarcoma xenograft, TE-671 MR, was established in athymic mice by serial melphalan treatment of the parent xenograft, TE-671, at the 10% lethal dosage (LD10); significant resistance was evident after ten passages of the ... [Establishment of a melphalan-resistant rhabdomyosarcoma xenograft ](/publication/675197) [Link to item](https://www.ncbi.nlm.nih.gov/pubmed/2582434) [Cite](/publication/675197#cite) Journal Article Cancer Research \u00b7 December 15, 1989 A melphalan-resistant human rhabdomyosarcoma xenograft, TE-671 MR, was established in athymic mice by serial melphalan treatment of the parent xenograft, TE-671, at the 10% lethal dosage (LD10); significant resistance was evident after ten passages of the ... [Establishment of a Melphalan-Resistant Rhabdomyosarcoma Xenograft Sulfoximine-Mediated Glutathione Depletion ](/publication/760924) [Cite](/publication/760924#cite) Journal Article Cancer Research December 15, 1989 [ESTABLISHMENT OF A MELPHALAN-RESISTANT RHABDOMYOSARCOMA XENOGRAFT WITH Ther 1989 [The relation of quinidine-induced elevation of serum digoxin concentration to the conversion ](/publication/669337) [Cite](/publication/669337#cite) Journal Article J Med \u00b7 October 26, 1989 [Hematopoietic reconstitution in a patient with Fanconi's anemia by means blood Pediatr \u00b7 September 1989 [Cerebrospinal fluid protein elevation secondary to a subdural fluid collection in a child receiving [Full text](https://dx.doi.org/10.1016/s0022-3476(89)80851-0) [Link to item](https://www.ncbi.nlm.nih.gov/pubmed/2769503) Lab Invest \u00b7 September 1989 The immunocytochemical demonstration of intermediate filament proteins in three human neuroepithelial tumor cell lines maintained in vitro on a three-dimensional matrix was correlated with the proportion of cells in S phase. The cell lines of a medulloblas ... [Relationship of the demonstration of intermediate filament protein to kinetics of three human neuroepithelial tumor cell lines. Lack of neural-related proteins in most cells in S phase: a double-labeled immunohistochemical study on matrix Journal Article Proc Natl Acad Sci U S A \u00b7 September 1989 alpha-Particles such as those emitted by 211At may be advantageous for radioimmunotherapy since they are radiation of high linear energy transfer, depositing high energy over a short distance. Here we describe a strategy for labeling monoclonal antibodies ... [Labeling monoclonal antibodies and Article J Clin Oncol \u00b7 July 1989 We conducted a phase II study of intravenous (IV) melphalan in the treatment of children with recurrent medulloblastoma and in the initial treatment of children with poor-prognosis medulloblastoma and pineoblastoma. There was one complete response (CR) and ... [Phase II treatment of medulloblastoma and pineoblastoma with melphalan: clinical therapy based on experimental medulloblastoma. ](/publication/669359) [Full Cytogenet \u00b7 July 1, 1989 The karyotypes of seven human glioblastomas were followed through serial subcutaneous passage in athymic mice. One tumor maintained the same hypodiploid stemline as seen in the original biopsy. Three tumors that originally had near-diploid stemlines showed ... [Chromosomal composition of malignant human Surg \u00b7 May 1989 Central venous catheters have proven to be an important aid for the care of pediatric patients with malignancies receiving chemotherapy. A rare complication of such catheters is pulmonary septic emboli. This report describes a 15-year-old white girl and Experimental Neurology \u00b7 May 1989 [A NUDE RAT MODEL OF LEPTOMENINGEAL TUMOR DISSEMINATION (LTD) OF HUMAN MEDULLOBLASTOMA ](/publication/861321) [Full text](https://dx.doi.org/10.1097/00005072-198905000-00173) [Cite](/publication/861321#cite) Journal Article J Natl Cancer Inst \u00b7 April 5, 1989 In previous studies we demonstrated that administration of buthionine sulfoximine (BSO) to athymic BALB/c mice bearing intracranial resulted in highly selective depletion of glutathione in neoplastic tissue with minimal effects on c ... melphalan Journal Article N Y State J Med \u00b7 April 1989 New York City, with six medical schools and an elaborate emergency medical system, would appear to be a locale with optimal resources for coronary care. To assess coronary care facilities and practices, a comprehensive questionnaire was prepared by a multi ... [Coronary care in New York City hospitals. ](/publication/669163) [Link to item](https://www.ncbi.nlm.nih.gov/pubmed/2733870) [Cite](/publication/669163#cite) Journal Article J Neurosurg \u00b7 April 1989 The level of O6-alkylguanine-deoxyribonucleic acid (DNA) alkyltransferase (AT) was determined in 15 human brain-tumor xenografts in athymic mice. This enzyme is a primary intracellular repair mechanism for lesions produced at the O6 position of guanine by ... [O6-alkylguanine-DNA Neurology \u00b7 January 1989 We report six patients with progressive primary tumors of the brain who had prolonged periods with stable contrast-enhancing CT lesions following initial responses to chemotherapy. Chemotherapy was discontinued after 21 to 36 months, despite the persistenc ... [Criteria for termination of phase II chemotherapy for patients with progressive or recurrent brain tumor. ](/publication/669131) [Full text](https://dx.doi.org/10.1212/wnl.39.1.62) [Link to Oncol \u00b7 1989 Brainstem tumors arise in portions of the rhombencephalon and mesencephalon. Some authorities include diencephalic tumors in this group. We have reviewed our clinical experience of 69 children (less than 21 years of age) with brainstem tumors evaluated and ... [Selection of a management strategy [Full text](https://dx.doi.org/10.1002/mpo.2950170209) [Link to item](https://www.ncbi.nlm.nih.gov/pubmed/2704333) [Cite](/publication/669295#cite) Journal pacemakers. ](/publication/669368) [Full Neurol \u00b7 January 1989 An extensive panel was used to characterize the phenotype ... [Phenotypic analysis of four The ganglioside patterns of medulloblastomas have never been established; in this study we report the ganglioside profile of the human medulloblastoma cell line TE-671 grown as a xenograft in nude mice. Gangliosides were isolated and structurally analyzed ... [Ganglioside of Neurosurgery \u00b7 1989 The level of O6-alkylguanine-deoxyribonucleic acid (DNA) alkyltransferase (AT) was determined in 15 human brain-tumor xenografts in athymic mice. This enzyme is a primary intracellular repair mechanism for lesions produced at the O6 position of guanine by ... [O6-Alkylguanine-DNA Journal Article Biochem \u00b7 November 15, 1988 D-54 MG, a human glioma-derived continuous cell line growing as subcutaneous or intracranial xenografts in athymic mice, was found to be sensitive to the effects of D,L-buthionine-(SR)-sulfoximine, a selective inhibitor of \u00b7 November 1988 [Validity of the type A a reprise. \u00b7 November 1988 Although the inotropic and dromotropic effects of cardiac glycosides in atrial fibrillation (AF) are well recognized, their action on AF itself is not clear. Accordingly, to determine whether cardiac glycosides prolong AF, the duration of electrically indu ... [Effects of acetyl strophanthidin on duration of dog. ](/publication/669183) [Full text](https://dx.doi.org/10.1007/BF00051197) [Link to immunoreactivity. ](/publication/669400) [Link to item](https://www.ncbi.nlm.nih.gov/pubmed/2846242) [Cite](/publication/669400#cite) Journal Article Cancer Res \u00b7 October 15, 1988 Monoclonal antibodies (MAbs) targeted to glioma-associated antigens may allow the selective delivery of imaging and therapeutic agents to brain tumors; the use of MAb fragments may be a strategy to further improve tumor uptake of such agents relative to no ... [Comparative localization of murine monoclonal antibody [Link to item](https://www.ncbi.nlm.nih.gov/pubmed/3167830) [Cite](/publication/675164#cite) Journal Article Cancer Res \u00b7 October 1, 1988 Melphalan transport, glutathione levels, and glutathione-S-transferase activity were measured in two continuous human medulloblastoma cell lines and transplantable xenografts in athymic nude mice, TE-671 and glutathione were 10.0 ... [Melphalan ](/publication/675158) [Link to item](https://www.ncbi.nlm.nih.gov/pubmed/3416297) [Cite](/publication/675158#cite) Journal Article American Journal of Neuroradiology \u00b7 September 1, 1988 [TUMOR VERSUS EDEMA - TL-201 AND SPECT IMAGING IN COMPARISON MR OF GLIOMAS ](/publication/871803) [Link to item](http://gateway.webofknowledge.com/gateway/Gateway.cgi?GWVersion=2&SrcApp=PARTNER_APP&SrcAuth=LinksAMR&KeyUT=WOS:A1988P880400089&DestLinkType=FullRecord&DestApp=ALL_WOS&UsrCustomerID=47d3190e77e5a3a53558812f597b0b92) [Cite](/publication/871803#cite) Pediatr Infect Dis J \u00b7 August 1988 [Combined medical and surgical management of severe pseudomembranous colitis. ](/publication/669161) [Link to item](https://www.ncbi.nlm.nih.gov/pubmed/3174303) [Cite](/publication/669161#cite) Journal Article Neurosurgery \u00b7 August 1988 An 8-year-old boy was treated with irradiation (66 Gy) for a brain stem glioma. Five months after the completion of radiotherapy, magnetic resonance imaging demonstrated apparent tumor progression despite the patient's neurological improvement. The child c ... [Transient late magnetic resonance imaging changes suggesting progression of brain stem glioma: implications for entry criteria for phase II trials. ](/publication/669250) [Full text](https://dx.doi.org/10.1227/00006123-198808000-00024) [Cite](/publication/669250#cite) Journal Article Cancer Res \u00b7 August 1, 1988 A series of bifunctional alkylators were tested against the genotypically and phenotypically heterogeneous continuous human medulloblastoma cell lines, TE-671, Daoy, and D283 Med in vitro and against TE-671 Daoy growing as s.c. and intracranial xenogra ... chemotherapy [Link to item](https://www.ncbi.nlm.nih.gov/pubmed/3390813) [Cite](/publication/693671#cite) Journal Article Cancer Res \u00b7 May 15, 1988 Lack of tumor specificity renders current modalities for treating malignant glioma ineffective. The administration of 131I-labeled antibody (Mab) reacts with [Cite](/publication/675097#cite) Journal Article Cancer Res \u00b7 May 15, 1988 The effect and therapeutic consequences of buthionine-(SR)-sulfoximine (BSO)-mediated depletion of glutathione in the human medulloblastoma-derived cell line, TE-671, growing as s.c. xenografts in athymic nude mice were examined. The melphalan [Link to Journal and Experimental Neurology \u00b7 May 1, 1988 [ANTIGENIC Journal of Neuropathology and Experimental Neurology \u00b7 May 1, 1988 [INTERMEDIATE FILAMENT EXPRESSION OF 3 CULTURED HUMAN NEUROEPITHELIAL TUMOR-CELL LINES (MEDULLOBLASTOMA, RETINOBLASTOMA [Link to item](http://gateway.webofknowledge.com/gateway/Gateway.cgi?GWVersion=2&SrcApp=PARTNER_APP&SrcAuth=LinksAMR&KeyUT=WOS:A1988N498700151&DestLinkType=FullRecord&DestApp=ALL_WOS&UsrCustomerID=47d3190e77e5a3a53558812f597b0b92) [Cite](/publication/865505#cite) Journal Article Cancer Res \u00b7 April 15, 1988 Xenografts from eight malignant human gliomas were established in athymic mice and were used to study amplification and expression of the epidermal growth factor receptor (EGFR) gene. Tissue identity between biopsy and xenografts was confirmed by karyotypi ... [Amplification and expression of the epidermal growth factor in human glioma xenografts. ](/publication/675147) [Link to item](https://www.ncbi.nlm.nih.gov/pubmed/3258189) [Cite](/publication/675147#cite) Journal Article Am J Pathol \u00b7 March 1988 D341 Med is a new continuous cell line and transplantable xenograft derived from a cerebellar medulloblastoma. This line grew in vitro in suspension culture with spontaneous macroscopic spheroid formation and demonstrated 20-fold amplification of c-myc. and item](https://www.ncbi.nlm.nih.gov/pubmed/3279793) [Cite](/publication/669477#cite) Journal Article Proceedings of the American Association for Cancer Research \u00b7 March 1, 1988 [SELECTIVE BUTHIONINE SULFOXIMINE (BSO)-MEDIATED item](http://gateway.webofknowledge.com/gateway/Gateway.cgi?GWVersion=2&SrcApp=PARTNER_APP&SrcAuth=LinksAMR&KeyUT=WOS:A1988N264701418&DestLinkType=FullRecord&DestApp=ALL_WOS&UsrCustomerID=47d3190e77e5a3a53558812f597b0b92) [Cite](/publication/865413#cite) Journal Article Proceedings of the American Association for Cancer Research \u00b7 March 1, 1988 [LOSS OF EPIDERMAL GROWTH-FACTOR RECEPTOR GENE AMPLIFICATION AS MALIGNANT ESTABLISH IN CULTURE ](/publication/865449) [Link to item](http://gateway.webofknowledge.com/gateway/Gateway.cgi?GWVersion=2&SrcApp=PARTNER_APP&SrcAuth=LinksAMR&KeyUT=WOS:A1988N264700309&DestLinkType=FullRecord&DestApp=ALL_WOS&UsrCustomerID=47d3190e77e5a3a53558812f597b0b92) [Cite](/publication/865449#cite) Journal J [Link to item](https://www.ncbi.nlm.nih.gov/pubmed/3339400) [Cite](/publication/669236#cite) Journal Article Cancer Res \u00b7 February 1, 1988 The development of Mabs, particularly those reactive with primary brain tumors but not with normal brain, provides a potential means of delivering therapeutic agents selectively to human malignant gliomas. Mab 81C6, an IgG2b [Link to item](https://www.ncbi.nlm.nih.gov/pubmed/2446747) [Cite](/publication/675133#cite) Journal Article Cancer Research \u00b7 January 1, 1988 The development of Mabs, particularly those reactive with primary brain tumors but not with normal brain, provides a potential means of delivering therapeutic agents selectively to human malignant gliomas. Mab 81C6 an IgG2b 1988 Malignant undifferentiated sarcoma (mesenchymoma) of the liver is a rare tumor of childhood, with fewer than 100 cases reported in the literature. The overall prognosis for patients with this malignancy is poor. In this report, two children with hepatic me ... [Childhood hepatic mesenchymoma: \u00b7 1988 The composition of the blood influences rheology and therefore might affect hemodynamics. During cardiac catheterization and angiography, blood is sampled and contrast media, fluid, and heparin are administered. To determine the effects of these perturbati ... [Hematologic changes occurring to item](https://www.ncbi.nlm.nih.gov/pubmed/3180213) [Cite](/publication/669407#cite) Journal Article Neurosurg \u00b7 1988 The localisation of the radioiodinated Fab fragment monoclonal antibody (Mab) 81C6, reactive with a glioma-associated extracellular matrix athymic mice bearing subcutaneous and intracranial \u00b7 January 1988 Seven human medulloblastomas (four primary cerebellar, three recurrent or metastatic) were karyotyped in direct preparation and/or short-term or early culture. One tumor had a 46,XX stem line. Four of the six remaining tumors contained one or more i(17q), ... item](https://www.ncbi.nlm.nih.gov/pubmed/3422050) [Cite](/publication/675195#cite) Journal Article Am J Med \u00b7 October 23, 1987 Sixteen pediatric patients diagnosed with a variety of autoimmune-mediated hematocytopenias were treated with one to 50 courses of intravenous gamma globulin (IVIG), pH 4.25, over the course of one to 30 months. Thirteen patients had immune thrombocytopeni ... [Efficacy of intravenous [Link to item](https://www.ncbi.nlm.nih.gov/pubmed/3118707) [Cite](/publication/669280#cite) Journal Article Am J Med \u00b7 October 23, 1987 Two pediatric patients with severe aplastic anemia, elevated antiplatelet antibody levels, refractoriness to human lymphocyte antigen-matched platelet transfusions, and sustained bleeding problems were treated immunoglobulin (IVIG), intravenous immunoglobulin. Two literature. ](/publication/669338) [Full text](https://dx.doi.org/10.1016/0002-9343(87)90548-1) [Link to item](https://www.ncbi.nlm.nih.gov/pubmed/3118706) [Cite](/publication/669338#cite) Journal Article Alcohol Clin Exp Res \u00b7 October 1987 The association of alcohol abuse, especially binge drinking, and atrial fibrillation, recently termed \"holiday heart,\" has been recognized for some time. The effects of alcohol on atrial fibrillation, however, have not been studied. Accordingly, measuremen ... [Effects of alcohol J Pers Soc Psychol \u00b7 October 1987 The nature of the relation between personality factors and coronary heart disease (CHD, the nation's greatest killer) is one of the most important if controversial issues in the field of psychology and health. Although there is still a great deal of concep ... [Personality, type A behavior, and coronary heart disease: the role of emotional expression. ](/publication/669157) [Full text](https://dx.doi.org/10.1037//0022-3514.53.4.783) [Link item](https://www.ncbi.nlm.nih.gov/pubmed/3681651) 1987 [Visual internal urethrotome for incision of dense perirenal scar tissue removal. ](/publication/669090) [Full text](https://dx.doi.org/10.1016/0090-4295(87)90254-8) [Link to item](https://www.ncbi.nlm.nih.gov/pubmed/3629773) [Cite](/publication/669090#cite) Journal Article Cancer Treat Rep \u00b7 September 1987 We treated D-54 MG, an extensively characterized human glioma tumor line, in athymic mice with each of 20 antineoplastic drugs and two radiation doses. PCNU, melphalan, cyclophosphamide, and fludarabine were highly active against sc tumors. A single radiat ... [Therapeutic profile of the glioma athymic mice. ](/publication/675051) [Link to item](https://www.ncbi.nlm.nih.gov/pubmed/3621219) [Cite](/publication/675051#cite) Journal Article Am J Med \u00b7 August 1987 High concentrations of digoxin-like immunoreactive substance (DLIS) have been identified in amniotic fluid and in blood during pregnancy. In this study, urine from healthy women was analyzed for DLIS during pregnancy and following delivery, and levels were ... [Urinary digoxin-like immunoreactive 1987 [The to May 1987 [Psychological predictors of heart disease: a quantitative review. ](/publication/669196) [Link to item](https://www.ncbi.nlm.nih.gov/pubmed/3602244) [Cite](/publication/669196#cite) Journal Article Cancer Res \u00b7 March 15, 1987 We used double-label quantitative autoradiography to study blood flow (with [131I]iodoantipyrine) and blood-to-tissue transport (with [14C]-alpha-aminoisobutyric acid) in 20 TE-671 xenotransplanted into nude rats. Microscopically, two dist ... [Simultaneous measurements of blood flow Article J Clin Oncol \u00b7 March 1987 We treated 103 patients with confirmed anaplastic 74 patients glioblastoma multiforme (GBM) and 29 patients with ... [Phase Article Proceedings of the American Association for Cancer Research \u00b7 March 1, 1987 [EXPERIMENTAL RADIOTHERAPY OF SUBCUTANEOUS (SC) AND item](http://gateway.webofknowledge.com/gateway/Gateway.cgi?GWVersion=2&SrcApp=PARTNER_APP&SrcAuth=LinksAMR&KeyUT=WOS:A1987G979901554&DestLinkType=FullRecord&DestApp=ALL_WOS&UsrCustomerID=47d3190e77e5a3a53558812f597b0b92) [Cite](/publication/865359#cite) Journal Article Proceedings of the American Association for Cancer Research \u00b7 March 1, 1987 [THERAPEUTIC SYNERGY OF THIOPURINES AND ALKYLATING DRUGS XENOGRAFT ](/publication/865369) [Link to item](http://gateway.webofknowledge.com/gateway/Gateway.cgi?GWVersion=2&SrcApp=PARTNER_APP&SrcAuth=LinksAMR&KeyUT=WOS:A1987G979901649&DestLinkType=FullRecord&DestApp=ALL_WOS&UsrCustomerID=47d3190e77e5a3a53558812f597b0b92) [Cite](/publication/865369#cite) Journal Article Proceedings of the American Association for Cancer Research \u00b7 March 1, 1987 [AMPLIFICATION AND EXPRESSION OF THE EPIDERMAL GROWTH-FACTOR to item](http://gateway.webofknowledge.com/gateway/Gateway.cgi?GWVersion=2&SrcApp=PARTNER_APP&SrcAuth=LinksAMR&KeyUT=WOS:A1987G979900092&DestLinkType=FullRecord&DestApp=ALL_WOS&UsrCustomerID=47d3190e77e5a3a53558812f597b0b92) [Cite](/publication/865372#cite) Journal Article Proceedings of the American Association for Cancer Research \u00b7 March 1, 1987 [MELPHALAN CYTOTOXICITY AND RESISTANCE IN MEDULLOBLASTOMA (MBT) [Cite](/publication/865404#cite) Journal Article Am J Pathol \u00b7 February 1987 The majority of cells in a rapidly dividing human medulloblastoma cell line (D283 MED) are shown to express the two high-molecular-weight human neurofilament (NF) subunits, whereas a three polypep ... [A rapidly dividing three neurofilament [Link to item](https://www.ncbi.nlm.nih.gov/pubmed/3103453) [Cite](/publication/675048#cite) Journal Article J Neurooncol \u00b7 1987 Conventional therapy for brain tumors, consisting of neurosurgical intervention and radiotherapy, has not resulted in the successes achievable in other childhood malignancies. The role of adjuvant chemotherapy, well defined in many childhood cancers, has n ... [The chemotherapy of posterior [Cite](/publication/669085#cite) Journal Article Health Psychol \u00b7 1987 Excessive exposure to the sun has been related to the development of various types of skin cancer, but use of sunscreen decreases the risk. The present project was designed to empirically examine psychosocial factors in sunbathing and sunscreen use. One hu Pediatr Neurosci \u00b7 1987 A significant cohort of children with central nervous system tumors will fail initial therapeutic intervention and demonstrate recurrent disease. Treatment of children with these recurrent tumors requires a comprehensive multidisciplinary approach, with co ... [Recurrent brain \u00b7 1987 Lymphohistiocytic erythrophagocytosis (LE) is a usually fatal disease characterized by fever, organomegaly, hyperlipidemia, central nervous system involvement, and cellular immunodeficiency. Treatment with corticosteroids, cytotoxic chemotherapy, and Article Can J Cardiol \u00b7 1987 To determine the acute effects of atrial fibrillation on regional blood flow, measurements were made in awake dogs with this arrhythmia induced and sustained by rapid atrial stimulation. Atrial fibrillation reduced cardiac output (from 3.7 +/- 0.3 to 3.0 + ... [The effects of atrial fibrillation on regional blood flow in the awake dog. ](/publication/669348) [Link to item](https://www.ncbi.nlm.nih.gov/pubmed/3607591) [Cite](/publication/669348#cite) Journal Article Pediatr Hematol Oncol \u00b7 1987 Broviac and Hickman catheters facilitate the care of children with cancer but provide a source of potential infection. We describe a child with a Broviac catheter who developed left-sided bacterial endocarditis shunting was A 17-month-old boy in whom immune-mediated thrombocytopenia (ITP) was the presenting manifestation of infection with human immunodeficiency virus (HIV) is being successfully managed with intermittent high-dose intravenous gamma globulin (IVIG) allowing item](https://www.ncbi.nlm.nih.gov/pubmed/2449828) [Cite](/publication/720350#cite) Journal Article Am J Med \u00b7 December 1986 [Randomized clinical trials and common sense. ](/publication/669083) [Full text](https://dx.doi.org/10.1016/0002-9343(86)90403-1) [Link to item](https://www.ncbi.nlm.nih.gov/pubmed/3799632) [Cite](/publication/669083#cite) Journal Article Am J Ophthalmol \u00b7 November 15, 1986 Current therapy for patients with trilateral retinoblastoma, consisting primarily of surgical intervention and radiotherapy, has resulted in no long-term survivors. The use of adjuvant chemotherapy has not improved this outcome. After observing a tumor res ... [Treatment of trilateral retinoblastoma [Link to item](https://www.ncbi.nlm.nih.gov/pubmed/3777087) [Cite](/publication/669474#cite) Article Cancer Res \u00b7 June 1986 Seven classical alkylators were tested for activity against the continuous human medulloblastoma cell line TE-671 grown in vitro and as s.c. and intracranial xenografts in athymic mice. Drugs tested item](https://www.ncbi.nlm.nih.gov/pubmed/3698009) [Cite](/publication/675121#cite) Journal Febs May 26, 1986 The major mono- and disialogangliosides of the extensively characterized established human glioma line D54MG were isolated and purified from subcutaneous solid xenografts grown in athymic (nu/nu) mice. Structural determination showed that they belonged to ... [Characterization of new gangliosides of the lactotetraose series in Article Cancer Genet Cytogenet \u00b7 April 1, 1986 A 4 year old girl with sickle cell disease developed acute lymphocytic leukemia null cell type. The bone marrow karyotype was 46,XX,del(9)(p13). This girl is among the few patients with acute lymphocytic leukemia and abnormalities of #9 to have an isolated ... [9p- in a girl with acute lymphocytic leukemia and cell disease. ](/publication/669188) [Full text](https://dx.doi.org/10.1016/0165-4608(86)90007-5) [Link to item](https://www.ncbi.nlm.nih.gov/pubmed/3456265) [Cite](/publication/669188#cite) Journal Article Neurosurgery \u00b7 March 1986 We conducted a Phase II study of combination therapy with vincristine and cyclophosphamide in the treatment of patients with recurrent or metastatic medulloblastoma. Fourteen patients were treated with text](https://dx.doi.org/10.1227/00006123-198603000-00014) [Link to item](https://www.ncbi.nlm.nih.gov/pubmed/3703192) [Cite](/publication/669383#cite) Journal Article Proceedings of the American Association for Cancer Research \u00b7 March 1, 1986 [CHEMOTHERAPY OF HUMAN MEDULLOBLASTOMA WITH CLASSICAL ALKYLATORS ](/publication/865314) [Link to item](http://gateway.webofknowledge.com/gateway/Gateway.cgi?GWVersion=2&SrcApp=PARTNER_APP&SrcAuth=LinksAMR&KeyUT=WOS:A1986C539701509&DestLinkType=FullRecord&DestApp=ALL_WOS&UsrCustomerID=47d3190e77e5a3a53558812f597b0b92) [Cite](/publication/865314#cite) Journal Article Proceedings of the American Association for Cancer Research \u00b7 March 1, 1986 [KARYOTYPIC FINDINGS IN 6 CASES OF HUMAN MEDULLOBLASTOMA ](/publication/865407) [Link to item](http://gateway.webofknowledge.com/gateway/Gateway.cgi?GWVersion=2&SrcApp=PARTNER_APP&SrcAuth=LinksAMR&KeyUT=WOS:A1986C539700138&DestLinkType=FullRecord&DestApp=ALL_WOS&UsrCustomerID=47d3190e77e5a3a53558812f597b0b92) [Cite](/publication/865407#cite) Journal Article Proceedings of the American Association for Cancer Research \u00b7 March 1, 1986 [LOCALIZATION OF ANTI-HUMAN J Pers Soc Psychol \u00b7 February 1986 This research examined the effects of personality/social skills and individual differences in expressive style on impression formation. Particular attention was given to the role of nonverbal behaviors in the formation of initial impressions. Sixty-two sub ... [Impression formation: the to item](https://www.ncbi.nlm.nih.gov/pubmed/3517289) [Cite](/publication/669143#cite) Journal Article Am J Cardiol \u00b7 February 1, 1986 The pathogenesis of alcohol cardiomyopathy is obscure. Because systemic hypertension is observed in one-third of alcoholics, the relation of this finding to left ventricular (LV) function was analyzed in 66 alcoholics (26 with a blood pressure of 160/95 mm ... [Cardiac function item](https://www.ncbi.nlm.nih.gov/pubmed/3946213) Toxicol \u00b7 February 1986 Acrylonitrile (ACN) has been tested for carcinogenicity by various routes in a number of rat strains. At relatively high levels of administration (e.g. 500 ppm in the drinking-water) there were statistically significant increases in microscopically detecta ... [Primary brain tumours in Fischer 344 drinking-water. 1986 Mycoplasma pneumoniae, which usually causes mild infections in normal children, has been shown to cause isolated cases of severe pneumonia in children with sickle cell disease. We recently observed an outbreak of Mycoplasma pneumonia in three sisters with ... [Severe Mycoplasma pneumonia in three sisters with ](/publication/669261) [Full text](https://dx.doi.org/10.3109/08880018609031225) [Link Pediatr Hematol Oncol \u00b7 1986 To determine the value of the direct platelet associated IgG (PAIgG) level as a prognostic indicator idiopathic thrombocytopenia purpura (ITP), 18 children with ITP were studied. Ten of the 18 had PAIgG levels measured at diagnosis, before any ... [Prognostic implications \u00b7 1986 The four permanent human glioma-derived cell lines reported here are the first such lines for which the karyotypes have been followed from the original biopsies through the establishment of the lines in culture. Although ploidy changes were seen, each line ... [Specific chromosomal abnormalities characterize four established cell lines derived human gliomas. ](/publication/674962) [Full text](https://dx.doi.org/10.1007/BF00687952) [Link to item](https://www.ncbi.nlm.nih.gov/pubmed/2881426) [Cite](/publication/674962#cite) Journal Article Cancer Res \u00b7 January 1986 The continuous human medulloblastoma cell line TE-671 was grown as s.c. and intracranial xenografts in athymic nude mice. Tumor-bearing animals were treated with chemotherapeutic agents at the 10% lethal dose; s.c. xenografts were to Journal Article of Journal of Neuro Oncology \u00b7 January 1, 1986 [COOPERATIVE STUDIES OF GLIOMAS AND MEDULLOBLASTOMAS ](/publication/865417) [Link to item](http://gateway.webofknowledge.com/gateway/Gateway.cgi?GWVersion=2&SrcApp=PARTNER_APP&SrcAuth=LinksAMR&KeyUT=WOS:A1986D375900080&DestLinkType=FullRecord&DestApp=ALL_WOS&UsrCustomerID=47d3190e77e5a3a53558812f597b0b92) [Cite](/publication/865417#cite) Journal Article Cancer Treat Rep \u00b7 December 1985 Diaziquone (AZQ) is a benzoquinone derivative exhibiting significant effects against CNS tumors. This study investigates the pharmacokinetics of AZQ for three different durations of continuous iv infusions, over 20 mins, 4 hrs, and 6 hrs, in nine patients ... [Pharmacokinetics of diaziquone after three different Journal Article Neurol Clin \u00b7 November 1985 Medulloblastoma is the most common primary tumor of the CNS in childhood. Surgical intervention alone will not cure this tumor, and the addition of whole neuraxis irradiation has led to a 50 to 60 per cent, 5-year survival. The role of adjuvant chemotherap ... [Rational approaches the chemotherapy of [Cite](/publication/669100#cite) Journal Article J Neuropathol Exp Neurol \u00b7 November 1985 A new continuous cell line and transplantable xenograft, D283 Med, was derived from the peritoneal implant and ascitic fluid of a child with metastatic medulloblastoma and grew in vitro in suspension culture with spontaneous macroscopic spheroid formation. ... [Establishment and characterization of the human Exp Biol Med \u00b7 October 1985 The changes produced by atrial fibrillation on myocardial blood flow and energetics are unclear. Accordingly, the effects of atrial fibrillation on myocardial blood flow and oxygen consumption were studied in 18 anesthetized dogs. With atrial fibrillation ... [The effects of atrial [Link to item](https://www.ncbi.nlm.nih.gov/pubmed/4034526) [Cite](/publication/669116#cite) Journal Article Cancer \u00b7 October 1, 1985 Traditional criteria and definitions for response and relapse are not completely suitable for children with brain tumors. Response and relapse for brain tumors need to be defined using the most objective criteria available, that is, the computed tomography ... [Criteria and definitions for response and brain tumors. ](/publication/669356) [Full text](https://dx.doi.org/10.1002/1097-0142(19851001)56:7+<1824::aid-cncr2820561321>3.0.co;2-h) [Link to item](https://www.ncbi.nlm.nih.gov/pubmed/3896461) \u00b7 October 1985 Glutamate analogues have been used in many different experimental approaches in neurobiology. A small number of these analogues have been classified as gliotoxic. We have examined the effect of seven glutamate analogues gliotoxic and two neurotoxic) ... text](https://dx.doi.org/10.1111/j.1471-4159.1985.tb05540.x) [Link to item](https://www.ncbi.nlm.nih.gov/pubmed/2863331) [Cite](/publication/675008#cite) Journal Article Cancer Res \u00b7 September 1985 The human glioma-derived cell line D-54 MG and the human medulloblastoma-derived cell line TE-671 have been shown to be sensitive in culture to the pharmacological interference with glutamine metabolism by acivicin, 6-diazo-5-oxo-L-norleucine, and methioni ... [Combination chemotherapy and medulloblastoma. ](/publication/675057) [Link to item](https://www.ncbi.nlm.nih.gov/pubmed/4028000) [Cite](/publication/675057#cite) Journal Article Cancer Res \u00b7 September 1985 Cellular supply of glutamine, an essential substrate for growth, is derived from extracellular fluid and de novo synthesis. We investigated the relative importance of these sources to the growth of six human anaplastic glioma- and one human medulloblastoma ... [Influence of glutamine on the growth of medulloblastoma in culture. ](/publication/675182) [Link to item](https://www.ncbi.nlm.nih.gov/pubmed/2862994) [Cite](/publication/675182#cite) Journal Article Am J Dis Child \u00b7 July 1985 Clinical, hematologic, and immunologic findings were reviewed in 21 patients with glycogenosis Ib. Fifteen of the patients suffered from moderate to severe bacterial infections. Ten patients had excessive epistaxis or bleeding from surgical sites, and eigh ... [Infectious and bleeding Pers Soc Psychol \u00b7 May 1985 Understanding the precise nature of the links among styles of behavior, emotional expression, and the development of heart disease is a major challenge in psychology and health. In the present research, 60 men at high risk for coronary heart disease were e ... [Type A behavior, nonverbal expressive [Link to [Cite](/publication/669135#cite) Journal Article Neuropathology and Experimental Neurology \u00b7 May 1985 [ESTABLISHMENT AND PRELIMINARY CHARACTERIZATION OF THE HUMAN MEDULLOBLASTOMA CELL TRANSPLANTABLE XENOGRAFT Exp Res \u00b7 1985 Two hundred and fifty-six consecutive alcoholics admitted for detoxification, but not having delirium tremens, were evaluated for hypertension. Thirty-three per cent (84) of the alcoholics had a blood pressure greater than or equal to 160/95 mm Hg on or wi ... [Hypertension associated with alcohol withdrawal: assessment ](/publication/669467) [Full text](https://dx.doi.org/10.1111/j.1530-0277.1985.tb05533.x) [Link to item](https://www.ncbi.nlm.nih.gov/pubmed/3890591) [Cite](/publication/669467#cite) Journal Article Proceedings of the American Association for Cancer Research \u00b7 January 1, 1985 [Sensitivity of human medulloblastoma (MED) to classical alkylators ](/publication/750854) [Cite](/publication/750854#cite) Journal Article Proceedings of the American Association for Cancer Research \u00b7 January 1, 1985 [Glutamine based combination chemotherapy in culture for human glioma and medulloblastoma ](/publication/760927) [Cite](/publication/760927#cite) Journal Article Cancer Research \u00b7 January 1, 1985 [INVITRO VERSUS INVIVO CORRELATIONS OF CHEMOSENSITIVITY ](/publication/865368) [Link to item](http://gateway.webofknowledge.com/gateway/Gateway.cgi?GWVersion=2&SrcApp=PARTNER_APP&SrcAuth=LinksAMR&KeyUT=WOS:A1985AUX8200092&DestLinkType=FullRecord&DestApp=ALL_WOS&UsrCustomerID=47d3190e77e5a3a53558812f597b0b92) [Cite](/publication/865368#cite) Journal Article Proceedings of the American Association for Cancer Research \u00b7 January 1, 1985 [SENSITIVITY OF HUMAN MEDULLOBLASTOMA (MED) TO CLASSICAL ALKYLATORS ](/publication/865421) [Link to item](http://gateway.webofknowledge.com/gateway/Gateway.cgi?GWVersion=2&SrcApp=PARTNER_APP&SrcAuth=LinksAMR&KeyUT=WOS:A1985AGD9401299&DestLinkType=FullRecord&DestApp=ALL_WOS&UsrCustomerID=47d3190e77e5a3a53558812f597b0b92) [Cite](/publication/865421#cite) Journal Article Proceedings of the American Association for Cancer Research \u00b7 January 1, 1985 [GLUTAMINE BASED COMBINATION CHEMOTHERAPY IN CULTURE FOR HUMAN GLIOMA AND MEDULLOBLASTOMA ](/publication/865463) [Link to item](http://gateway.webofknowledge.com/gateway/Gateway.cgi?GWVersion=2&SrcApp=PARTNER_APP&SrcAuth=LinksAMR&KeyUT=WOS:A1985AGD9401271&DestLinkType=FullRecord&DestApp=ALL_WOS&UsrCustomerID=47d3190e77e5a3a53558812f597b0b92) 1984 [Management solid tumors in children. ](/publication/669202) [Link to item](https://www.ncbi.nlm.nih.gov/pubmed/6096080) [Cite](/publication/669202#cite) Journal Article Cancer Res \u00b7 November 1984 An in vitro clonogenic assay was used to test the chemosensitivity of the human medulloblastoma cell line TE-671. Dose-response relationships for reduction in colony were generated for cyclophosphamide, vincristine, Adriamycin, J Am Coll Cardiol \u00b7 October 1984 Atrial fibrillation has a variable effect on myocardial blood flow in the intact heart. To assess its action on myocardial blood flow in the ischemic heart, measurements were made in nine dogs after ligation of the left anterior descending coronary artery ... [Effects of atrial fibrillation on myocardial blood flow in ischemic heart the dog. [Full text](https://dx.doi.org/10.1016/s0735-1097(84)80399-x) [Link to item](https://www.ncbi.nlm.nih.gov/pubmed/6481012) [Cite](/publication/669471#cite) Journal Article Jama \u00b7 September 14, 1984 Indications for permanent pacing in the bradyarrhythmias are summarized. In the absence of symptoms, pacing is justified only when Mobitz type II block or complete atrioventricular (AV) block is localized in the bundle-branch system. All other abnormalitie ... [Indications for pacing in the treatment of bradyarrhythmias. Report of an independent study group. ](/publication/669369) [Link to item](https://www.ncbi.nlm.nih.gov/pubmed/6471249) [Cite](/publication/669369#cite) Journal Article J Pediatr \u00b7 September 1984 [Frequency bone marrow ](/publication/669139) [Full to item](https://www.ncbi.nlm.nih.gov/pubmed/6590828) to item](https://www.ncbi.nlm.nih.gov/pubmed/6746134) [Cite](/publication/669165#cite) Journal Article Am J Vet Res \u00b7 June 1984 Peripheral lymphocytes from macaques inoculated with Toxocara canis (VLM) were standard mitogens. single ... for diagnosis larva migrans: clinical experimental findings in macaques and human beings. ](/publication/669439) [Link to item](https://www.ncbi.nlm.nih.gov/pubmed/6742587) [Cite](/publication/669439#cite) Journal Article Cancer Res \u00b7 June 1984 We used diaziquone (NSC 182986) alone and in combination with other antineoplastic drugs to treat six human glioma and one human medulloblastoma tumor lines growing s.c. in athymic mice. Pharmacokinetic studies of diaziquone in the plasma of athymic mice i ... [Treatment of human glioma and medulloblastoma tumor lines in mice with diaziquone-based combinations. ](/publication/675274) [Link to item](https://www.ncbi.nlm.nih.gov/pubmed/6722774) [Cite](/publication/675274#cite) Journal Article Neurology \u00b7 May 1984 We have evaluated the efficacy of intravenous 2,5-diaziridinyl-3,6-biscarboethoxyamino-1,4-benzoquinone (diaziquone or AZQ, NSC-182986) in the treatment of recurrent primary anaplastic brain tumors. Three of 16 evaluable patients (18.8%) showed clinical an ... [Treatment of patients with recurrent primary brain ](/publication/669194) [Full text](https://dx.doi.org/10.1212/wnl.34.5.615) [Link to Neuropathology and Experimental Neurology \u00b7 May 1984 [130 INFLUENCE OF GLUTAMINE ON GROWTH OF HUMAN MEDULLOBLASTOMA [Cite](/publication/865457#cite) (Phila) \u00b7 1984 A 28-month-old white male, 7 months status postenucleation for retinoblastoma, presented with lethargy, irritability, anemia, and thrombocytopenia. Bone marrow examination revealed almost total replacement of marrow elements with clumps of small round baso ... [Retinoblastoma metastatic to bone Cardiovasc Pharmacol \u00b7 1984 Ethanol produces a generalized decline in brain flow in awake dogs. The reduction in flow is most marked and persistent in the cerebellum. In the anesthetized animal with brain blood flow already depressed, this effect is obscured. The possible relationshi ... [The effects of ethanol on brain blood flow awake dogs. ](/publication/669398) [Full text](https://dx.doi.org/10.1097/00005344-198403000-00021) [Link to item](https://www.ncbi.nlm.nih.gov/pubmed/6200726) [Cite](/publication/669398#cite) Journal Neuro Oncology \u00b7 January 1, 1984 [THE USE OF HUMAN MEDULLOBLASTOMA MODELS TO DESIGN RATIONAL THERAPY ](/publication/865395) [Link to item](http://gateway.webofknowledge.com/gateway/Gateway.cgi?GWVersion=2&SrcApp=PARTNER_APP&SrcAuth=LinksAMR&KeyUT=WOS:A1984TK98200105&DestLinkType=FullRecord&DestApp=ALL_WOS&UsrCustomerID=47d3190e77e5a3a53558812f597b0b92) [Cite](/publication/865395#cite) Journal Article Proceedings of the American Association for Cancer Research \u00b7 January 1, 1984 [INVITRO AND INVIVO CHEMOSENSITIVITY OF HUMAN MEDULLOBLASTOMA Journal of Neuro Oncology \u00b7 January 1, 1984 [GLUTAMINE REQUIREMENTS OF HUMAN AND MEDULLOBLASTOMA IN CULTURE ](/publication/865478) to item](http://gateway.webofknowledge.com/gateway/Gateway.cgi?GWVersion=2&SrcApp=PARTNER_APP&SrcAuth=LinksAMR&KeyUT=WOS:A1984TK98200018&DestLinkType=FullRecord&DestApp=ALL_WOS&UsrCustomerID=47d3190e77e5a3a53558812f597b0b92) [Cite](/publication/865478#cite) Journal Article Journal of \u00b7 January 1, 1984 [CLINICAL-TRIALS OF DIAZIQUONE \u00b7 December 1983 The pathophysiology of alcohol-induced acute pancreatitis is not clear. Ischemic injury has been suggested as a possible mechanism. To examine the effects of ethanol on pancreatic and splanchnic blood flow, measurements were made in fasted, conditioned awa ... [The effects of ethanol on pancreatic blood flow in awake and anesthetized dogs. ](/publication/669142) [Link to item](https://www.ncbi.nlm.nih.gov/pubmed/6420795) [Cite](/publication/669142#cite) Journal Article Clin Nephrol \u00b7 October 1983 To determine the contribution of the dialyzate to the hemodynamic changes that occur during hemodialysis, echocardiographic measurements obtained during identical conditions of hemodialysis except for the use of different dialyzates were compared. With an ... [Hemodynamic changes of J Neuropathol Exp Neurol \u00b7 September 1983 A model was developed for the in vitro and in vivo study of the continuous cell line, TE-671, derived from a human medulloblastoma. TE-671 grew in vitro as sheets of uniform triangular- to spindle-shaped cells with round to oval nuclei and sparse cytoplasm ... [A model for human medulloblastoma. Growth, morphology, and vitro [Full text](https://dx.doi.org/10.1097/00005072-198309000-00001) [Link to item](https://www.ncbi.nlm.nih.gov/pubmed/6886736) [Cite](/publication/675138#cite) 15, 1983 The anaerobic diphtheroid Propionibacterium acnes was identified as the organism responsible for \"shunt\" nephritis in two adolescents with ventriculoatrial shunts inserted previously for the management of medulloblastoma. cases of \"shunt\" nephri to item](https://www.ncbi.nlm.nih.gov/pubmed/6861076) [Cite](/publication/669190#cite) Journal Article Cancer Res \u00b7 July 1983 The human medulloblastoma cell line TE-671 was grown s.c. and intracranially in athymic nude mice. Tumor-bearing animals treated with chemotherapeutic agents or radiation were compared to untreated tumor-bearing controls. Tumors growing s.c. were sensitive ... [Chemotherapy and radiation therapy of human medulloblastoma in athymic mice. ](/publication/675174) [Link to item](https://www.ncbi.nlm.nih.gov/pubmed/6850617) [Cite](/publication/675174#cite) Journal Article Jama \u00b7 December 10, 1982 [Munchausen's syndrome and cardiac catheterization. A case of a pernicious interaction. ](/publication/669401) [Link to item](https://www.ncbi.nlm.nih.gov/pubmed/7143674) [Cite](/publication/669401#cite) Journal Article [Full text](https://dx.doi.org/10.1378/chest.82.2.202-b) [Link to item](https://www.ncbi.nlm.nih.gov/pubmed/7094655) J \u00b7 July 1982 Serum digoxin and/quinidine concentration were measured before and following the institution of quinidine therapy in 11 patients who were receiving maintenance oral digoxin therapy and who required quinidine therapy for suppression of extrasystoles. Steady ... [Use steady-state [Cite](/publication/669262#cite) Journal Med \u00b7 June [Case to item](https://www.ncbi.nlm.nih.gov/pubmed/7038079) [Cite](/publication/669457#cite) Journal Article Proceedings of the American Association for Cancer Research \u00b7 January 1, 1982 [Treatment of human brain tumors in athymic mice with aziridinylbenzoquinone (AZQ) ](/publication/750856) [Cite](/publication/750856#cite) Journal Article Pediatric Research \u00b7 January 1982 [Growth, morphology, and chemotherapeutic response of medulloblastoma (MBT) ](/publication/760930) [Cite](/publication/760930#cite) Journal Article Annals Neurology \u00b7 January 1, 1982 [Growth, morphology, and chemotherapeutic response of medulloblastoma in athymic mice ](/publication/760933) [Cite](/publication/760933#cite) Journal Article Proceedings of the American Association for Cancer Research \u00b7 January 1, 1982 [TREATMENT OF HUMAN-BRAIN TUMORS IN [Link to item](http://gateway.webofknowledge.com/gateway/Gateway.cgi?GWVersion=2&SrcApp=PARTNER_APP&SrcAuth=LinksAMR&KeyUT=WOS:A1982NT42100694&DestLinkType=FullRecord&DestApp=ALL_WOS&UsrCustomerID=47d3190e77e5a3a53558812f597b0b92) [Cite](/publication/865443#cite) Journal Article leukaemia. Journal Article Jama \u00b7 August 14, 1981 Because of a sharp increase in the number of permanent pacemakers inserted at The Brooklyn Hospital between 1972 and 1976, a peer-review committee was established to monitor subsequent pacemaker implantation. Total initial implants declined from 48 to 22 p ... [Impact of peer review in reduction of permanent pacemaker ](/publication/669075) [Link to item](https://www.ncbi.nlm.nih.gov/pubmed/7253139) [Cite](/publication/669075#cite) Journal Article Clin Nephrol \u00b7 August 1981 [Clinical study of the cardiac findings in patients on chronic maintenance hemodialysis: the relationship to coronary risk factors. ](/publication/669405) [Link to item](https://www.ncbi.nlm.nih.gov/pubmed/7261485) [Cite](/publication/669405#cite) Journal Article Am J Cardiol \u00b7 January 1981 [Acute effects of ethanol on myocardial blood flow in the text](https://dx.doi.org/10.1016/0002-9149(81)90290-3) [Link to item](https://www.ncbi.nlm.nih.gov/pubmed/7457409) Journal Article Clinical \u00b7 January 1, 1981 [Insulin infusion in ketolactic acidosis complicating malignancy ](/publication/772114) [Cite](/publication/772114#cite) Journal Article Jama \u00b7 August 15, 1980 To determine whether a single dose of quinidine sulfate might alter serum digoxin levels, patients receiving maintenance digoxin therapy who required quinidine had their serum digoxin levels measured after oral administration digoxin, quinidine, or both ... [Alteration of ](/publication/669119) [Link to item](https://www.ncbi.nlm.nih.gov/pubmed/6156244) [Cite](/publication/669119#cite) Journal Article Med Care \u00b7 April 1980 The relationship between physicians' nonverbal communication skills (their ability to communicate and to understand facial expression, body movement and voice tone cues to emotion) and their patients' satisfaction with medical care was examined in 2 studie ... [Predicting patient [Link to item](https://www.ncbi.nlm.nih.gov/pubmed/7401698) [Cite](/publication/669339#cite) Journal Article Chest \u00b7 December 1979 Two patients with chronic renal failure developed transient sinus node dysfunction requiring insertion of a temporary pacemaker while receiving procainamide to control ventricular arrhythmias. Blood levels of procainamide were found to be elevated, althoug ... [Procainamide-induced sinus node dysfunction in patients with failure. ](/publication/669371) [Full text](https://dx.doi.org/10.1378/chest.76.6.699) [Link to item](https://www.ncbi.nlm.nih.gov/pubmed/92391) [Cite](/publication/669371#cite) Journal Article Cardiovasc Res \u00b7 August 1979 To determine whether the acute cardiac depressant effects of ethanol could be attributed to its metabolite (acetaldehyde), either ethanol or acetaldehyde was intravenously infused into closed-chest dogs. At venous blood ethan ... [Demonstration of dissimilar acute Forum \u00b7 [Hemodynamic changes during dialysis. ](/publication/669110) [Link to item](https://www.ncbi.nlm.nih.gov/pubmed/552057) [Cite](/publication/669110#cite) Journal Article Angiology \u00b7 A patient with mitral stenosis and atrial flutter was found to have a normal diastolic closure rate (E to F slope). Following cardioversion, the typical echocardiographic features of mitral stenosis were found. After various interventions that increased he ... [Changing diastolic closure rates (E to F slopes) in a patient with mitral stenosis: a case report. ](/publication/669195) [Full text](https://dx.doi.org/10.1177/000331977903000109) [Link catheterization artery disease. ](/publication/669088) [Full text](https://dx.doi.org/10.1177/000331977802901202) [Link to item](https://www.ncbi.nlm.nih.gov/pubmed/742727) [Cite](/publication/669088#cite) Journal Article Br Heart J \u00b7 August 1978 To determine the frequency of atrioventricular conduction disturbances in aortic valve disease, 26 consecutive patients (age 54 +/- 2 years) with symptomatic aortic valve disease were studied by His bundle electrocardiography at the time of cardiac cathete ... \u00b7 December 1977 [Increased to item](https://www.ncbi.nlm.nih.gov/pubmed/413113) [Cite](/publication/669434#cite) Journal Article Eur J Cardiol \u00b7 July 1977 A case of persistent repetitive supraventricular tachycardia known to be present for at least 9 yr is reported. Although the patient appeared to tolerate the arrhythmia without any ill effects he was found to have moderate left ventricular dysfunction due ... [Persistent repetitive supraventricular tachycardia. Article J Thorac Cardiovasc Surg \u00b7 February 1977 Studies from our laboratory have demonstrated the presence of a vagally mediated reflex in acute cardiac tamponade. To determine the effect of thisreflex on cardiac performance, we continuously recorded hemodynamic parameters during induction of tamponade ... [Demonstration [Link to item](https://www.ncbi.nlm.nih.gov/pubmed/834066) [Cite](/publication/669267#cite) Journal closed-chest, alpha-chloralose-anesthetized, volume-expanded, alpha- and dogs with by atrial pacing had 30-90 ml of saline at 37 degrees C infused into the pericardial sac a) with vagus intact, b) after vag ... [Effect of autonomic blockade [Full text](https://dx.doi.org/10.1152/ajpheart.1977.232.1.H5) [Link to item](https://www.ncbi.nlm.nih.gov/pubmed/13662) [Cite](/publication/669096#cite) Journal Lab Rev \u00b7 January 1977 [Effective time management: a key to increased sales. ](/publication/669210) [Link to item](https://www.ncbi.nlm.nih.gov/pubmed/288611) [Cite](/publication/669210#cite) Journal Article Am J Cardiol \u00b7 August 1976 Diagnostic considerations [Full item](https://www.ncbi.nlm.nih.gov/pubmed/952271) [Cite](/publication/669153#cite) Journal Article Eur J Cardiol \u00b7 June 1976 A man with a 30-year history of pulmonary sarcoidosis, confirmed by lymph node biopsy and a positive Kveim reaction, developed an incomplete bilateral bundle branch block pattern. Cardiac catherization and angiography revealed normal pressures, hemodynamic ... [Sarcoidosis with incomplete bilateral bundle branch block pattern disappearing following steroid therapy: an electrophysiological study. ](/publication/669291) [Link to item](https://www.ncbi.nlm.nih.gov/pubmed/1278204) [Cite](/publication/669291#cite) Journal Article J Pers Soc Psychol \u00b7 June 1976 Psychological theories predicated on the assumption of human selfishness and theories based on principles of equity may lead to conflicting predictions about when a person will like his partner. Of special interest are a person's reactions to receiving unc ... [Effects of self-esteem and expected duration of interaction on liking for a highly rewarding partner. ](/publication/669351) [Full text](https://dx.doi.org/10.1037//0022-3514.33.6.686) [Link to item](https://www.ncbi.nlm.nih.gov/pubmed/1271231) [Cite](/publication/669351#cite) Journal Article J Electrocardiol \u00b7 1975 His bundle electrograms of 40 patients developing Wenckebach block during atrial pacing and four with spontaneous Wenckebach block above the His were reviewed to determine the frequency of classical Wenckebach periodicity. Thirty patients had \u00b7 August 1974 [Appearance of atrial rhythm with absent P wave in fibrillation. \u00b7 1974 [Aorto-coronary bypass graft surgery in a patient on home hemodialysis. ](/publication/669379) [Link to item](https://www.ncbi.nlm.nih.gov/pubmed/4547690) [Cite](/publication/669379#cite) Journal Article Br Heart J \u00b7 December 1973 [Bundle of His electrograms in congenital corrected transposition of the great arteries. A study of two adult cases. ](/publication/669148) [Full text](https://dx.doi.org/10.1136/hrt.35.12.1307) [Link to item](https://www.ncbi.nlm.nih.gov/pubmed/4759929) [Cite](/publication/669148#cite) Clin Pathol \u00b7 June 1973 [Changes in lipid values and lipoprotein patterns of serum samples with bacteria. February 1971 [Simultaneous and completely automated iron \u00b7 September 1970 [Plasma cortisol changes following mile run in conditioned subjects. Acta; International Journal of Clinical Chemistry, Not Available \u00b7 January 1962 [Observations on the determination of serum protein-bound iodine. ](/publication/669488) [Cite](/publication/669488#cite) Journal Article Clinica Chimica Acta; International Journal of Clinical Chemistry, Not Available \u00b7 January 1962 [A rapid screening test for abnormal hemoglobins. The detection of hemoglobin-A2. ](/publication/669534) [Cite](/publication/669534#cite) Journal Article Clinica Chimica Acta; International Journal of Clinical Chemistry, Not Available \u00b7 November 1961 [A standardized procedure for serum protein electrophoresis on cellulose acetate membrane strips. ](/publication/669486) [Cite](/publication/669486#cite) Journal Article Eye, Ear, Nose & Throat Monthly, Not Available \u00b7 September 1960 [Otoplasty for lop ear correction. ](/publication/669525) [Cite](/publication/669525#cite) Journal Article Technical Bulletin of the Registry of Medical Technologists, Not Available \u00b7 February 1960 [Simplification of certain aspects in the performance and interpretation of complement-fixation tests. ](/publication/669508) [Cite](/publication/669508#cite) Journal Article Clinical Chemistry, Not Available \u00b7 December 1959 [Spectrophotometric studies of the Zimmermann reaction. ](/publication/669516) [Cite](/publication/669516#cite) Journal Article A.M.A. Archives of Otolaryngology, Not Available \u00b7 October 1959 [Oroplasty. A new simplified technique. ](/publication/669521) [Cite](/publication/669521#cite) Journal Article The Journal of the American Osteopathic Association, Not Available \u00b7 June 1958 [Intramuscular iron therapy. ](/publication/669495) [Cite](/publication/669495#cite) Journal Article United States Armed Forces Medical Journal, Not Available \u00b7 June 1957 [Torsion of the appendix testis. ](/publication/669492) [Cite](/publication/669492#cite) Journal Article Clinical Chemistry, Not Available June 1956 [Azorubin in aqueous and methanolic solutions; Article Archives of Otolaryngology, Not Available \u00b7 May 1956 [Twenty-five years of otolaryngology in a university hospital. ](/publication/669503) [Cite](/publication/669503#cite) Journal Article Clinical Chemistry, Not Available \u00b7 April 1955 [Clinical significance of the magnesium: calcium ratio; technic for the determination of magnesium and calcium in biologic fluids. ](/publication/669518) [Cite](/publication/669518#cite) Journal Article The Journal of Laboratory and Clinical Medicine, Not Available \u00b7 August 1954 [The use of glycogen as a substrate for the determination of serum amylase. ](/publication/669527) [Cite](/publication/669527#cite) Journal Article American Journal of Ophthalmology, Not Available \u00b7 August 1951 [Boeck's sarcoid; a review and a report of a case demonstrating multiple iris nodules, acute secondary glaucoma, and keratopathy. ](/publication/669506) [Cite](/publication/669506#cite) study of convection-enhanced delivery 01 ... [Taking sides: importance of tumor laterality in understanding cognitive testing in primary brain tumor patients. ](/publication/1459066) [Cite](/publication/1459066#cite) Conference Supportive Care in Cancer ep226 ... [Cognitive performance at diagnosis and beyond disease progression in newly diagnosed glioblastoma patients. ](/publication/1459074) [Full text](https://dx.doi.org/10.1007/s00520-018-4193-2) [Cite](/publication/1459074#cite) convection-enhanced delivery for recurrent malignant glioma. [Cite](/publication/1459075#cite) Conference Supportive Care in Cancer PS060 ... [Perceived cognitive dysfunction at diagnosis and beyond disease progression in newly diagnosed glioblastoma patients. ](/publication/1459085) [Cite](/publication/1459085#cite) Conference Supportive Care in II tril of aprepitant ondansetron alone in prevention of Measurements in Patients with Low-grade Glioma: Comparison of Automated Software Packages. ](/publication/1460333) [Cite](/publication/1460333#cite) Conference [Psychosocial Distress and its Effects on the Health-Related Quality of Life of Primary Brain Tumor Patients. ](/publication/1460334) [Cite](/publication/1460334#cite) Conference Neuro Oncology ATCT-13 bevacizumab and temozolomide with continuation of bevacizumab progression: quality of the primary brain tumor combination adult patients with recurrent malignant item](https://meetinglibrary.asco.org/record/109976/abstract) [Cite](/publication/1460564#cite) Conference [Complementary and Alternative Medicine in the Primary Brain Tumor Population and its Association with Health-Related Quality of Life. ](/publication/1460566) [Cite](/publication/1460566#cite) Conference Neurology 007 ... [Complementary and alternative medicine in the primary brain tumor population and its association with health reported Quality of Life. "}